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 RÉSUMÉ 
Mécanismes sous-tendant la formation des NETs et les réponses des neutrophiles aux cristaux 
d’urate 
 
Par 
Olga Tatsiy 
Programme d’immunologie 
 
Thèse présentée à la Faculté de médecine et des sciences de la santé en vue de l’obtention 
du diplôme de philosophiae doctor (Ph.D.) en Immunology Faculté de médecine et des 
sciences de la santé, Université de Sherbrooke, Sherbrooke, Québec, Canada, J1H 5N4 
 
 Les neutrophiles représentent un élément essentiel du système immunitaire inné. Ils sont les premiers 
leucocytes à migrer au site d’inflammation. Une fois au site inflammatoire, les neutrophiles effectuent une 
multitude de réponses fonctionnelles : la phagocytose, la dégranulation, la flambée oxydative ainsi que la 
production de médiateurs lipidiques et de cytokines. En plus de ces réponses, les neutrophiles produisent 
aussi des trappes extracellulaires (NETs). La production de NETs a initialement été décrite comme une 
réponse antimicrobienne, mais des évidences récentes ont montré son implication dans le développement de 
plusieurs maladies (goutte, arthrite inflammatoire, psoriasis, etc.) et dans certains cancers.  
 Malgré l’importance des NETs, les voies de signalisation contrôlant leur formation en réponse à des 
stimuli physiologiques ne sont que partiellement élucidées. De plus, les méthodes de quantification 
couramment utilisées pour étudier la formation des NETS comportent plusieurs désavantages. C’est 
pourquoi les travaux présentés dans cette thèse utilisent de nouveaux polymères fluorescents se liant 
uniquement à la chromatine extrudée, qui permettent une quantification spécifique et standardisée des NETs. 
Cette méthode a permis d’établir l’efficacité relative de plusieurs stimuli physiologiques induisant les NETs. 
Il a également été démontré, chez les neutrophiles activés avec du GM-CSF, du fMLP, ou du TNF, que 
l’inhibition des voies de signalisation de Syk et de PI3K bloque la NETose en interférant avec les étapes 
tardives de la formation des NETs. Par ailleurs, l’inhibition des voies de TAK1, de la MAPK p38, ou de 
MEK empêche aussi la formation des NETs, mais en affectant cette fois des étapes précoces de la NETose. 
En revanche, l’inhibition de PKC, des kinases de la famille Src ou de JNK n’a pas d’effet sur la formation 
de NETs; idem pour l’inhibition de la synthèse protéique ou de la transcription. Quant aux mécanismes 
impliqués dans la formation de NETs, nous avons vérifié le rôle de la NADPH oxidase dans la NETose 
induite par des stimuli physiologiques. En utilisant notre nouvelle technique de quantification, nous avons 
confirmé que la formation de NETs induite par le PMA est abolie par l’inhibition de la NADPH oxydase. 
Par contre, la formation de NETs en réponse à des agonistes physiologiques (fMLP, GM-CSF, TNF) est 
indépendante de la production de réactifs oxygénés (ROS). De plus nous démontrons pour la première fois 
que l’inhibition sélective de PAD4 diminue drastiquement la NETose chez les neutrophiles humains et ce, 
pour tous les stimuli testés. 
 Une autre section de la thèse porte sur l’interaction entre les cristaux d’urate monosodique (MSU) et 
les neutrophiles. Le dépôt de MSU dans les articulations déclenche la goutte, une maladie inflammatoire 
chronique répandue qui est communément associée à une importante infiltration des articulations 
enflammées par les neutrophiles. Le MSU induit chez les neutrophiles la production de cytokines et de 
chimiokines, la formation de ROS, ainsi que la relâche de peptides antimicrobiens et d’enzymes 
protéolytiques. Les neutrophiles activés par le MSU produisent également des NETs. Bien que plusieurs 
études aient porté sur les mécanismes contrôlant les effets des cristaux de MSU sur les neutrophiles, notre 
compréhension des voies de signalisation impliquées demeure fragmentaire. Dans la cadre de la thèse, les 
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changements génomiques et protéomiques causés par le MSU chez les neutrophiles ont été étudiés. De plus, 
les rôles de multiples voies de signalisation induites par le MSU chez les neutrophiles ont été examinés. 
Nous montrons pour la première fois que les neutrophiles peuvent sécréter la chimiokine CCL4 en réponse 
au MSU. Nous démontrons de surcroît que les cristaux de MSU activent tardivement les facteurs de 
transcription NF-κB, CREB, et C/EBP et que au moins NF-κB est impliqué dans la production de cytokines. 
Enfin, nous avons établi que le MSU active les MAPK chez les neutrophiles, que leur activation est tributaire 
de TAK1 et/ou de Syk, et que ces voies de signalisation participent à la production de cytokines et à la 
NETose.  
 Les résultats présentés dans cette thèse avancent substantiellement les connaissances actuelles sur les 
voies de signalisation et les mécanismes moléculaires contrôlant la synthèse et la relâche des cytokines ainsi 
que la formation de NETs en réponse à des stimuli physiologiques (MSU, GM-CSF, fMLP, TNF) chez le 
neutrophile humain. Etant donné le rôle crucial joué par les neutrophiles et leurs réponses fonctionnelles 
dans plusieurs pathologies, ces découvertes pourraient mener à l’identification de cibles moléculaires 
nouvelles dans une perspective thérapeutique.  
 
Mots clés : Neutrophiles, Trappes extracellulaires, Signalisation, MSU, goutte 
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Summary 
 
 New insights into the mechanisms of neutrophil extracellular traps (NET) formation and 
monosodium urate crystal (MSU)-induced neutrophil responses 
 
By 
Olga Tatsiy 
 Immunology Program 
 
Thesis presented at the Faculty of medicine and health sciences for the obtention of degree 
of philosophiae doctor (Ph.D.) in Immunology, Faculty of Medicine and Health Sciences, 
Université de Sherbrooke, Sherbrooke, Québec, Canada, J1H 5N4 
 
 Neutrophils are an essential component of the innate immune system. They are the first and most 
abundant leukocytes to migrate to the site of inflammation. Upon arrival, neutrophils perform various 
functional responses: phagocytosis, respiratory burst, production of lipid mediators and cytokines, 
neutrophil extracellular trap (NET) formation, etc.  
 Despite the importance of NETs, signaling pathways that control NET formation are only partialy 
understood. Likewise, current quantification methods that are used to study mechanisms of NET formation 
suffer from significant drawbacks. As part of this thesis, we used new fluorescent polymers that only bind 
extruded chromatin, allowing a specific and standardized quantification of NETosis that could not be easily 
performed before. This approach allowed us to rank the relative potency of various physiologic NET 
inducers reliably, and to show that inhibition of the Syk or PI3K pathways blocks NETosis by acting upon 
late events in NET formation. By comparison, inhibition of the TAK1, p38 MAPK, or MEK pathways also 
disrupted NETosis, but by acting on early events. In contrast, inhibiting PKC, Src family kinases, or JNK 
failed to prevent NET formation; inhibitors of translation and transcription (cycloheximide and actinomycin 
D respectively) were likewise ineffective. The role of the NADPH oxidase in NET formation was also 
revisited. We confirmed that pharmacological PKC activator (PMA) induced NET formation that depends 
on the oxidase, contrarily NETosis occurring in response to physiological agonists is ROS-independent. 
Finally, we demonstrated for the first time that selective inhibition of protein arginine deiminase 4 (PAD4) 
potently prevents NETosis in human neutrophils by all stimuli tested.  
 The second part of my thesis is devoted to revisiting how monosodium urate (MSU) crystals interact 
with neutrophils. Deposition of insoluble MSU in joints is known to trigger gout, a prevalent chronic 
inflammatory disease that is commonly associated with massive neutrophil infiltration. Several studies have 
focused on the mechanisms underlying the numerous actions of MSU crystals towards neutrophils. 
However, our knowledge of the signaling pathways involved remains fragmentary. During the work on this 
thesis, genomic and proteomic changes triggered by MSU in neutrophils were examined. Additionally, the 
role of various signaling pathways in MSU-induced neutrophil functional responses was studied. This 
allowed us to show for the first time that neutrophils can secrete CCL4 in response to MSU. Accordingly, it 
was demonstrated that MSU crystals belatedly activate transcription factors NF-κB, CREB, and C/EBP, and 
at least the former is involved in cytokine generation. Additionally, we showed that MSU activates MAPKs 
in neutrophils, that they are under the control of TAK1 and/or Syk, and that they participate in cytokine 
generation and NET formation.  
 Data obtained during the work on this thesis substantially extends current knowledge of neutrophil 
signaling pathways controlling the cytokine generation and NET formation. Taking in to account the 
involvement of neutrophil functional responses in various pathologies (and especially gouty arthritis), our 
findings identify potential molecular targets that could be exploited for therapeutic intervention. 
 
Keywords: neutrophils, extracellular traps, signaling, MSU, gout
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INTRODUCTION 
 
1. Innate immunity and neutrophils 
 
Innate immunity is a complex aspect of host defense comprised of many cell types and a 
myriad signaling molecules, working together against injury or infection. It is an old 
evolutionary construction that has proved remarkably effective against most types of micro-
organisms. Innate immunity tackles most common viruses, bacteria, fungi, and protozoa, as 
well as host cells undergoing damage or malignant transformation, all the while tolerating 
healthy host cells and normal flora (Hopcraft and Damania, 2017; Machado et al., 2004). 
Components of innate immunity are the first to intervene upon pathogen invasion, thereby 
preventing infection and restoring homeostasis. When incapable of eliminating the cause of 
infection, innate immune cells attempt to restrain pathogen spreading, while triggering the 
adaptive immunity machinery. Adaptive immunity is by comparison antigen-specific and has 
memory. It is therefore more efficient than the robust innate immunity, but takes much longer 
to be mobilized. As mammals are continuously faced with a varied microbial challenge, proper 
functioning of innate immunity is critical for maintaining health. Inappropriate functioning of 
innate immunity leads to a broad spectrum of disorders, ranging from mild, tolerable chronic 
conditions to life-threatening diseases (Kumar and Sharma, 2010; Machado et al., 2004; 
Mantovani et al., 2011).  
 
Although quite sophisticated, the innate immune response boils down to crosstalk and 
interactions between its main components: anatomical barriers, phagocytic leukocytes, the 
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complement system, and mediators such as cytokines (Alberts et al., 2002). That said, 
polymorphonuclear leukocytes, or neutrophils, are often considered the main effectors of 
innate immunity, as they are the most numerous population of leukocytes patrolling the 
bloodstream and usually the first to infiltrate the tissues (Kolaczkowska and Kubes, 2013).  
Neutrophils are exquisitely adapted to encounter pathogens primarily due to high mobility 
and deformability. This is in part facilitated by a flexible multi-lobe shaped nucleus that 
ensures the cell’s challenges of moving through cell junctions or the extracellular matrix 
(Carvalho et al., 2015). Originating from the bone marrow, neutrophils are released in the 
bloodstream, from where they migrate to the site of injury. Neutrophils are approximately 12-
14 µm in diameter, produced each day in huge quantities (1011) in response to growth factors 
such as granulocyte colony-stimulating factor (G-CSF) (Dancey et al., 1976; Hong, 2017). 
The extensive production of these cells is offset by their short lifespan that ranges from 8 to 
12 hours (Summers et al., 2010). In the absence of infection and inflammation, neutrophils 
die by spontaneous apoptosis (Geering and Simon, 2011). The mechanisms that regulates 
production and neutrophil quantities remain largely unknown (Vietinghoff and Ley, 2008).  
 
Neutrophils deploy three main strategies to combat infection. First response that involves 
clearing extracellular pathogens by neutrophils is phagocytosis, a process of ingestion of 
microorganisms and fusing them with cytotoxic vacuoles (Lee et al., 2003a). Second, if the 
pathogens are too big or there are too many of them, neutrophils start to produce large amounts 
of lytic enzymes and reactive oxygen species (ROS) into extracellular space (degranulation) 
(Chen and Junger, 2012; Lacy, 2006). Third step, forming neutrophil extracellular traps 
(NETs). NETs constrain pathogens and allow for the targeted release of granule contents 
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(Brinkmann et al., 2004a). Following microbial degradation, neutrophils usually undergo 
apoptosis and elimination by macrophages (Haslett et al., 1995; Silva, 2011).  
 
Due to their high cytotoxic potential, neutrophils must be strictly controlled by multiple 
mechanisms to prevent harm to the tissue (Kruger et al., 2015). Circulating neutrophils exist 
in an incompletely activated state, and are only activated in the vicinity of the infection 
(Condliffe et al., 1998). Stimuli include many host and pathogen-derived molecules, including 
cytokines, chemokines, growth factors and leukotrienes (Vogt et al., 2018). Neutrophils 
express an extensive repertoire of surface receptors recognizing the latter, whose binding 
triggers functional responses (Futosi et al., 2013).  
 
Neutrophil activation enhances the production of cytotoxic agents and mobilization of 
secretory vesicles, as well as adherence and chemotactic potential. This activation process is 
reversible, enabling the neutrophil to return to a semi-activated state and migrate back to 
vasculature in case of false alarm (Condliffe et al., 1998; Kitchen et al., 1996). The complete 
molecular mechanisms behind neutrophil migration and activation are still mostly unknown, 
but evidence suggests that these are multistep processes and that several pathways are 
involved. What seems apparent is that neutrophils are highly phenotypically plastic. 
According to specific microenvironment demands, they can modulate their surface molecules 
and take on specialized tissue-specific roles (Amulic et al., 2012; Kumar and Sharma, 2010; 
Mantovani et al., 2011; Nathan, 2006; Sadik et al., 2011).  
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2. Neutrophils in inflammation 
 
Being major players of innate immunity, neutrophils actively participate in the 
inflammatory response that involves a highly conserved cascade of events, and mobilizes an 
assortment of leukocytes and signaling molecules (Rosales, 2018). Various factors can trigger 
the inflammation cascade, most notably infection, injury or exposure to foreign particles. 
Inflammatory process is commonly seen as a defense mechanism (protection against 
pathogens), however it can also harm the host, causing collateral tissue damages, and septick 
shock (Medzhitov, 2008).  
 
Acute inflammatory reaction starts with vascular response which is characterized by 
alteration of the microvasculature near the damaged site, under the action of inflammatory 
mediators (Pober and Sessa, 2015). Acute inflammatory mediators: histamine (mast cells and 
basophils) and serotonin (platelets) induce changes in vascular flow followed by 
vasodilatation and oedema (Rankin, 2004). Vasodilation (widening of the blood vessel), is 
mediated by nitric oxide (NO) and prostaglandins (PGI2, PGD2, PGE2 and PGF2α) produced 
by epithelial cells located on the intima of blood vessels. Oedema (fluid entry into the tissue) 
is a result of actions of histamine, bradykinin, leukotrienes, complement components, 
substance P and platelet-activating factor (PAF). Together, these factors, mediate delivery of 
soluble mediators and inflammatory cells to the site of injury (Friedl et al., 1989; Granger and 
Senchenkova, 2010; Sandoo et al., 2010; Sherwood and Toliver-Kinsky, 2004). Additionally, 
many different residential and recruited cell types at the inflammatory site can produce 
chemotactic cytokines (LTB4, CXCL8, CCL5, CXCL3, CXCL5, CXCL6 etc.) which induces 
the leukocyte influx (Krishnaswamy et al., 1999; Sokol and Luster, 2015).  
  15 
 
Neutrophils are the first and the most abundant leukocytes to swiftly migrate from 
circulation to the infected area (de Oliveira et al., 2016). Chemoattractants (CXCL2, CXCL8, 
MCP1, LTB4) released by macrophages residing in the tissues, epithelial cells and possibly 
other cell types, depending from the origin of affected tissue, alert circulating neutrophils 
causing a rapid influx to the site of infection (Beck-Schimmer et al., 2005; Filippo et al., 
2008). The cellular events accompanying the migration process to the inflamed tissue operate 
in a cascade and can be divided into several steps: margination, rolling, adhesion, diapedesis 
(transendothelial migration) and chemotaxis. Margination is a neutrophil movement from 
central blood stream towards periphery of the vessel mediated by fluid stasis at the site of 
inflammation. Margination promotes weak adhesive interaction between neutrophils and 
vascular endothelium (Sherwood and Toliver-Kinsky, 2004). Then neutrophils start to roll 
along the endothelial surface of postcapillary venules in search for an appropriate place to 
extravasate to the interstitium in the vicinity of the damaged tissue (Kim and Luster, 2015a). 
The motion of neutrophils along the chemokine gradient in this state is often described as 
“rolling” mediated by the interaction between selectins (expressed on endothelial cells) and 
their corresponding ligands (on leukocytes) (Alon et al., 1996; Rosen, 1993). During rolling, 
neutrophils continue to collect inflammatory cues. Signals from inflammatory chemokines 
transmitted to neutrophils induce G-protein coupled receptor- (GPCRs)-mediated integrins 
activation (Herter and Zarbock, 2013). Integrins like, Mac-1, ICAM-1 and VCAM-1 become 
activated, augmenting neutrophil affinity towards endothelial cells. These interactions, induce 
cytoskeletal rearrangement and polarization of the neutrophils, which lead to reduction of 
neutrophils rolling velocity and eventually arrest on endothelium (Voisin and Nourshargh, 
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2013; Williams et al., 2011). The changeover from migratory state to adhesion is highly 
dependent on the time the neutrophil spent in contact with activated endothelium. The 
stabilization of this connection activates signaling cascades that initiate transendothelial 
migration (TEM). Neutrophils can transmigrate between endothelial cell junctions 
(paracellular TEM) or through the body of the endothelial cells (transcellular TEM). Likewise, 
studies have demonstrated that the majority of TEM events happen via paracellular route (~70-
90%) (Nourshargh and Alon, 2014). The complete mechanism of TEM remains elusive, 
however several endothelial transmembrane proteins (PECAM-1, ICAM-1, VE-cadherin, 
JAM and CD99) have been shown to play a role (Alcaide et al., 2009; Ley et al., 2007; 
Williams et al., 2011; Zen and Parkos, 2005). After TEM, following strong chemotactic 
gradient, neutrophils arrive at the inflammation focus, where their full activation coordinates 
a robust response (Liew and Kubes, 2019). 
 
Under normal conditions, neutrophils are short-lived cells, a property fit for avoiding 
unneeded inflammation. However, in an inflammatory state, neutrophils encounter a mixture 
of pro-inflammatory mediators (such as granulocyte–macrophage colony-stimulating factor 
(GM-CSF), granulocyte colony – stimulating factor (G-CSF), TNF-α, bacterial components, 
C-reactive protein, serum amyloid A) that activates them and prolong their lifespan (delayed 
apoptosis) (El Kebir and Filep, 2010; Greenlee-Wacker, 2016; Takano et al., 2009). In the 
form of positive feedback, activated neutrophils attract even more neutrophils and other 
immune cell types to the proximity. This process is modulated by variety of pro-inflammatory 
cytokines and chemokines secreted by neutrophils (Selders et al., 2017; Tamassia et al., 2018). 
Neutrophil functional responses (phagocytosis; radical oxygen generation; degranulation; 
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cytokine, chemokine, lipid mediators production; and NETs) induced at the site of 
inflammation will be discussed in more detail further. 
 
Beyond their prominent role in the acute phase of inflammation, neutrophils also play 
important role in the resolution phase (El Kebir and Filep, 2010b). The induction of apoptosis 
in spent neutrophils and their subsequent phagocytosis by macrophages (efferocytosis) is 
central to the inflammation resolution. Aging neutrophils downregulate a number of 
membrane proteins including CD16 (FcγRIII), CD31 (PECAM-1), CD32, CD35 
(Complement receptor 1), CD43, CD45, CD44, CD47 (IAP), CD50 (ICAM-3), CD55 
(Complement regulatory protein DAF), CD62L (L-selectin), CD63, CD66b, CD87 (uPAR), 
CD88 (C5a receptor), and CD120a (tumor necrosis factor receptor 1), thus significantly 
changing the apoptotic neutrophil surface (Greenlee-Wacker, 2016a). Additionally, dying 
neutrophils secrete mediators (annexin A1, lactoferrin, lipoxins, resolvins) that inhibit further 
neutrophil recruitment and promote neutrophil apoptosis and clearance by macrophages 
(Greenlee-Wacker, 2016b). Upon efferocytosis of apoptotic neutrophils, macrophages 
downregulate production of proinflammatory cytokines and lipid mediators (IL-8, GM-CSF, 
LTB4, IL-1 β, TNF) and switch to an anti-inflammatory program. Anti-inflammatory 
macrophages start to produce TGF-β and prostaglandin E2 (PGE2). This represents a turning 
point that triggers a deep change in the macrophage secretion profile and promotes resolution 
(Fadok et al., 1998; Ortega-Gómez et al., 2013; Serhan et al., 2008; Sugimoto et al., 2016). 
 
Although inflammation has been heavily researched at the cellular and molecular levels, 
our understanding of the process continues to evolve. It is important to underline that each 
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tissue has a specific signature of the inflammation process, as a result of a unique 
microenvironment interacting locally with a highly plastic and adaptable immune system. This 
can also be clinically relevant, as specific manifestations of the disease may require 
appropriate medical treatments. 
 
3. Neutrophil functional responses 
3.1. Phagocytosis 
 
Phagocytosis is a process by which neutrophils and other immune system cells internalize 
solid particles larger than 0.5 µm into intracellular vacuoles called phagosomes. Although the 
process was discovered more than 100 years ago, our understanding of the complex molecular 
mechanisms underlying phagocytosis is incomplete (Rosales and Uribe-Querol, 2017).  
 
Neutrophils can engulf both opsonized and non-opsonized particles, involving different 
receptors and pathways (Hiemstra and Daha, 1998). Nonopsonized receptors, also known as 
pathogen recognition receptors (PRRs), can directly recognize molecular groups on the 
surface of phagocytic target. Thus, there are several families of PRRs expressed by 
neutrophils: Toll-like receptors (TLR1,2,4,5,6,8,9); C-type lectins (Dectin-1, Mincle, MDL-1 
Mcl, CLEC-2); Nod-like receptors (NOD2, NLRP3); and RIG-like receptors (RIG-1, MDA5) 
(Kumar et al., 2011). However, ingestion of pathogenic particles by neutrophils is more 
effective if recognized by opsonins that adhere to foreign particles, promoting their 
recognition and subsequent phagocytosis (Verhoef, 1998). Neutrophil phagocytosis of the 
opsonized particles is mainly mediated by two classes of receptors. Receptors that recognize 
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the Fc portion of immunoglobulin G (IgG) and those that recognize fragments of the 
complement. Neutrophils express different complement receptors: integrin family [CR3 
(CD11b/CD18) and CR4 (CD11c/CD18)]; GPCR (C5aR); mannose-dinding lectin and 
surfactant protein A (C1qR); SCR family receptor (CR1) (DeFranco et al., 2007; Sengeløv, 
1995). Although they involved in neutrophil phagocytosis their signaling pathways remain 
uncertain (Futosi et al., 2013; Petty and Todd, 1993; Vik and Fearon, 1985, O’shea et al., 
2008). In contrast, Fc receptors that bind Ig-opsonized pathogens, are the best characterized 
phagocytic receptors. Neutrophils express various Fc receptors [FcγRIIIb (low affinity IgG 
receptor, exclusive for neutrophils), FcγRIIa (low affinity IgG receptor), FcγRI (IgG 
receptor), FcαRI (IgA receptor), FcεRI (IgE receptor), FcεRII (IgE receptor)]. Fcγ receptor 
family is the most significant for triggering phagocytosis (Fanger et al., 1998) (Futosi et al., 
2013; Kumar et al., 2011; Lee et al., 2003; Nordenfelt and Tapper, 2011). 
 
Recognition of foreign particles by membrane-bound receptors activates downstream 
signaling, resulting in polymerization of actin fibers, membrane rearrangement and 
phagosome formation (Futosi et al., 2013b; García-García and Rosales, 2013). At this point, 
the phagosome is still immature as it has not yet acquired antimicrobial properties. Following 
internalization, the receptor is recycled back to the membrane, while the entrapped particle 
resides in the early phagosome. The phagosome then fuses with neutrophil granules, forming 
a phagolysosome, rich with bactericidal molecules and lytic enzymes (Nordenfelt and Tapper, 
2011b). Neutrophil granules can be classified based on their contents to primary containing 
myeloperoxidase (MPO) and CD63; secondary carrying lactoferrin and CD66b; tertiary that 
lost CD66b but acquiring gelatinases; and finally, secretory particles encompassing albumin,  
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Table 1. Content of Human Neutrophil Granules and Secretory Vesicles. (adapted from 
(Borregaard and Cowland, 1997, authorization requested order #4661401049529) 
 
 Azurophil Granules   Membrane:  CD63; CD68; V-type H+-ATPase 
 Matrix:  Acid β-glycerophosphatase;  
 Acid mucopolysaccharide; α1-Antitrypsin;  
 α-Mannosidase;  
 Azurocidin/CAP37/heparin binding protein; 
 Bactericidal permeability increasing protein; 
 β-Glycerophosphatase; β-Glucuronidase;  
 Cathepsins; Defensins; Elastase; Lysozyme; 
Myeloperoxidase; 
 N-Acetyl-β-glycosaminidase; Proteinase-3; 
Sialidase; Ubiquitin-protein 
 Specific Granules  Membrane:  CD11b; CD15 antigens; CD66; CD67; 
 Cytochrome b558; fMLP-R;  
 Fibronectin-R; G-proteinα-subunit;  
 Laminin-R; NB 1 antigen; 19-kD protein;  
 155-kD protein; Rap1, Rap2; SCAMP; 
 Thrombospondin-R; TNF-R; 
 Urokinase-type plasminogen activator-R;  
 VAMP-2; Vitronectin-R 
 Matrix:  Β2-Microglobulin; Collagenase; Gelatinase; 
 hCAP-18; Histaminase; Heparanase; 
Lactoferrin301; Lysozyme; NGAL;  
 Urokinase-type plasminogen activator;  
 Sialidase; SGP28;  
 Vitamin B12-binding protein; 
 Gelatinase Granules  Membrane:  CD11b; Cytochrome b558;  
 Diacylglycerol-deacylating enzyme; fMLP-R;  
 SCAMP; VAMP-2; V-type H+-ATPase; 
 Urokinase-type plasminogen activator-R 
 Matrix:  Acetyltransferase; β2-Microglobulin; 
Gelatinase; Lysozyme 
 Secretory Granules  Membrane:  Alkaline phosphate; CR1; 
 Cytochrome b558; CD11b; CD14; CD16 * 
 fMLP-R; SCAMP; V-type H+-ATPase; 
 Urokinase-type plasminogen activator-R;  
 VAMP-2; CD10 CD13 CD45 *;  
 C1q-receptor *; DAF * 
 Matrix:  Plasma proteins (including tetranectin)  
• This localization is based on kinetics of upregulation in response to stimulation with 
inflammatory mediators, but has not yet been demonstrated by subcellular localization 
by immunocytochemistry. 
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alkaline phosphatase, and CD35. The full list of various granules content is summarized in the 
Table 1. (Borregaard and Cowland, 1997). In addition, formation of neutrophils 
phagolysosome initiates activation of NADPH oxidase on the phagolysosome membrane, that 
induces an oxidative burst inside of the phagolysosome. This creates a highly toxic 
microenvironment for the destruction of microorganisms (Freeman and Grinstein, 2014; Lee 
et al., 2003; Nordenfelt and Tapper, 2011; Scott et al., 2003). Detailed mechanism of NADPH 
oxidase activation and ROS production is described in the next section. 
 
3.2. Oxidative burst and degranulation 
 
During phagocytosis, neutrophils significantly increase their oxygen consumption, 
ultimately resulting in the production of ROS, catalyzed by the nicotinamide adenine 
dinucleotide phosphate oxidase (NADPH) complex (Figure 1). In resting neutrophils catalytic 
core of the NADPH complex (gp91phox and gp22phox) resides at the membranes of phagosome, 
secretory vesicles, specific granules and the plasma membrane. Regulatory subunits (p67phox, 
p40phox, p47phox) reside in the cytosol. During neutrophil activation the cytosolic complex 
translocates to the membrane and interacts with the catalytic core which results in NADPH 
oxidase activation. Additionally, GTPase protein, Rac2 binding to catalytic core of NADPH 
is required for ROS production (Babior et al., 2002; Nguyen et al., 2017).  
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Figure 1. Structure and activation of Nox2 NADPH oxidase.  
Activation involves translocation of the cytosolic subunits p47phox, p67phox, p40phox and Rac to 
the membrane where they bind to cytochrome b558, composed of p22phox and gp91phox (Nox2) 
subunits (adapted from Dworakowski et al., 2006, distributed under the Creative Commons 
Attribution License) 
 
Fully active NADPH oxidase mediates production of ROS: superoxide anions (O2− ) or 
hydrogen peroxide (H2O2). The ROS may be further reduced by a number of different cellular 
protection systems, including superoxide dismutase (catalyzes the reduction of O2− to H2O2), 
catalase (catalyzes the reduction of H2O2 to H2O), and glutathione peroxidase (catalyzes the 
oxidation of glutathione by H2O2). Likewise, O2− can react with nitric oxide (NO) to process 
very reactive peroxynitrite molecule. This reaction is catalyzed by cellular NO synthase. 
Hydrogen peroxide can also be metabolized to hypochlorous acid (HOC1) by 
myeloperoxidase, localized in azurophil granules (Babior et al., 2002; Nguyen et al., 2017; 
PACHER et al., 2007; Ray et al., 2012).  
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The process of NADPH assembly that occurs on the cellular membrane inducing ROS 
production towards extracellular space is called an oxidative burst (also referred as respiratory 
burst). The oxidative burst is one of the main functional responses that enable neutrophils to 
protect the host. Apart from their cytotoxic potential, ROS also have a regulatory role, 
functioning as a molecular switch in cellular redox pathways (Ray et al., 2012). Mutations in 
genes coding for NADPH oxidase subunits cause severe life threatening chronic 
granulomatous disease (CGD), underpinning the importance of this enzyme. This implies that 
the activation of NADPH oxidase has to be strictly regulated as not to cause ROS production 
in homeostatic state (Chen and Junger, 2012; Groemping and Rittinger, 2005; Nguyen et al., 
2017; Roos, 2016). 
 
Neutrophils not only produce ROS into extracellular space, they can also release lytic 
enzymes, antimicrobial peptides and inflammatory mediators that are contained in the 
intracytoplasmic granules (Table 1). This process is called degranulation represents another 
defense mechanism of pro-inflammatory neutrophils. Degranulation can be induced by 
various mediators (CXCL8, fMLP, C5a, LTB4) and controlled by distinct signaling pathways 
that include the Src family of tyrosine kinases, β-arrestins, the tyrosine phosphatase MEG2, 
the kinase MARCK, Rabs and SNAREs, and the Rho GTPase, Rac2. Likewise, it was shown 
that an increase in intracellular Ca2+ and hydrolysis of guanosine triphosphate (GTP) as well 
as of adenosine triphosphate (ATP) is needed for the translocation and release of granular 
content. However, the mechanism that control neutrophil degranulation is not well understood 
(Lacy, 2006; Lacy and Eitzen, 2008; Sheshachalam et al., 2014).  
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In summary, both degranulation and respiratory burst play an important role in host defence 
against invading microorganism. However, dysregulation of these functional responses can 
be implicated in pathologies (sever asphyxic episodes of asthma, rheumatoid arthritis, septic 
shock, CGD, etc.)(Brieger et al., 2012; Lacy, 2006; Sheshachalam et al., 2014). 
 
  3.3. Inflammatory mediators  
 
Besides the traditional functional responses discussed in the above paragraphs, neutrophils 
also can secrete a variety of mediators that allow them to communicate with surrounding 
microenvironment. Neutrophils are often the first to arrive at the site of inflammation. Thus, 
in addition to their function for the rapid elimination of the pathogens, neutrophils can also 
orchestrate the continuation of the immune response and induce migration of other leukocytes 
to inflamed sites through the production of lipid and polypeptide mediators (Bennett and 
Gilroy, 2016a; Billingham, 1987; Mayadas et al., 2014a; Tamassia et al., 2018b). 
 3.3.1. Lipid mediators 
 
Lipid mediators are compounds formed from polyunsaturated fatty acids (PUFAs) such as 
arachidonic acid (AA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) 
(Bennett and Gilroy, 2016b). Some of the lipid mediators derived from the metabolism of AA, 
are called eicosanoids (Khanapure et al., 2007). The main eicosanoids generated by 
neutrophils are leukotriene (LT) B4, PGE2 and thromboxane (TX) A2 (Ford-Hutchinson et al., 
1980; Goldstein et al., 1978; Zurier, 1976). 
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During neutrophil activation an increase in intracellular calcium, provides the translocation 
of type IV cytosolic phospholipase A2 (cPLA2) to the nuclear membrane (Lin et al., 1992). 
Then cPLA2 cleaves AA in the sn-2 position of phospholipids. Released AA can be used by 
several metabolic pathways: the leukotriene formation pathway and the prostanoid formation 
pathway (Figure 2) (Sala et al., 2010). 
 
Figure 2. Lipid Mediators.  
Prostaglandins (PGD2, PGE2 and PGF2) and Thromboxane A2 (TxA2) are derived from arachidonic 
acid by cyclooxygenase (COX) mediated pathway. Leukotrienes (LTB4 and Cysteinyl-leukotrienes-
LTC4, LTD4 and LTE4) are produced by the action of 5-lipoxigenase (5-LO). (adapted from Bajaj 
and Ishmael, 2013, distributed under the Creative Commons Attribution License) 
 
 
Leukotriene formation pathway initiates with the translocation of 5-LO to the nuclear 
membrane (Ford-Hutchinson et al., 1980; Rådmark and Samuelsson, 2009). Produced at the 
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earlier step AA binds to 5-lipoxygenase activating protein (FLAP) for presentation to 5-LO. 
Thus, 5-LO catalyzes oxygenation of AA to 5(S)-hydroperoxy-6-trans-8,11,14-cis-
eicosatetraenoic acid (5-HPETE), and further dehydration to the leukotriene A4 (LTA4) 
(Rådmark and Samuelsson, 2009). Subsequently, LTA4 can be converted to LTB4 by LTA4 
hydrolase (Haeggström, 2000). It is known that LTB4 have several effects at the inflammatory 
site, such as increased vascular permeability and adhesion to endothelial cells, its main action 
on neutrophils: potent chemoattractant and activator of degranulation (Bennett and Gilroy, 
2016; Gimbrone et al., 1984; Khanapure et al., 2007). The 10-9 M concentration of LTB4 is 
sufficient to trigger neutrophil chemotaxis, thus allowing them to move towards a 
concentration gradient at the site of inflammation (Dos Santos and Davidson, 1993).  
 
Prostanoid (PGs, prostacyclins, TXs) formation in neutrophils is mediated by the COX (also 
known as prostaglandin G/H synthase) enzyme that catalyzes two reactions by which AA is 
transformed to PGH2, the common precursor of all prostanoids (St-Onge et al., 2007). There 
are two known COX isoforms in humans: COX-1 and COX-2. However, COX2-mediated 
prostanoid formation seems to be more important in the context of inflammation (Dubois et 
al., 1998). After PGH2 is formed, it can be isomerized to PGE2. This reaction can happen in 
non-enzymatic manner or provided by one or more of several PGE2 synthases. Likewise, 
thromboxane synthase uses PGH2 to form TXA2. Once produced, these mediators leave the 
cell spontaneously or by transporters, and activate their respective receptors. Eight G protein-
coupled prostanoid receptors have been characterized in humans (Narumiya and FitzGerald, 
2001). Both PGE2 and TXA2 are produced by neutrophils and have their role during 
inflammation. Eicosanoid- TXA2 has generally pro-inflammatory effects, such as platelet 
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activation and aggregation, as well as increased expression of adhesion molecules (ICAM-1, 
VCAM-1, ELAM-1) by endothelial cells (Nakahata, 2008). No reported effects of TXA2 on 
neutrophils were found. 
 
On the other hand, PGE2 can play both pro- or anti-inflammatory role, depending on the 
situation, the cell and the receptor involved. It can cause vasodilation, participate in edema 
and fever. In addition, it has been implicated in cytokine production by dendritic cells (DCs) 
(Yao et al., 2009), thus contributing greatly to the course of inflammation (Legler et al., 2010). 
An anti-inflammatory role of PGE2 includes suppression of CCL19 production by DCs and 
monocytes, direct inhibition of IL-2 synthesis and IL-2 receptor expression by T cells, and 
suppression the cytotoxic activity of natural killer cells (NK) (Nakanishi and Rosenberg, 
2013). In addition, PGE2 can inhibit neutrophil inflammatory responses: chemotaxis and 
superoxide anion production (Armstrong, 1995; Talpain et al., 1995). Likewise, PGE2 
promotes neutrophil reverse migration (Loynes et al., 2018). 
 
In summary, lipid mediators produced by neutrophils play important pro- and anti-
inflammatory role during inflammation (Bennett and Gilroy, 2016b; Stables and Gilroy, 
2011). Dysregulated production of lipid mediators is implicated in chronic inflammatory 
disorders (Chiurchiù et al., 2018; Heller et al., 1998). 
 3.3.2. Peptidic mediators (cytokines, chemokines) 
 
Cytokines are crucial signaling molecules mediating information between cellular 
components of innate and adaptive immunity (Zhang and An, 2007). These are small 
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molecules produced by immune and non-immune cells, involved in autocrine and paracrine 
signaling. They have multiple roles, foremost among which is the management of essential 
homeostatic processes such as inflammation, tissue reparation or angiogenesis (Lackie, 2010). 
Neutrophils have long been thought to have little or no transcriptional activity or protein 
synthesis ability; however, data generated in the early 1990s has established that they are 
potent producers of a diverse palette of biologically active molecules. Neutrophils are both 
targets and producers of a wide repertoire of cytokines (Cassatella et al., 1997; Tamassia et 
al., 2018). They can therefore be involved in physiologically beneficial or detrimental 
processes. It has been shown that cytokines influence neutrophil behavior in multiple ways, 
including cytokine production itself, adhesion, phagocytosis, ROS production, degranulation 
and (more recently) NET formation (Garley et al., 2017; Tecchio et al., 2014).  
 
The production of cytokines by neutrophils can sometimes be constitutive (as in the case 
of IL-1ra, IL-18BP, or IL-8) but it is generally triggered upon cell stimulation. Various signals 
from the local microenvironment can indeed promote the production of cytokines (Kim and 
Luster, 2015b). Ligation of Fcγ receptors, pattern recognition receptors, Toll-like receptors, 
chemoattractant receptors, and complement receptors have all been shown to elicit cytokine 
expression (O’shea et al., 2008). The cytokines being produced by neutrophils exert multiple 
effects including the regulation of inflammation, angiogenesis, chemotaxis, and so on. The 
list of cytokines produced by human neutrophils is summarized in Table 2 (Tamassia et al., 
2018). 
 
 Anti-inflammatory cytokines IL-1ra; TGFβ1; TGFβ2 
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 Proinflammatory cytokines IL-1α; IL-1β; IL-6; IL-18; Il-22; G-CSF; MIF 
 C-C chemokines  CCL2; CCL3; CCL4; CCL17; CCL18; 
CCL19; CCL20; CCL22; CCL23 
 C-X-C chemokines CXCL1; CXCL2; CXCL3; CXCL5; CXCL6; 
CXCL8; CXCL9; CXCL10; CXCL11 
 Angiogenic and fibrogenic factors angiopoietin1; Bv8; FGF2; HB-EGF; HGF 
TGFα; VEGF 
 Immunoregulatory cytokines IL-12p40; IL-21; IL-23 
 TNF family members APRIL; BAFF; CD30L; CD40L; FasL; 
RANKL; lymphotoxinβ; TNFα; TRAIL 
 Other cytokines activin A; amphiregulin; endothelin; midkine; 
oncostatin M; PBEF 
 
Table 2. List of cytokines reproducibly shown to be produced by human neutrophils (adapted 
from Tamassia et al., 2018 , authorization requested ref # 4657831121245) 
 
Chemokines, mostly belonging to CXC and CC families, are of major importance for 
coordinating innate and adaptive immune responses, mobilizing neutrophils, monocytes, DCs, 
NK cells and T helper cells, and orchestrating their sequential recruitment to inflammatory 
sites (Tecchio and Cassatella, 2016; Yang et al., 2017). Among pro- and anti-inflammatory 
cytokines, the interleukin family is important in fine-tuning the inflammatory and immune 
responses. The tumor necrosis (TNF) family, including TRAIL, FasL and BAFF, is also 
critical for adequate inflammatory and immune processes. The timely production of vascular 
endothelial growth factor (VEGF) makes neutrophils important in the context of an 
angiogenetic switch. Colony stimulating factors like G-CSF are powerful signals sparking 
additional production of immune cells in the bone marrow, and modulating the function of 
myeloid cells (Meda et al., 1994; Scapini and Cassatella, 2014; Tamassia et al., 2018; Tecchio 
and Cassatella, 2016; Tecchio et al., 2014).  
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Cytokine production is highly regulated on multiple levels. Signaling pathways that control 
various cytokine production in human neutrophils will be presented in a further section.  
 3.3.2.1. Cytokine signaling  
 
In human neutrophils, the main upstream intermediates that control cytokine production 
are kinases such as TAK1, p38 MAPK, MEK/ERK, Syk/Src and PI3K/Akt, and transcription 
factors such as NF-κB, C/EBP and CREB. The involvement of these signaling molecules in 
cytokine generation will be described in more detail below. 
 
TAK1 (or MAP3K7)  
 
Initially, this kinase was identified as a TGFβ-activated kinase (Yamaguchi et al., 1995), 
thus its name. As a member of the MAP3K family, TAK1 is unique in that its activity requires 
associated proteins called TAB1 (TAK1 associated protein 1), TAB2, TAB3 (Ishitani et al., 
2003; Kanayama et al., 2004; Shibuya et al., 1996; Takaesu et al., 2000) or TAB4 (Prickett et 
al., 2008). Thus TAB1 and TAB4 directly bind TAK1 and induce it transautophosphorylation 
in vitro. Moreover TAB2 and TAB3 also activate TAK1 when overexpressed. However, 
unlike TAB1 or TAB4, the TAB2 and TAB3 proteins do not directly activate TAK1 in vitro. 
In contrast, activation of the TAK1 / TAB2 (or TAB3) complex requires an E1-catalyzed 
ubiquitination reaction (a ubiquitin activating enzyme), Ubc13 / Uev1A (E2: a ubiquitin-
conjugating enzyme) and TRAF6 (E3: a ligase ubiquitin) (Wang et al., 2001).  
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In neutrophils TAK1, TAB1, TAB2, and TAB4 are constitutively associated with IκB 
kinase (IKK) a/b subunits and are expressed both in the nucleus and cytoplasm. Activation of 
the TAK1 complex in response to inflammatory mediators (TNFα, lpopolysaccharide (LPS)) 
induces subsequent phosphorylation of the IKK complex, leading to the activation of 
transcription factor NF-κB. Additionally, NF-κB activation requires phosphorylation of 
nuclear factor of kappa light polypeptide gene enchancer in B-cells inhibitor (IκB) and its 
subsequent degradation by the 26S proteasome (Ear et al., 2010; Kravtsova-Ivantsiv and 
Ciechanover, 2015). 
 
It was shown that TAK1 activation is vital for neutrophil cytokine production in response 
to TNFα, LPS, fMLP, and GM-CSF. Thus, specific inhibition of TAK1 with 5Z-7-oxozeaenol 
prevented both mRNA accumulation and protein release of CXCL8, CCL4, and CCL3 in LPS- 
and TNFα -activated neutrophils (Ear et al., 2010). Additionally, it was shown that neutrophils 
secrete TNFa in response to LPS activation. Both LPS-induced TNFα mRNA expression and 
protein secretion were inhibited by 5Z-7-oxozeaenol (Ear et al., 2010). More evidence was 
obtained showing the critical role of TAK1 in neutrophil cytokine secretion. Inhibition of 
TAK1 prevented IL1-ra and CXCL8 mRNA accumulation and protein secretion by fMLP- 
and GM-CSF-activated neutrophils. Blocking of TAK1 kinase also intercepted GM-CSF-
induced CCL4 mRNA production and protein release (Sylvain-Prévost et al., 2015). 
 
All of these lines of evidence confirm the critical role of TAK1 in neutrophil cytokine 
generation in response to various stimuli. 
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 MAP kinases (p38 MAPK, MEK/ERK) 
 
Sequential activation of protein kinases is a common signal transduction phenomenon in 
several cell types (Campbell et al., 1995). Each MAPK cascade is activated either by a small 
GTP-binding G protein or an adaptor protein, which transmits the signal directly to MAPK 
kinase kinase (MAP3K). Subsequently, the signal is transmitted downstream of the cascade, 
MAP2K, MAPK and MAPK-activated protein kinases (MAPKAPK) (Chang and Karin, 2001; 
L’Allemain, 1994; Tanoue and Nishida, 2002). It is important to note that activation of MAP 
kinases requires phosphorylation of a tripeptide motif (Thr-Xaa-Tyr) (Brancho et al., 2003). 
Thus, MAPKs phosphorylation sites are threonine (Thr) and tyrosine (Tyr), the middle group 
is used to distinguish between different MAPKs (Payne et al., 1991). 
 
It was shown that in human neutrophils, MAP kinases p38 and MEK/ERK are activated in 
response to physiological stimuli (LPS, TNFα, fMLP, GM-CSF, etc.) (Coxon et al., 2003; 
McLeish et al., 1998; Nahas et al., 1996; Zu et al., 1998). Ear et al. (2010) demonstrated that 
in response to LPS and TNFα, phosphorylation of p38 MAPK and MEK/ERK and JNK were 
abolished by TAK1 inhibition, indicating that TAK1 acts upstream of all three MAPKs in 
LPS- and TNFα-activated neutrophils. Additionally, inhibitors of the p38 MAPK and 
MEK/ERK pathways substantially diminished the release of CXCL8, CCL4, CCL3 cytokines 
in neutrophils stimulated with LPS or TNFα; p38 MAPK inhibitor SB203580 also 
significantly decreased TNFa secretion by LPS-activated neutrophils (Figure 3) (Cloutier et 
al., 2007).  
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Figure 3. Schematic representation of MAPK pathways in human neutrophils  
In response to LPS and TNFα, phosphorylation of p38 MAPK and MEK/ERK and JNK were abolished 
by TAK1 inhibition. Inhibitors of the p38 MAPK and MEK/ERK pathways substantially diminished 
the release of CXCL8, CCL4, CCL3 cytokines in neutrophils stimulated with LPS or TNFα, while 
JNK inhibition did not effect cytokine production (Ear et al., 2010, Cloutier et al., 2007). 
 
In neutrophils p38 MAPK and MEK/ERK were also activated in response to fMLP and 
GM-CSF. However, only ERK phosphorylation is profoundly affected by TAK1 inhibition in 
response to fMLP and GM-CSF, indicating that TAK1 acts upstream of MEK/ERK but not 
p38 MAPK in fMLP- and GM-CSF-activated neutrophils. Finally, it was shown that 
MEK/ERK inhibitor (PD98059) blocks neutrophil secretion of CXCL8, CCL4, and IL-1ra in 
response to GM-CSF and fMLP, while p38 inhibitors (SB203580, SB202190) had no effect 
(Sylvain-Prévost et al., 2015). 
 
In summary, both act downstream of TAK1 and participate in cytokine secretion in LPS- 
and TNFα-activated neutrophils. However, in response to chemoattractants or growth factors, 
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TAK1 mainly acts through the MEK/ERK pathway. Likewise, MEK/ERK kinases but not p38 
MAPK are involved in fMLP and GM-CSF induced cytokine release in human neutrophils 
 
PI3K/Akt 
 
PI3K is a heterodimeric enzyme composed of a regulatory and catalytic subunit. The PI3K 
family is complex and can be divided into three sub-families (classes: I, II, and III), taking 
into account their structural characteristics, their activation mechanisms, and the substrate 
specificity of their catalytic subunit. However, regardless of their class, all PI3Ks share a 
common substrate: phosphatidylinositol (PI). The enzymatic reaction catalyzed by PI3K leads 
to the formation of phosphorylated lipids: PI → PI 3-phosphate, (PI(4)P) → PI 3,4-
bisphosphate, (PI(4,5)P2) → PI 3,4,5-triphosphate (PI(3,4,5)P3) (Hawkins and Stephens, 
2015). These phosphorylated lipids work as second messengers, subsequently binding 
intracellular proteins containing a pleckstrin homology (PH) domain. Akt is a Ser/Thr kinase 
containing a PH domain. Upon PI3K activation, Akt translocates to the membrane where it 
binds PI(3,4,5)P3. This binding induces conformational changes that allow Akt activation by 
other kinases. Akt has two phosphorylation sites that are essential for kinase activation, Thr308 
in the kinase domain and Ser473 in the C-terminal domain (Alessi and Cohen, 1998; Kandel 
and Hay, 1999; Manning and Toker, 2017). 
  
It was shown that the PI3K/Akt pathway is implicated in pro-inflammatory cytokine 
production by human neutrophils. Indeed, inhibition of LPS- and TNFα-activated neutrophils 
with LY294002 (a pan-PI3K inhibitor) vastly decreased CCL3, CCL4, and CXCL8 secretion 
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(Fortin et al., 2011). Likewise, inhibition of PI3K significantly decreased cytokine (CCL4 and 
CXCL8) release by fMLP and GM-CSF activated neutrophils. Additionally, significant 
inhibition of IL-ra secretion by LY294002 was observed in GM-CSF-activated neutrophils 
(Sylvain-Prévost et al., 2015). Cross intercepted talk between Akt and TAK1 was 
investigated. Thus it was shown that in human neutrophils, Akt acts downstream of TAK1 in 
response to LPS and TNFα, while in GM-CSF- and fMLP-activated cells, TAK1 does not 
affect Akt phosphorylation (Fortin et al., 2011; Sylvain-Prévost et al., 2015). 
 
   Together, this evidence indicates an important role of PI3K/Akt pathway in cytokine 
secretion by neutrophils activated with physiological stimuli. 
 
Syk/Src 
 
Both Syk and Src family kinases belong to the family of non-receptor tyrosine kinases 
(NRTKs). These enzymes catalyze the transfer of phosphate groups to tyrosine residues on 
protein substrates. Substrate phosphorylation causes changes in their function and/or 
enzymatic activity, leading to specific biological responses including cell differentiation, 
proliferation, adhesion, survival, etc. (Gocek et al., 2014; Mócsai et al., 2010; Roskoski, 2004; 
Tsang et al., 2008; Turner et al., 2000; Varmus et al., 1989). The activity of NRTKs is tightly 
regulated, as summarized below.  
 
All members of Src tyrosine kinases family contain a 14-carbon myristoyl group attached 
to a Src homology (SH)-4 domain, a SH3 domain, a SH2 domain, a SH2-kinase linker, a 
protein–tyrosine kinase domain (the SH1 domain) and a C-terminal regulatory segment that 
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has an auto-inhibitory phosphorylation site (Tyr-530) (Roskoski, 2005). Under resting 
conditions, Src is phosphorylated at Tyr-530; this restrains the enzyme and prevents 
accessibility of the SH2 and SH3 domains to external ligands. Activation of Src kinase starts 
with the dephosphorylation of Tyr-530, which subsequently leads to conformational changes 
and an intermolecular autophosphorylation at tyrosine 419 (Tyr-419); this residue is present 
in the activation loop, and its phosphorylation promotes kinase activity (Brickell, 1992; Gocek 
et al., 2014; Roskoski, 2005; Superti-Furga and Courtneidge, 1995; Varmus et al., 1989). 
 
The Syk structure consists of a C-terminal kinase domain, a N-terminal pair of SH2 
domains separated by an inter-SH2 linker, and a SH2-domain-kinase linker. Unlike Src kinase, 
Syk has a second SH2 instead of an SH3 domain. Recruitment of Syk to immune receptors 
involves binding of the tandem SH2 domains of Syk to motifs in the receptor known as 
immune tyrosine activation motifs (ITAMs). Binding of Syk kinase to phosphorylated ITAMs 
results in conformational changes that disrupt its autoinhibited structure, thus allowing kinase 
activation. After activation, Syk is tyrosine phosphorylated by trans- or autophosphorylation. 
Thus Syk have multiple phosphorylation sites that regulate its activity and serve as docking 
motifs for other proteins. These sites include Tyr-348 and Tyr-352 within the SH2-linker 
region, Tyr-525 and Tyr-526 within the activation loop of the kinase domain, Tyr-630 in the 
C terminus of Syk, and other sites (de Castro, 2011; Gocek et al., 2014; Mócsai et al., 2010; 
Tohyama and Yamamura, 2009; Tsang et al., 2008). 
 
Despite the important role of NRTKs in various immune responses (Bjorge et al., 2000; 
Mócsai et al., 2010; Turner et al., 2000; Varmus et al., 1989), their involvement in cytokine 
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production by neutrophils was elusive until recently. In this respect, we reported that Src or 
Syk inhibition strongly represses the secretion of CXCL8 induced by physiological neutrophil 
agonists (i.e., LPS, TNFα, fMLP, and GM-CSF) (Cloutier et al., 2009a; Ear et al., 2010, 
Cloutier et al., 2009b; Mayer et al., 2013). However, TNF induced CXCL8 release in a Syk-
independent manner. In addition, CCL4 secretion was significantly prevented by Src and Syk 
inhibitors in fMLP- and GM-CSF-activated neutrophils, but was only moderately affected in 
LPS- or TNF-stimulated cells. These results indicate that Src or Syk inflammatory cytokine 
control is largely dependent on the stimulus. We also revised the mechanism by which these 
tyrosine kinases act on cytokine generation (Ear et al., 2017). Thus, the induction of 
inflammatory cytokine gene expression was unaffected by Src or Syk inhibition, suggesting 
that they act posttranscriptionally. Accordingly, several signaling intermediates known to 
affect cytokine translation (MNK1; ribosomal S6 kinase and its substrate, the S6 ribosomal 
protein; and to a lesser extent, of 4E-BP1) were found to be under the control of Src and Syk 
(Ear et al., 2017). Among these downstream targets, MNK1 is particularly relevant, as it was 
shown previously to participate in the translational regulation of cytokine generation in 
neutrophils (Fortin et al., 2013). In summary, results obtained indicate that Src and Syk control 
inflammatory cytokine generation at the translational level in primary neutrophils (Ear et al., 
2017). 
 
NF-κB, C/EBPβ, CREB transcription factors 
 
  Transcription factors (TF) are commonly composed of a DNA-binding domain, an 
activation domain and dimerization domain. The DNA-binding domain allows the attachment 
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to target sequences within target gene promoters. The activation domain is typically the target 
of post-translational modifications, such as phosphorylation and acetylation, altering the 
ability to interact with co-activators, co-repressors or proteins of the transcriptional 
machinery. The co-activators, co-repressors and co-regulators generally do not have a DNA 
binding domain and therefore need to interact with the transcription factors to perform their 
functions. Interactions between TF and co-activators upregulate the transactivations of target 
genes (Aerts, 2012; Latchman, 1993).  Also TFs can work as repressors, blocking the 
recruitment of RNA polymerase to specific genes (Nikolov and Burley, 1997; Owen-Hughes 
and Workman, 1994). 
 
  There are approximately 2600 proteins in the human genome that contain a DNA binding 
domain and are therefore potential transcription factors involved in the regulation some 20,000 
to 30,000 genes (Babu et al., 2004). The study of the cytokine and chemokine promoter 
sequences revealed the importance of several families of transcription factors: NF-κB 
(Nuclear factor - kappa B), C/EBP (CCAAT enhancer binding protein) and CREB (cAMP 
response element binding protein) (Escoubet-Lozach et al., 2002; Holloway et al., 2002; 
Nikolajczyk, 2006; Tsuruta et al., 1998), are among them. It was shown that in neutrophils, 
NF-κB, CREB1 and C/EBPβ play important roles in cytokine production, at least in response 
to LPS and TNFα. Additionally, upstream events were elucidated. Namely, both CREB1 and 
C/EBPβ act downstream of p38 MAPK and MSK1, while NF-κB acts downstream of IKK 
and TAK1 (Cloutier et al., 2009a; Ear et al., 2010). The PLB-985 cell line was used to 
investigate the role of NF-κB, CREB1 and C/EBPβ in cytokine production. It was shown that 
DMSO-differentiated PLB-985 cells have neutrophil-like transcription factor activation 
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profile, as well as cytokine production profile. Thus, overexpression of dominant-negative 
IκB-α [IκBα (S32,36A)] in differentiated PLB-985 cells significantly reduced the production 
of CXCL8, CCL4, and CCL3 in response to LPS and TNFα. These results indicate an 
important role of the NF-κB transcription factor in cytokine production by human 
granulocytes (Ear and McDonald, 2008). The same method was applied to investigate the role 
of CREB1 and C/EBPβ in cytokine generation. Overexpression of dominant-negative C/EBPβ 
(A-CEBP2N3T) and CREB1 (K-CREB) in neutrophil-like PLB-985 cells vastly inhibited 
CXCL8, CCL3 and CCL4 release in response to LPS and TNFα (Cloutier et al., 2009b; Mayer 
et al., 2013). Also, the induced generation of IL-1β and TNFα was significantly inhibited by 
K-CREB overexpression in differentiated PLB-985 cells (Mayer et al., 2013). In summary, 
the above results unveil the vital role of NF-κB, CREB1 and C/EBPβ in cytokine production 
by human granulocytes. 
 
3.4. NETs 
  3.4.1. History 
 
Early studies found that neutrophil stimulation with the potent PKC activator, phorbol 12-
myristate 13-acetate (PMA), initiated a unique form of cell death that is morphologically 
distinct from other known forms – necroptosis, apoptosis, autophagy, etc (Takei et al., 1996). 
Stimulation with PMA was observed to decrease chromatin density and to induce nuclear 
membrane degeneration. Stimulation for 3 hours increased cell membrane permeability, with 
cell death peaking after 4 hours incubation. Agarose and pulsed-field gel electrophoresis 
analysis confirmed that DNA had not been degraded (Takei et al., 1996), demonstrating that 
PMA induces DNA release.  
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Almost 10 years later, in 2004, Brinkman et al. demonstrated that neutrophils can form 
extracellular fibers that consist of chromatin associated with granular and nuclear proteins, 
which they named neutrophil extracellular traps (NETs) (Brinkmann et al., 2004b). 
Immunohistochemistry analyses revealed that NETs contained proteins from azurophilic 
(primary) granules such as neutrophil elastase, cathepsin G, and myeloperoxidase (Figure 4). 
Proteins from specific (secondary) granules and tertiary granules, such as lactoferrin and 
gelatinase, respectively, were also present. This group further postulated that DNA is a major 
structural component of NETs not only because all the DNA intercalating dyes that were tested 
strongly labeled NETs, but also because treatment with deoxyribonuclease (DNase) resulted 
in complete disintegration of the NETs. On the other hand, protease treatment left extracellular 
chromatin filaments intact. They showed that NETs reacted with antibodies against various 
histones (H1, H2A, H2B, H3, H4) and against the H2A-H2B DNA complex (Brinkmann et 
al., 2004). Likewise, they confirmed that neutrophils were actively forming NETs in response 
to various stimuli such as IL-8, LPS, or PMA. Later studies from this group found that 
NETosis represents a form of cell death distinct from apoptosis and necrosis (Fuchs et al., 
2007), supporting earlier work by Takei and colleagues. 
 
  41 
 
Figure 4. Representative image of NETs induced in vitro by fMLP in human neutrophils.  
NETs are visualized by costaining of myeloperoxidase (red) and nuclear material (DAPI, 
blue). Magnification is 40X. (Tatsiy, unpublished) 
 
More importantly, studies from Brinkman et al., demonstrated physiological functionality 
of the phenomenon, they showed that after induction, ‘sticky’ extracellular chromatin 
filaments trapped bacteria, both gram-positive and gram-negative, and successfully killed 
them (Brinkmann et al., 2004). Following this study, NETs were recognized as a bona fide 
neutrophil response that physically prevents spread of bacteria, increases effectiveness of 
neutrophil antimicrobial substances by ensuring there high local concentration, and assists in 
killing bacteria.  
 
3.4.1.1. Vital and suicidal NETs 
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Exploration of the mechanisms underlying NETosis highlighted different forms of 
NETosis (Yipp and Kubes, 2013). Several studies have suggested that NET formation may 
not always be associated with cellular membrane disruption, but could also be performed by 
cells that remain intact after DNA extrusion. This version of NETosis was called vital. After 
completing vital NETosis neutrophils could retain other host defense functions, such as 
migration and phagocytosis. During vital NETosis, DNA release from the nucleus occurs by 
packing of DNA in budding vesicles derived from the nuclear membrane, which subsequently 
exocytose without cellular membrane rupture (Figure 5) (Clark et al., 2007; Pilsczek et al., 
2010; Yipp et al., 2012a). This process was described to be rapid, occurring within 30-60 min, 
and induced by various stimuli (Byrd et al., 2013; Yipp et al., 2012a). 
 
In contrast, lytic NET release begins after 2 h and usually goes on for 4 – 6 h (Steinberg 
and Grinstein, 2007). Lytic NET formation or so-called suicidal NETosis is characterized by 
nuclear chromatin decondensation that is followed by nuclear and cellular membrane rupture 
(Brinkmann et al., 2004; Fuchs et al., 2007; Steinberg and Grinstein, 2007). Even though there 
is no clear understanding if these two types of NET formation are interconnected, it was agreed 
that mechanisms of vital and suicidal NET formation have to be divided and investigated 
separately (Yipp and Kubes, 2013). My further narrative along with work established in this 
thesis is focused on understanding signaling pathways and mechanisms that control suicidal 
NET formation. 
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Figure 5.Overview of NETosis.  
(a) Different stimuli, including PMA induce suicidal NETosis, which occurs after hours of 
stimulation. In response to PMA NADPH oxidase is activated, ROS are produced and 
PAD4 is activated, which results in chromatin decondensation. Afterward, neutrophil 
elastase (NE) and myeloperoxidase (MPO) are translocated into the nucleus to promote 
further unfolding of chromatin, with resultant disruption of the nuclear membrane. 
Chromatin is released into the cytosol, where it becomes decorated with granular and 
cytosolic proteins. Finally, NETs are released through disruption of the plasma membrane, 
and the neutrophil dies. (b) Vital NETosis is induced within minutes by S. aureus and other 
stimuli. PAD4 is activated and induces chromatin decondensation. Like in suicidal 
NETosis, NE is translocated into the nucleus to promote further chromatin decondensation 
and nuclear-membrane disruption. However, protein-decorated chromatin is expelled via 
vesicles, and the neutrophil stays alive for further functions. (adapted from Jorch and Kubes, 
2017, authorization requested ref # 4657390257467) 
 
3.4.2. NETosis as a functional response  
 
Distinguishing NETosis as a true neutrophil functional response (as opposed to just another 
type of cell death) was instrumental in prompting investigations to understand NET formation 
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mechanisms. In the pioneering report on NET formation (Brinkmann et al., 2004b), it was 
proposed that histone-rich chromatin filaments are released from intact, viable neutrophils. 
This was mainly based on the following observations: no cytosolic proteins were detected on 
the DNA filaments extruded from the cells; most cells excluded vital dyes; and NETs were 
detected within 30-60 min after stimulation with compounds known to prolong neutrophil 
lifespan, such as IL-8 and LPS (Fox et al., 2010; Remijsen et al., 2011). However, the same 
group later demonstrated that cellular membranes rupture during NETosis (Fuchs et al., 2007) 
was a distinguishing feature in comparison to apoptosis (Zhang et al., 2018). Similar 
observations were also reported by another group (Steinberg and Grinstein, 2007). Thus, it 
came to be encountered that in contrast to apoptosis, neutrophils undergoing NETosis did not 
display phosphatidylserine (PS) on their surface before plasma membrane disruption, 
preventing their clearance by phagocytes (Remijsen et al., 2011a; Segawa and Nagata, 2015). 
Likewise, in contrast to apoptosis or programmed necrosis, during NET formation both the 
nuclear and granular membranes disintegrate and granular content mixes with nuclear 
chromatin (Fuchs et al., 2007). Finally, NETosis does not feature the main morphological 
signs of apoptosis, such as membrane blebbing, nuclear chromatin condensation, PS exposure 
and internucleosomal DNA cleavage before plasma membrane rupture (Fuchs et al., 2007; 
Luo and Loison, 2008; Remijsen et al., 2011). Also, several lines of evidence were obtained, 
supporting that the tightly controlled mechanisms driving NETosis set it apart from those of 
necrosis or apoptosis. In particular, caspase activity, which is a crucial indicator of both 
necrosis and apoptosis, was not detected during neutrophils extracellular filament formation 
(Luo and Loison, 2008; Remijsen et al., 2011; Röhm et al., 2014). Moreover, necrotic 
neutrophils stain positive for F-actin, but not after undergoing NETosis (Marcos et al., 2010; 
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Ramos-Kichik et al., 2009; Remijsen et al., 2011). Collectively, the above evidence show that 
NETosis is a tightly controlled cellar process in its own right.  
 
Since the first description of NETs in 2004, our knowledge about this phenomenon has 
dramatically expanded, but there remain significant gaps in our understanding of the 
underlying mechanisms and upstream signaling. It is widely agreed now, that two major 
events precede NET formation: first is chromatin decondensation and association with 
antimicrobial proteins (Fuchs et al., 2007), second is chromatin extrusion (Neubert et al., 
2018a). Several studies focused on the mechanism of chromatin decondensation, but very little 
is known about the mechanisms that control chromatin extrusion.  
 
3.4.2.1. The first major step of NETosis: chromatin decondensation 
 
It is important to mention that all the data described below, except for those relating to 
‘citrullination,’ were obtained using PMA as a stimulus to induce NETosis. This particular 
compound is a PKC activator (Chang and Beezhold, 1993) that has been widely used because 
of its affordability and high potency to induce NET formation. 
 
3.4.2.1.1. Neutrophil elastase (NE) and myeloperoxidase (MPO) promote 
chromatin decondensation 
 
In 2010 the same group that initially described NETs proposed a model of chromatin 
decondensation (Papayannopoulos et al., 2010). They demonstrated that NE is essential to 
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initiate NET formation and that in cooperation with MPO, it drives chromatin decondensation. 
To this end, they developed a cell-free nuclear decondensation assay using intact nuclei and 
cytoplasmic extracts from neutrophils. Incubation of intact nuclei with various concentrations 
of MPO led to chromatin decondensation. Interestingly, this process did not depend on MPO 
activity. Likewise, incubation of intact nuclei with NE led to chromatin decondensation and 
was prevented by the addition of a NE inhibitor (NEi). Addition of the two proteases to the 
intact nuclei accelerated decondensation, showing that both proteins synergize. Then using 
western blot (WB) analysis, they confirmed that NE partially degrades core histones during 
PMA-induced NET formation and that this process can be reversed by NEi (Papayannopoulos 
et al., 2010). Summarizing these data, the following model was proposed.  
 
Upon activation, NE somehow escapes the granules and translocates to the nucleus, where 
it cleaves histones and thereby promotes chromatin decondensation. In addition, MPO 
similarly escapes cytoplasmic granules, enters the nucleus, and binds to chromatin in the late 
stages of the process to promote further chromatin decondensation (Papayannopoulos et al., 
2010). 
 
In subsequent studies, the same authors added some details to the above model. They 
described the mechanism of ROS-mediated NE translocation to the nucleus. Using an anti-
NE antibody, they isolated a new complex that they named “azurosome”. This complex 
contained NE, cathepsin G (CG), azurocidin (AZU), MPO, lactoferrin (LTF), proteinase 3 
(PR3), and lysozyme (LYZ). In resting neutrophils, the azurosome was associated with a 
subset of azurophilic granule membranes. Upon activation of the oxidase complex, ROS such 
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as H2O2 trigger the activation and dissociation of NE/CG/AZU from the granules and release 
into the cytoplasm. The dissociated part of the azurosome binds to F-actin and degrades it, 
which allows active NE to enter the nucleus. Notably, that mechanism of controlled granule 
component release does not seem to involve membrane fusion, but the exact mechanism of 
NE release remains unknown (Metzler et al., 2014).  
 
3.4.2.1.2. LL37 mediates disruption of the nuclear membrane during NET 
formation  
 
The antimicrobial peptide, LL37, a member of the α-helical cathelicidins, binds and 
damages bacterial membranes that are deficient in cholesterol and sphingomyelin (Xhindoli 
et al., 2016). Increased levels of LL37 are found in inflamed or infected tissues where it can 
exert direct microbicidal activity against not only bacteria but also fungi and enveloped viruses 
(Alalwani et al., 2010; Kahlenberg and Kaplan, 2013; Tjabringa et al., 2003). During their 
maturation, neutrophils produce and store LL37 in their secondary neutrophilic granules. In 
response to stimuli such as IL-8, neutrophils can release LL37 (Dürr et al., 2006). Conversely, 
LL37 can chemoattract neutrophils, thus recruiting even more leukocytes to sites of injury or 
infection, while increasing the local concentration of pro-inflammatory mediators (De Yang 
et al., 2000). Immunofluorescence microscopy analyses revealed that addition of LL37 to 
PMA-activated neutrophils dramatically increases NET formation (Neumann et al., 2014a). 
Moreover, LL37 alone can induce nuclear rupture and subsequent neutrophil extracellular trap 
formation (Neumann et al., 2014b, 2014a). Additional immunohistochemistry assays showed 
that externally added LL-37 translocates towards the nucleus and co-localizes to the nucleus 
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membrane. This leads to the loss of nuclear membrane receptor signal - lamin B during the 
process of NET formation (Neumann et al., 2014a). Collectively, these data support the 
involvement of LL37 in nuclear membrane rupture.  
 
3.4.2.2. The second major step of NETosis: chromatin extrusion  
 
It was proposed that cellular membrane rupture during NETosis is driven by material 
properties of swollen chromatin, escaped from the ruptured nuclear envelope. Proposers of 
this hypothesis even noticed a correlation between time of chromatin extrusion and neutrophil 
size. They showed that smaller neutrophils form NETs faster than larger size neutrophils 
(Neubert et al., 2018b). However, this hypothesis was based on the experiments performed 
with PMA-activated neutrophils. In addition, it was demonstrated that different stimuli induce 
different combinations of NET types (Hakkim et al., 2011). PMA, predominantly induces 
diffuse NETs that are characterized by leaked chromatin forming a diffused “cloud” around 
the cellular membrane. On the other hand, many physiological stimuli were observed to form 
NETs featuring a meshwork of long filaments, which some refer to as spread NETs (Hakkim 
et al., 2011). To date, no explanation has been put forward to clarify the mechanism of long 
filament formation. 
 
3.4.3. The role of endogenous ROS 
 
A link between ROS production and NET formation was initially postulated after 
examination the ability of neutrophils derived from patients with chronic granulomatous 
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disease (CGD) to form NETs. CGD patients have a defective NADPH oxidase complex, 
which renders them incapable of forming ROS. Neutrophils from CGD patients did not 
undergo NETosis in response to PMA or S. aureus ingestion (Fuchs et al., 2007). Likewise, 
the NADPH oxidase inhibitor, DPI, prevents NET formation in neutrophils derived from 
healthy donors in response to PMA and some bacteria. Additionally, it was shown that some 
ROS ( e.g., singlet oxygen, HOCl, H2O2) can directly induce NETs (Akong-Moore et al., 
2012; Nishinaka et al., 2011; Palmer et al., 2012). Together, these findings led to the 
widespread view that NET formation is a ROS-dependent process (Björnsdottir et al., 2015; 
Stoiber et al., 2015). 
 
However, most of the studies of NETosis were performed using PMA (a powerful NADPH 
oxidase activator) as a stimulus (Karlsson et al., 2000). Conversely, many stimuli that induce 
little or no ROS ( e.g., IL1b, TNFa, GM-CSF) were found to be NET inducers (Pang et al., 
2013a; Parker et al., 2012a). Over time, more evidence were obtained regarding various 
physiological stimuli (poor ROS inducers (Nguyen et al., 2017)) that can potently induce 
NETs (Kaplan and Radic, 2012). The actual role of the NADPH oxidase in NET formation 
therefore deserves to be elucidated, and this particular point will be investigated in this thesis. 
 
3.4.4. The role of PAD4 and citrullination 
 
Activation of neutrophils with pro-inflammatory stimuli strongly promotes histone 
citrullination (Neeli et al., 2008; Wang et al., 2009a). Citrullination is the conversion of 
positively charged arginine side chains into polar but uncharged citrulline side chains, by 
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deimination (Figure 6). This process therefore decreases the ability of histones to interact with 
negatively-charged DNA (Bicker and Thompson, 2013). There are five human peptidyl 
arginine deiminases (PADs) known to catalyze such conversions, with PAD4 being the most 
extensively studied isoform. PAD4 enzyme activation is calcium-dependent. Calcium binding 
induces significant conformational changes that are important for catalytic activity (Wang and 
Wang, 2013). PAD4 is expressed in various leukocytes and is especially abundant in 
neutrophils (Jones et al., 2009). PAD4 is the only member of the PAD family to feature a 
nuclear localization sequence and as a result, it mainly localizes to the nucleus, where it targets 
histones H2A, H3, and H4 (Wang et al., 2009). However, it is important to note that PAD2, 
another member of the PAD family that is expressed in neutrophils, is also known to localize 
to the nucleus (Zhou et al., 2017). 
 
 
Figure 6. Peptidyl arginine deiminas (PAD) enzymes catalyze the conversion of protein arginine 
residues to citrulline. 
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This process decreases the ability of histones to interact with negatively-charged DNA and 
leads to chromatin decondensation (adapted from Mohanan et al., 2012, distributed under 
the Creative Commons Attribution License) 
 
Data from several groups supports the importance of PAD4-catalyzed histone 
hypercitrullination in chromatin decondensation during NETosis. Immunofluorescence 
analyses of differentiated HL60 neutrophil-like cells demonstrated that before treatment with 
calcium ionophore, nuclei showed a clear multilobular structure, while after treatment, nuclei 
became round; this process was found to be tightly coupled with an increase in H4Cit staining 
(Wang et al., 2009). Incubation of the cells with Cl-amidine, a potent pan-PAD inhibitor, 
partially prevented nuclear metamorphosis (Wang et al., 2009). Additionally, overexpression 
of PAD4 in osteosarcoma U2OS cells, which are incapable of forming NETs, induced 
apoptosis-independent chromatin decondensation and the formation of NET-like structures 
(Leshner et al., 2012). Furthermore, neutrophils isolated from PAD4-knockout mice 
demonstrated complete inhibition or impaired NET formation, depending on the conditions 
(Li et al., 2010). Together these data suggest an important role for PAD4 during the 
decondensation step of NETosis. 
 
Even though PAD4 involvement in NET formation has been proposed in various models, 
it remains unclear, which PAD isoform is involved in human NET formation. In this context, 
both PAD2 and PAD4 are expressed in human neutrophils and associated with NETs in 
response to inflammatory stimuli. The abrogation of NET formation by the pan-PAD 
inhibitor, Cl-amidine, likewise does not allow one to determine which PAD isoform is 
involved. 
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3.4.5. NET signaling 
 
A limited number of studies have addressed the signaling pathways involved in NET 
formation in response to physiological stimuli. It is known that stimuli of different origin such 
as cytokines (IL8, TNFa), TLR ligands (LPS), chemotactic peptides (fMLP), immobilized 
immune complexes (iIC), and polysaccharides (β-glucan) can induce NET formation. Some 
singnaling pathways were described to be involved for certain stimuli, but a general picture 
has not yet emerged.  
 
For instance, it was shown that in response to iIC, neutrophils undergo ROS-dependent 
NETosis that requires FcγRIIIb. Additionally, iIC-induced phosphorylation of Akt, p38 
MAPK, ERK1/2 and activation of PI3K. Inhibition of these signaling molecules disrupted 
NET formation in response to iIC. Furthermore, upstream signalling events were evaluated. 
PP2 (pan-Src inhibitor) prevented iIC-induced activation of Akt, p38 MAPK, ERK1/2, PI3K 
and abolished NET formation. This indicates that Src kinase activation is involved in iIC-
induced NETosis and acts upstream of Akt, p38 MAPK, ERK1/2, PI3K. The role of another 
tyrosine kinase, Syk, was also evaluated. The Syk inhibitor, piceatannol, also blocked 
NETosis in response to iIC (Behnen et al., 2014).  
 
A study by Carestia et.al (2016) showed that PI3K, p38 MAPK, ERK1/2 and Src are also 
involved in NET formation induced by LPS. However, levels of inhibition were not as marked 
as for iIC-induced NETosis. Indeed, p38 MAPK inhibition abolished NET formation in 
response to LPS, while inhibition of PI3K, ERK1/2 and Src reduced NET formation only by 
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about 40%. It is worthy of to note that Caresia et.al used a pan-Src inhibitor (PP1); this aspect 
might be important, since PP1 and PP2 have different specificities for various Src family 
kinases (Carestia et al., 2016). 
 
More studies investigated the role of PI3K, Syk, TAK1 and Src kinases during NET 
formation in response to physiological stimuli. Wortmannin, a pan-PI3K inhibitor, prevented 
NET formation in response to fMLP (Itakura and McCarty, 2013). β-glucan-induced NETs 
were abolished by both Src and Syk inhibitors (PP2 and PRT-060318, respectively) (Nanì et 
al., 2015). In addition, it was shown that TAK1 inhibitor, (5Z)-7-Oxozeaenol, significantly 
decreased FcγRIIIb-induced NET formation (Alemán et al., 2016).  
 
In summary, disparate lines of evidence indicate that TAK1, PI3K/Akt, MAPKs (p38 
MAPK and ERK1/2) and Syk/Src signaling pathways are involved in NET formation, at least 
in response to some physiological stimuli. 
 
3.4.6. The importance of NETs in homeostasis and disease 
 
As professional microbe killers, neutrophils are most often the first line of defense of the 
innate immune system. Classical neutrophil functional responses include phagocytosis and 
degranulation, as well as lipid mediator synthesis. In the 1990s, it was shown that neutrophils 
can also produce a broad spectrum of pro-inflammatory chemokines and cytokines, which 
influence the inflammatory and immune reactions. More recently, NETosis emerged as 
another powerful means of defense against different types of pathogens – bacteria, yeasts, 
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fungi, viruses. A role for NETs has been demonstrated and postulated in infectious diseases 
and autoimmunity. This section is an overview of the evidence. 
 
3.4.6.1. Insidious traps: NETs in infection 
 
3.4.6.1. Bacterial infections 
 
Some of the first studies to show the biological relevance of NETs were conducted using 
sepsis patients. In vitro and in vivo experiments demonstrated trapping and subsequent killing 
of gram-positive and gram-negative bacteria by NET filaments (Brinkmann et al., 2004b; 
Pilsczek et al., 2010; Wartha et al., 2007; Yost et al., 2009). It was concluded that NETs were 
contributing to host defense during severe bacterial sepsis. Additionally, NETs were shown 
to be produced in response to septic stimuli intravascularly. This process was activated by 
LFA-1-mediated platelet-neutrophil interactions in both murine and human sepsis (McDonald 
et al., 2012). To further investigate the importance of NETs for disease outcome, DNase was 
perfused, and it abolished NET formation during staphylococcal infection and led to a 
significantly accelerated release of bacteria from the entry site. This increased presence of 
bacteria in the bloodstream (bacteremia) and reduced the lifespan of animals. Another element 
that suggested a role for NETs in sepsis pathogenesis was obtained using NE knockout mice 
(NE-/-). Elastase is a granular protease that associates with NETs. In NE-/- mice, defective 
bacterial killing and increased susceptibility to sepsis were observed following Klebsiella 
pneumonia or Escherichia coli infection (Belaaouaj et al., 1998; Yipp et al., 2012). More 
compelling evidence was provided in a later study, which demonstrated that NE-/- mice failed 
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to produce NETs (Papayannopoulos et al., 2010a). Thus, it has now become established that 
NETs play an essential role in several bacterial diseases (Hasler et al., 2016; Stephan and 
Fabri, 2015).  
 
Interestingly, some bacteria have developed countermeasures against the toxic effect of 
NETs. Staphylococcus aureus induces NETs that kill them essentially via the virulence factor 
Panton-Valentine leukocidin, but to escape, S. aureus expresses a nuclease that degrades 
NETs, thereby enhancing infectivity in a mouse respiratory tract infection model . Other 
strategies applied by bacteria are summarized in Table 2 (Hasler et al., 2016). 
 
Infectious organism Mechanism of evasion Effect 
Staphylococcus aureus Endonuclease 
Virulence and evasion of 
killing 
Group A streptococcus Endonuclease 
Virulence and evasion of 
killing 
Neisseria gonorhoeae Thermonuclease 
Virulence and evasion of 
killing 
Neisseria meningitidis 
Cathepsin G inhibition and 
bacterial outer 
membrane vesicle 
release 
Virulence and evasion of 
killing 
Yersinia enterocolitica Endonuclease 
Virulence and evasion of 
killing 
Vibrio cholerae Endonuclease 
Virulence and evasion of 
killing 
Bordetella pertussis Adenylate cyclase toxin Inhibition of NET formation 
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Leptospira species Endonuclease 
Virulence and evasion of 
killing 
Sepsis 
CXCR2 and phospholipase 
D2 activation 
Inhibition of NET formation 
Mycobacterium 
tuberculosis 
IL-10 adherent to NETs Reduced macrophage activity 
 
Table 3. Strategies of bacteria directed against neutrophil extracellular traps. (adapted from 
Hasler et al., 2016, distributed under the Creative Commons Attribution License) 
 
3.4.6.1.2. Viral infections 
 
Several viruses have been found to stimulate NET formation including influenza A, human 
immunodeficiency virus (HIV)-1, hantaviruses, etc. (Schönrich and Raftery, 2016). The 
mechanism of NET induction by viruses is not entirely understood. However, it was shown 
that HIV-1 triggers NET formation via the TLR7 and TLR8 receptors. NETs capture and 
partially inactivate HIV-1 virus. This inactivation can be reversed either by MPO inhibitor or 
by an anti-defensin antibody, showing an essential role of NET-associated proteins against 
viral infection (Saitoh et al., 2012). More data were obtained showing antiviral properties of 
NETs. Histones, which account for the majority of proteins on NETs, showed potent antiviral 
activity against influenza A viruses. Likewise, influenza viruses often trigger pneumonitis 
with excessive neutrophil infiltration and NET formation that contribute to severe lung tissue 
damage (Narasaraju et al., 2011). Respiratory syncytial virus (RSV) also induces NET 
formation. NETs can capture RSV virions and prevent their attachment to epithelial cells in 
vitro (Cortjens et al., 2016). 
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Additionally, pathogenic hantaviruses can induce ROS-dependent NET formation and 
stimulate production of high levels of antinuclear antibodies. However, it is still unknown if 
these antibodies have an impact on viral replication or NET activity (Schönrich and Raftery, 
2016). To summarize, this data shows that NETs play an active role during a viral infection. 
3.4.6.1.3. Fungal infections 
 
Fungi are another type of pathogens that trigger NETosis. It was demonstrated that fungi 
are susceptible to NET-mediated killing. NETs can kill both yeast and hyphal forms of 
Candida albicans (Urban et al., 2006). NETs induced by Candida albicans were highly 
dependent on PAD4 activity, as NET formation was abrogated in neutrophils from PAD -/- 
mice (Urban et al., 2009). Furthermore, NETs are induced in response to different 
morphotypes of Aspergillus fumigatus, i.e., resting or swollen conidia and hyphae. NET 
formation in response to A. fumigatus was utterly abolished by NDPH inhibitor, DPI 
(diphenyliodonium), showing that ROS production is important for NET induction by A. 
fumigatus (Bruns et al., 2010). Also, it was demonstrated that β-glucan receptor signaling is 
required for A. fumigatus NET-mediated inhibition and/or killing in vitro. Additionally, A. 
fumigatus developed the escaping NET mechanism. Namely, it was shown that the virulence 
factor produced by A. fumigatus, galactosaminogalactan, directly inhibits NET-associated 
factors (Hasler et al., 2016; Lee et al., 2015). Even though the mechanism and signaling 
cascades controlling NET induction in response to fungi remain poorly understood, the data 
above indicate the involvement of NET in the host response against fungal invasion. 
3.4.6.1.4. Parasitic infections 
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Even though NETs are a potent pathogen killing mechanism, they are not omnipotent. For 
instance, Leishmania infantum was found to be resistant to NET killing thanks to an 
endogenous nuclease activity (Guimarães-Costa et al., 2014). However, other Leishmania 
species are susceptible to NET-provided assassination. L. donovani inducing NETosis in a 
dose-dependent manner and this generation is ROS-independent. Another ROS-independent 
NETosis was observed in response to L. amazonensis. Specifically, it was demonstrated that 
both PAD4 and MPO inhibitors reduced NET formation induced by L. amazonensis. 
However, parasites can also induce ROS-dependent NETosis. For example, NETs induced by 
Trypanosoma cruzi were abolished by DPI inhibition (Bonne-Année et al., 2014). 
Additionally, NET formation in response to Plasmodium falciparum infection has been 
associated with the induction of an autoimmune response that varies between children and 
adults. In children, circulatory NETs adherent to parasites were associated with potentially 
damaging antinuclear antibodies against double stranded DNA (Hasler et al., 2016; Morgado 
et al., 2015). 
 
The exact role of NETs during parasitic host invasion remains unknown. However, results 
of thes studies indicate that NETs prevent parasite spreading using discrete signaling 
pathways.  
 
3.4.6.2. NETosis in autoimmunity 
 
NET structures, featuring long chromatin filaments decorated with granular proteins, gives 
them the potential to act as physical and antimicrobial barriers that first entrap and then kill 
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pathogens at the site of inflammation (Brinkmann et al., 2004b; Buchanan et al., 2006; Urban 
et al., 2006). As described in the previous section, NETs are found in a variety of infections. 
However, NET formation can also occur in non-pathogenic conditions, such as autoimmune 
diseases (Hakkim et al., 2010; Pinegin et al., 2015). Prolonged formation of NETs due to 
impaired NET degradation is thought to be associated with autoimmune diseases such as 
systemic lupus erythematous, rheumatoid arthritis, psoriasis, etc. (Bonanni et al., 2015; 
Hakkim et al., 2010; Lee et al., 2017). This chapter will be devoted to how NETs impact 
autoimmunity.  
 
3.4.6.2.1. Systemic lupus erythematosus (SLE) and NETs 
 
SLE is an autoimmune disorder that causes chronic inflammation in connective tissues, 
such as cartilage and the lining of blood vessels. The signs and symptoms of SLE involve 
different organs, and its development is described as multifactorial. There is no cure for SLE, 
and the source of the antigens targeted by the immune system remains unknown (Kaul et al., 
2016).  
 
Patients with SLE have high levels of anti-ribonucleoprotein and anti-DNA antibodies in 
their serum, and it is speculated that these antibodies are induced by NET components (Gupta 
and Kaplan, 2016). Likewise, these patients have a distinct low-density granulocyte (LDG) 
population, which is not found in healthy controls (Denny et al., 2010). It was shown that 
LDGs have an enhanced capacity to produce NETs spontaneously and to generate large 
quantities of IFN-α (Lood et al., 2016).  
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Several animal studies have reported a relationship between SLE and NETs (Banchereau 
and Pascual, 2006; Garcia-Romo et al., 2011; Sokolove et al., 2013). These studies revealed 
that ribonucleoprotein immune complexes induce NET formation and require mitochondrial 
ROS for maximal NET stimulation. In turn, extracellular release of oxidized mitochondrial 
DNA is proinflammatory in vitro, and when this DNA is injected into mice, it induces type 1 
interferon synthesis and endothelial damages, indicating that mitochondrial ROS play a role 
in the induction of NETosis during SLE (Banchereau and Pascual, 2006; Döring et al., 2012a). 
Furthermore, the impact of SLE-targeted therapies was tested on NET formation. Celastrol, a 
triterpenoid compound that downregulates mitochondrial ROS (Garcia-Romo et al., 2011), 
inhibits the neutrophil oxidative burst and NET formation induced by TNFα. Another 
compound was tested, called tofacitinib – a JAK inhibitor that blocks signaling downstream 
of multiple cytokines implicated in lupus pathogenesis. Both spontaneous and LPS‐induced 
NETosis were significantly decreased in neutrophils obtained from tofacitinib‐treated mice 
(Sokolove et al., 2013). Together, these observations support a role for NETs in the 
pathogenesis of SLE (Grayson and Kaplan, 2016; Lee et al., 2017) 
3.4.6.2.2. NETosis in psoriasis  
 
Psoriasis is a chronic multifactorial, inflammatory skin disease that affects about 3% of the 
human population (Gudjonsson and Elder, 2007). Chronic inflammation during psoriasis is 
characterized by the intense proliferation and aberrant differentiation of keratinocytes, and the 
infiltration of the epidermis with lymphocytes and neutrophils. The major inflammatory 
molecules that characterize psoriasis are TNF-α, IFN-γ, TGF-β, and interleukins (including 
IL-1, IL-17, and IL-22) (Martin et al., 2013). Moreover, an increased number of NETotic cells 
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was observed in the peripheral blood of patients with psoriasis compared to healthy subjects 
(Hu et al., 2016). Several mechanisms that might explain involvement of NET formation in 
the disease progression were described. For example, it was shown that disrupted mechanism 
of reactivity to self-DNA by plasmacytoid dendritic cells (pDC) plays a role in the 
inflammation that activates the skin to react with hyperkeratosis in psoriasis. Normally, pDCs 
have no reactivity to self-DNA. However, analysis of the affected skin from psoriatic patients 
revealed the presence of LL-37/DNA and LL37/RNA complexes (Herster et al., 2019). It was 
shown that these complexes co-localize with DC clusters in the epidermis. Moreover, the LL-
37/DNA complex colocalizes with pDC, while LL-37/RNA complex with myeloid DC 
(mDC). Likewise, it was revealed that peptide LL-37 colocalize with TLR9 inside the 
endosomes of pDCs in the affected skin (Lande et al., 2007; Skrzeczynska-Moncznik et al., 
2012). To investigate the molecular mechanism of this process, insoluble LL37/DNA 
complexes were added to the culture of pDC. It was shown that LL37/DNA complex enters 
TLR9-containing endosomes and induces a powerful IFN-α response. To summarize, 
LL37/DNA complexes play an important role in psoriasis progression. Even though it is 
known that neutrophils also can produce LL37, the source of LL37 in the context of psoriasis 
appears to be predominantly endothelial cells of skin vessels, which produce and release LL37 
in response to inflammatory cytokines (Hwang et al., 2014; Martinelli et al., 2004; Takahashi 
et al., 2010). So what is the source of DNA in psoriasis? Like it was mentioned in previous 
sections LL37 alone can induce NET formation. Thus, it was shown that neutrophils 
undergoing extracellular trap formation are the origin of DNA detected in psoriasis 
(Skrzeczynska-Moncznik et al., 2012a). 
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Apart from LL37/DNA, another complex was found to colocalize with pDCs in psoriatic 
skin, i.e. DNA/NE/SLPI. In the affected parts of the psoriatic skin, the DNA/NE complex was 
found in association with secretory leukocyte proteinase inhibitor (SLPI). SLPI is expressed 
by neutrophils (Jacobsen et al., 2008; Jin et al., 1997; Wingens et al., 1998) and controls serine 
protease activity. SLPI is thought to play an essential role in limiting protease-mediated tissue 
injury associated with inflammation, especially at mucosal/epithelial surfaces, as well as in 
wound healing (Reardon et al., 2011; Zhu et al., 2002). The main target for SLPI is an enzyme 
of the neutrophil primary granules, NE, that plays a crucial role in chromatin decondensation 
during NETosis. In vitro experiments demonstrated that addition of DNA/NE/SLPI 
complexes into the culture of pDC induces great production of type I IFNs (Hu et al., 2016; 
Skrzeczynska-Moncznik et al., 2012b). Thus, all the above findings support the involvement 
of NETs and associated proteins in psoriasis pathogenesis. 
3.4.6.2.3. NETs in Rheumatoid arthritis (RA) 
 
Rheumatoid arthritis is the most commonly diagnosed type of autoimmune inflammatory 
arthritis. It affects almost 1% of the world population. Like most autoimmune diseases, RA 
etiology is multifactorial. Rheumatoid arthritis causes pain, swelling and, if untreated, 
progressive damage to joints that leads to increased morbidity and death. Inflamed joints of 
RA patients are massively infiltrated with neutrophils (Aletaha and Smolen, 2018). Around 
80% of RA patients have autoantibodies to citrullinated protein antigens (CPAs) in their blood 
(Keidel et al., 2014). Recent research suggests that ACPAs play a crucial role in RA. A 
potential mechanism that leads to ACPA generation in RA was highlighted in several studies 
(Aletaha and Blüml, 2016; Stadt et al., 2011). Autoantibodies to CPAs contain nuclear 
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proteins ( e.g., histones), cytoplasmic proteins ( e.g., vimentin and enolase), membrane-
associated proteins ( e.g., myelin basic protein), and extracellular proteins ( e.g., filaggrin, 
collagen II, fibrinogen, and calreticulin) (Kurowska et al., 2017). Anti-citrullinated-
H2A/H2B-reactive RA antibodies selectively recognize NETs produced by RA joint 
neutrophils (Corsiero et al., 2016). Thus, it was suggested that NETs are a source of ACPAs 
implicated in RA pathogenesis. Moreover, neutrophils express and degranulate high levels of 
PAD2 and PAD4, leading to their accumulation in the synovial fluid (SF) of RA patients 
(Spengler et al., 2015). 
 
In addition, NETing neutrophils were detected in the peripheral blood, synovial fluid, 
synovial tissues, rheumatoid nodules and skin of RA patients (Khandpur et al., 2013). 
Furthermore, the number of NETotic neutrophils in the peripheral blood of RA patients 
significantly correlated with the levels of ACPA in the serum (Khandpur et al., 2013). 
Additionally, it was shown that NETs can induce an inflammatory phenotype in synovial 
fibroblasts (SFL). NET-activated SFLs were internalizing peptides associated with NETs via 
RAGE-TLR9 signaling pathway promoting upregulation of MHC class II. Thus, activated 
SFL were presenting internalized NET-associated citrullinated peptides loaded onto MHS 
class II to Ag-specific T cells (Carmona-Rivera et al., 2017; Grayson and Kaplan, 2016). In 
conclusion, the results listed above reveal a credible link between RA pathogenesis and NETs 
(and their components).  
3.4.6.2.4. NETs in vascular inflammation and thrombosis 
 
Vasculitis is a chronic auto-inflammatory condition characterized by the presence of anti-
neutrophil cytoplasm autoantibodies (ANCAs) (Kessenbrock et al., 2009). Thus ANCA react 
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with components of neutrophilic granules and monocytic lysosomes. Vasculitis associated 
with ANCA is classified into three distinct vasculitides, which involve inflammation of the 
small- and medium-sized blood vessels: microscopic polyangiitis (MPA); granulomatosis 
with polyangiitis (GPA, previously known as Wegener granulomatosis); and eosinophilic 
GPA (previously known as Churg-Strauss Syndrome) (Kallenberg, 2014). Microscopic 
polyangiitis and eosinophilic GPA feature autoantibodies against MPO, while granulomatosis 
with polyangiitis features autoantibodies against proteinase 3 (PR3). The presence of 
autoantibodies against NET-associated enzymes (MPO, PR3), and the finding that ANCA can 
induce NETosis in neutrophils, together suggest NET involvement in disease pathogenesis. In 
this respect, extracellular DNA traps associated with MPO and PR3 were detected in kidney 
biopsies from patients with active glomerulonephritis (ANCA vasculitis that affects kidneys) 
(Kessenbrock et al., 2009). Also, the number of NET products positively correlated with 
disease activity (Söderberg et al., 2015).  
 
Moreover, ANCA-associated inflammation of blood vessels commonly leads to 
thrombosis, and thrombi from these patients are rich in NETs (Kambas et al., 2014). Finally, 
it was proposed that NETs might be directly associated with thrombosis development. 
Intravascularly formed NETs interact with fibrinogen, thus promoting fibrin deposition, and 
this fibrous meshwork promotes platelet activation and aggregation (Fuchs et al., 2010; Hasler 
et al., 2016). More work has to be done to elucidate the mechanism of NET involvement 
during vascular inflammation and thrombosis. However, evidence already obtained points to 
the existence of a link between the NET formation and disease progression.  
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3.4.6.2.5. NETs in atherosclerosis (AS)  
 
Atherosclerosis (AS) is a chronic inflammatory disease. During AS, arteries harden 
through a build-up of plaques in the intima of blood vessels (Tuttolomondo et al., 2012). Main 
classical risk factors of AS include dyslipoproteinaemia, diabetes, smoking, hypertension, and 
genetic abnormalities. The inflammation is initiated by infiltration and retention of 
cholesterol-rich apolipoprotein B (apo B)-containing lipoproteins in the artery wall (Shapiro 
and Fazio, 2017). This accumulation later leads to an arterial injury that causes endothelial 
dysfunction, promoting infiltration of the vessel wall by neutrophils, macrophages, and DCs 
(Linton et al., 2000).  
There are several lines of evidence supporting a role for NETs in the initiation and 
maintenance of the chronic inflammatory process in AS. It is known for example that NETs 
are the source of LL-37/DNA complexes (or its murine equivalent, DNA/Cramp) that are 
detected in atherosclerotic plaques (Döring et al., 2012a, 2012b). In mice fed with a fat-
enriched diet, resulting in a significant deterioration of the vessel walls, the level of Cramp, 
co-localized predominantly with neutrophils, was dramatically increased in the aortic walls. 
Likewise, feeding Cramp-/- mice the same fat-enriched diet caused significantly less damage 
to blood vessels in comparison to wild-type mice. There were also considerably fewer 
neutrophils in the aorta walls of Cramp-/- mice compared to control animals. In humans, more 
NET markers (i.e., complexes of citrullinated histones or MPO with DNA, nucleosomes), 
were found in tissue sections of coronary vessel walls of 282 patients with coronary artery 
diseases (Borissoff et al., 2013). Finally, in a mouse model of AS in which apolipoprotein E 
(ApoE)-deficient mice were fed a high-fat diet for eight weeks, NET accumulation surrounded 
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cholesterol crystals in atherosclerotic lesions (Yamamoto et al., 2018). To test NET 
involvement in this AS disease model, two neutrophil proteases, NE (also known as ELANE) 
and PR3, were deleted in the mice lacking ApoE. The resulting triple knockout animals had 
less NETosis rate, as well as smaller atherosclerotic lesions and lower systemic IL-1β levels, 
compared to ApoE-/- mice expressing NE and PR3 (Jorch and Kubes, 2017; Warnatsch et al., 
2015). This again suggests a potential role for NETs and/or these proteases in AS.  
This chapter was dedicated to the role of NETs during various pathophysiological 
conditions. In summary, the relevance of NETs seems clear but the impact is controversial. 
NET generation is an important mechanism of host defence against bacterial and parasitic 
invasion, as well as against fungi and viruses. However, constitutive NET formation during 
chronic inflammation of various origins contributes to disease progression. Further studies are 
needed to understand the singling pathways that control NET formation in response to 
physiological stimuli. Thus, understanding of NET formation mechanisms associated with 
specific diseases may lead to the identification of important therapeutic targets. 
 
3.4.7. Methods for the detection of NETs 
 
The initial description of NETs as an antimicrobial response, as well as their involvement 
in various diseases, generated widespread interest to study the underlying mechanisms, as well 
as the upstream signaling pathways. For this purpose, several approaches have been used that 
are described in this section. 
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3.4.7.1. Electron microscopy  
 
Brinkmann et al. used electron and fluorescence microscopy for NET visualization. They 
confirmed that NETs consist of chromatin that is associated with granular and nuclear proteins 
(such as elastase, cathepsin G, MPO; and the histones H1, H2A, H2B, and H3, respectively). 
Their study, therefore, established NET “markers” that were used by other researchers 
afterward (Brinkmann et al., 2004b). However, electron microscopy is not a very practical 
approach to quantify NETs in large amounts of samples.  
 
3.4.7.2. Fluorescence microscopy  
 
Chromatin being at the core of NET structure, every immunohistochemistry protocol of 
NET visualization includes DNA labeling. However, even if there is an argument that 
extruded decondensed chromatin accumulates more signal than the packed chromatin 
remaining in the cell, the use of a DNA dye alone is not sufficient for NET quantification. 
Thus, additional markers are generally used along with DNA labeling with MPO and NE being 
the most common ones (Carmona-Rivera and Kaplan, 2016; Mitroulis et al., 2011a; 
Papayannopoulos et al., 2010b). However, this approach suffers from a potentially significant 
drawback. Given the propensity of several neutrophil granule proteins to strongly associate 
with cell membranes upon their release from the cells (Owen et al., 1995; Pryzwansky et al., 
1979), the above observation raises the possibility of an abundant nonspecific signal. A crucial 
control is lacking, i.e., the digestion of NETs with DNase, to determine if all of the 
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fluorescence is in fact associated with NETs (as total fluorescence is typically counted by 
investigators using this approach).  
 
3.4.7.3. Spectrofluorometric quantification of NETs 
 
Spectrofluorometric NET quantification is widely used to investigate NETosis. It is based 
on the staining of DNA released during NET formation, using a DNA dye (such as Sytox 
green) described as being non-permeable dye by its manufacturer. Thus, extruded DNA is 
quantified and standardized to total DNA (using another DNA dye that is cell permeable, such 
as DAPI). This method is straightforward and allows to analyze numerous samples at once. 
However, it can’t be considered as reliable, as its correlation with microscopy observation is 
unsatisfactory. NET morphology can vary depending on the stimulus (yielding either spread 
or diffused NETs); also, different inhibitors might affect different steps of NET formation 
(decondensation or extrusion), and none of these factors can be verified without microscopy. 
Likewise, dead and lysed cells are typically counted as NETing cells, contributing to a strong 
false positive signal. Furthermore, Sytox Green should be used at concentrations of 500 nM 
or less in eukaryotic cells according to its manufacturer, whereas most investigators use it at 
3 µM or more (Gray et al., 2013; Gupta et al., 2014; Khan et al., 2017; White et al., 2016). 
There is therefore a definite risk of a nonspecific signal that should be accounted for, but 
usually it is not. 
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Thus, methodological approaches of NET quantification listed above suffer from 
significant inherent drawbacks. The biggest issue is the inclusion of an abundant nonspecific 
signal. This crucial issue will be fully addressed in this thesis. 
 
 4. Chronic inflammation 
 
As discussed earlier, physiological inflammation is a pivotal part of the innate immune 
system that is self-regulated through various molecular feedback loops which enables the 
resolution of the process, withdrawal of the infection cause and restoring the tissue to a regular 
state. However, the process is occasionally unable to terminate, prolonging for months, or 
even years. This state is referred to as chronic inflammation, and is recognized as a cause or 
comorbidity of many contemporary diseases (Pahwa and Jialal, 2019).  
 
The causes of chronic inflammation are not entirely elucidated, but there seem to be a few 
common elements. The onset of acute and chronic inflammation appears to be the same. 
However, the process advances into a chronic condition either because the immune system 
fails to eradicate the infection cause, and the source persists; or the course of the process is 
unable to terminate even if the initial cause has been eliminated. In a smaller number of cases, 
a low level of ungoverned inflammatory response persists over time, with no apparent reason. 
Some autoimmune disorders, like systemic lupus erythematosus or rheumatoid arthritis, also 
carry a chronic inflammatory component, as the innate immune system mistakenly attacks 
host antigens (Garn et al., 2016; Pahwa and Jialal, 2019).  
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Available data reveal several predisposing risk factors that increase the probability of 
developing a disease associated with chronic inflammation. Unadvisable nutritional habits 
accompanying our contemporary lifestyle are among the forerunners of a myriad of diseases 
bearing a chronic inflammation component (Minihane et al., 2015). Low-quality, industrial 
food with high-calorie content that is typically consumed in developed countries, induces the 
accumulation of fatty tissue, secreting adipokines and other pro-inflammatory cytokines. 
Smoking is another behaviorally modifiable risk factor, associated with prolonged 
inflammation (Lee et al., 2012). Everyday stress, another hallmark of modern lifestyle, 
accompanied by irregular sleep patterns, elevates cytokine production and represents another 
probable cause (Liu et al., 2017). Advanced age and misbalanced hormonal status have been 
repeatedly correlated with chronic inflammatory diseases (Okin and Medzhitov, 2012). In 
sum, poor dietary habits, smoking, sedentary lifestyle accompanied by an aging population, 
all symbols of present-day lifestyle in developed countries, represent potent risk factors for 
developing chronic inflammation-related diseases. 
 
Chronic diseases are long term, slowly progressing disorders demanding constant 
medical attention and ultimately reducing the quality of life. Altogether, these disorders 
represent a significant health burden in the western world as it is estimated that they indirectly 
cause roughly 60% of deaths globally every year (Morabia and Abel, 2006). Some chronic 
diseases with a strong autoimmune component like atherosclerosis and diabetes, are followed 
by aftermaths such as myocardial infarction and stroke. Several types of common carcinomas 
including lung, ovarian, prostate and pancreatic cancers also develop a persistent immune 
response. In all, chronic inflammation can affect almost every tissue, provoking various 
  71 
diseases, like chronic obstructive pulmonary disease, rheumatoid arthritis, Alzheimer’s 
disease, allergic asthma, chronic kidney disease, and inflammatory bowel disease.  
 
Some commonly used medications such as aspirin were found to relieve the symptoms of 
chronic inflammation, but often corticosteroids are prescribed or non-steroidal anti-
inflammatory drugs (NSAIDs) like ibuprofen (Straub and Cutolo, 2016). 
 
It is generally accepted that effector cells dominating the chronic inflammatory response 
are macrophages and T cells as opposed to acute inflammation where the principal 
inflammatory cells are neutrophils (Miyasaka et.al.,2016). The role of neutrophils in chronic 
inflammation is therefore less elucidated. For long it has been thought that their main 
contribution to chronic illness is through damaging host bystander cells, as they exhibit 
relatively low target specificity. However, new emerging evidence brings together a broader 
picture (Soehnlein et al., 2017). 
 
Chronic inflammation causes local changes in the inflamed tissue like fibrosis and a 
remodeled vascular network (Kis et al., 2011), but as time progresses systemic metabolic 
changes may occur. Hyperglycemia and hyperlipidemia accompanying the advancement of 
pathogenesis provoke extramedullary production of neutrophils, augmenting the influx to 
circulation (Nagareddy et al., 2013).  
 
Neutrophils have been implicated in the onset and progression of type-1 diabetes (Huang 
et al., 2016a). The granular cargo released during the course of inflammation was shown to 
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impair islet cells. This initiates the diabetogenic T-cell response and further advancement of 
disease. Anti-neutrophil treatments were demonstrated to delay and restrict the progression of 
type-1 diabetes (Huang et al., 2016b). 
 
Chronic obstructive pulmonary disease (COPD) is a wide-spread condition characterized 
by progressive tissue deterioration. A large body of evidence suggests that proteases released 
by neutrophils such as elastases are among the mediators of COPD (Hoenderdos and 
Condliffe, 2013).  
 
The role of neutrophils in allergic asthma is also backed by clinical evidence. Neutrophils 
are recruited into lungs of affected patients, especially during the acute phase of disease, 
promoting and prolonging symptoms. Also, neutrophil-attracting chemokines like IL-8 and 
IL-17 are prominent performers in uncontrolled asthma (Gao et al., 2017). Several studies 
showed that neutrophils also have a role in sensitization to different allergens like pollen. 
Exposure to allergens leads to neutrophil accumulation, which later on facilitates sensitization 
through insufficiently understood mechanisms (Arebro et al., 2017).  
 
Chronic kidney disease is another condition affected by inadequate neutrophil activity. 
Reactive oxygen species have been implicated in the development of proteinuria, modification 
of glomerular filtration pace and overall change in morphological and functional properties of 
glomerular cells (Stock et al., 2018). Matrix metalloproteinases and leukotrienes released by 
granular discharge cause changes in tissue structure and vascular network of the kidney. 
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Further on, the overexpression of adhesion molecules accompanying neutrophil migration was 
associated with the severity of glomerulonephritis (Mayadas et al., 2010). 
 
Chronic neurodegenerative disease, like Alzheimer’s is also influenced by neutrophils. 
Evidence suggests that granular proteins like neutrophil elastases and cathepsins exert 
neurotoxic effects (Stock et al., 2018). A recent study demonstrated that blocking a neutrophil 
receptor in a mouse model averted the influx of neutrophils to the brain, diminishing amyloid 
plaque and microgliosis. These animals also showed improvement in long-term memory (Cruz 
Hernández et al., 2019).  
 
Another inflammatory condition where neutrophils play an essential role is chronic gout 
(So, 2013). Because this particular context is central to the work done in this thesis, it will be 
examined in more detail in the next section.  
 4.1. Gouty arthritis 
 
  Gout or gouty arthritis is the most common cause of chronic inflammatory arthritis; over 
2% of people diagnosed with rheumatoid arthritis will also develop gout (Jebakumar et al., 
2013), and the number of patients that have both has steadily increased in past years. 
Prevalence of gout in men is much higher than in women, and the burden of disease increases 
with a rise of the underlying risk factors (Roddy and Choi, 2014; Roddy et al., 2007). Several 
lifestyle-dependent factors such as alcohol consumption, meat consumption, and a high BMI 
increase the risk of gout (Lee et al., 2006).  
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  The prerequisite of gout is the hyperuricemia, a condition so defined when serum uric acid 
levels rise above 6.8 mg/dl – the concentration of urate solubility at physiologic temperature 
and pH. When uric acid concentration exceeds the limit of solubility, it crystallizes as a 
sodium-containing salt (Neogi, 2012). Monosodium urate crystals (MSU) cause an extremely 
acute inflammatory reaction, that is commonly associated with a massive infiltration of 
neutrophils (Ryckman et al., 2003). Clinically, gout is described as repeated episodes of acute 
arthritis involving one joint at a time. The most common clinical characteristics of gout are its 
sudden onset, which is associated with a high level of pain and swelling of the affected joint 
that reaches its peak within approximately 6 to 12 h. After few days gouty arthritis undergoes 
spontaneous resolution (Eggebeen, 2007; Pittman and Bross, 1999; Steiger and Harper, 2014).  
 
  The exact mechanisms of gout initiation and resolution are not clearly defined although 
there is a model that can be suggested, based on the data available (Figure 7). Experiments 
with human serum in vitro demonstrated that MSU can activate a broad range of complement 
proteins of both the classical and alternative pathways. The activation of many complement 
proteins appears to involve direct interactions with the negatively-charged crystal surface, 
resulting in the generation of active C5a and C5b (Martin and Harper, 2010; Pekin and 
Zvaifler, 1964; Popa‐Nita and Naccache, 2010; Tramontini et al., 2004). Thus, complement 
complexes associated with MSU induce activation of residential macrophages, which in turn 
produce pro-inflammatory cytokines (IL-1 beta, IL-8, and TNF alpha). Pro-inflammatory 
cytokines like IL-1 beta increase surface expression of adhesion molecules on endothelial 
cells. Both IL-8 produced by macrophages and up-regulation of E-selectin expression by 
endothelial cells can induce neutrophil recruitment to the site of MSU deposition. The 
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consequences of neutrophil interaction with MSU crystals include the synthesis and release of 
a large variety of mediators that include ROS ( e.g. O2−, H2O2, O2, NO), LTB4, PGE2, anti-
microbial peptides, enzymes, cytokines, chemokines such as IL-8, and S100A8 and S100A9 
(Popa‐Nita and Naccache, 2010; Ryckman et al., 2003; Simchowitz et al., 1982). Neutrophils 
stimulated with MSU also show a significant delay in apoptosis, presumably leading to their 
persistent and prolonged activity during gouty inflammation (Akahoshi et al., 1997). Both 
increased recruitment and prolonged lifespan likely work together to accumulate large 
numbers of neutrophils within the joint.  
 
  As for the resolution of gout, several factors have been described to contribute to the 
process. It was shown that synoviocytes exposed to complement complexes isolated from 
arthritic joints produced the monocyte chemoattractant, MCP-1/CCL2 (Martin and Harper, 
2010). Recruited during the initiation phase of inflammation, monocytes differentiate into 
anti-inflammatory macrophages that start to produce TGFb (Yagnik et al., 2004). Another 
likely mechanism that triggers resolution in gout is the clearance of apoptotic leukocytes by 
macrophages. In acute inflammation, the recognition and ensuing phagocytosis of apoptotic 
neutrophils by macrophages also induces a switch from the activated inflammatory phenotype 
to one that promotes resolution and involves TGFb secretion (Fadok et al., 1998). Some of 
the molecules decorating MSU crystals are also potentially involved in gout attack resolution. 
Analysis of such proteins from MSU crystals isolated from both gout patients and animal 
models during the early stages of inflammation, showed that crystals are initially coated with 
complement-activating IgG. However, during the resolution phase, IgG is displaced by 
apolipoproteins (Martin and Harper, 2010; Ortiz-Bravo et al., 1993). The deliberate coating 
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of MSU crystals with apolipoproteins can indeed suppress ongoing activation of complement 
proteins (Ortiz-Bravo et al., 1993). An additional factor that is potentially involved in the 
resolution of MSU-induced inflammation was described recently. It was shown that MSU-
activated neutrophils form NETs that aggregate around the crystals. These aggregated NETs, 
like NETs induced by other stimuli, feature neutrophil proteases that can degrade 
inflammatory mediators (cytokines and chemokines) produced by neutrophils in response to 
MSU, thereby promoting the resolution of MSU-induced inflammation (Figure 7) (Schauer et 
al., 2014). 
 
Figure 7. Proposed model of monosodium urate (MSU) crystal-induced inflammation.  
Complement proteins are cleaved and activated at the crystal surface, whereas tissue-
associated macrophages phagocytose MSU crystals and generate proinflammatory cytokines. 
These signals initiate and augment neutrophil recruitment, aided by the activation of adhesion 
molecules such as E-selectin on endothelial cells. Recruited neutrophils activated after contact 
with MSU crystals, produce NETs and interleukin (IL)-8, IL1b, etc. augmenting neutrophil 
accumulation. Differentiation of recruited monocytes into macrophages allows TGFb 
production after either MSU stimulation or uptake of apoptotic neutrophils and contributes to 
resolution. Simultaneously, coating of MSU crystals with apoliprotein (Apo) B and Apo E 
blocks ongoing activation of complement proteins and local cells. Aggregated NETs 
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(aggNET) contribute to the resolution by degrading inflammatory mediators. (adapted from 
Martin and Harper, 2010 , authorization requested ref # 4657311356754) 
 
 
Drugs currently used for the treatment of the acute gout attack inhibit the amplification of 
the inflammatory response to MSU crystals. For example, colchicine, a drug with clinical 
efficacy in acute gout (Ahern et al., 1987), inhibits neutrophil recruitment and activation 
(Nuki, 2008; Roberge et al., 1994). Non-steroidal anti-inflammatory agents (NSAIDs) prevent 
release of PGE2 and other AA metabolites from various cells in response to MSU crystals 
(Gordon et al., 1985; Pouliot et al., 1998). However, these treatments also lead to undesirable 
side-effects, and not all patients respond satisfactorily (Information et al., 2018). There is 
therefore a need to learn more about MSU signaling, in order to target the various neutrophil 
products made in response to MSU. This is a prerequisite to the development of novel 
treatments to prevent or treat acute gout attacks, and will be explored in this thesis. 
 
  4.1.1. MSU signaling 
 
 The receptor (or complex of receptors) specifically recognizing MSU crystals at the surface 
of human neutrophils is still unidentified. Various proteins can be absorbed on the surface of 
MSU crystals, each of which could potentially bind to a surface receptor on neutrophils. It 
was reported that MSU activates both the classical and the alternative complement pathways 
in vitro (Doherty et al., 1983; Hasselbacher, 1979), and that complement components ( e.g. 
C1q, C1r, and C1s) can all bind to MSU crystals. Additionally, MSU crystals avidly bind to 
IgG; however, activation of the classical complement pathway by MSU does not require the 
presence of immunoglobulins (Giclas et al., 1979). 
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Recent studies of the mechanisms that drive neutrophil activation by MSU crystals 
have led to the suggestion that Src family tyrosine kinases (Popa-Nita et al., 2007), PKC 
(Popa-Nita et al., 2009), and PI3Ks (Popa-Nita et al., 2007) are key signaling events. Thus 
MSU crystals activate classical PKC isoforms, and this activation is necessary for the MSU-
induced degranulation and generation of chemotactic activity in neutrophil supernatants 
(Popa-Nita et al., 2009). Evidence was also obtained that the tyrosine kinase, Syk, is a 
substrate of PKC and that the PKC-mediated serine phosphorylation of Syk is necessary for 
its interaction with the regulatory subunit of PI3K (p85), and thus to the subsequent activation 
of PI3Ks, as well as that of the PI3K effector, Akt (Popa-Nita et al., 2007). However, MSU 
crystals induced the formation of a complex containing p85 and Syk, which was entirely 
abrogated by PP2, a Src family kinase inhibitor, suggesting that Src-mediated tyrosine 
phosphorylation of Syk is essential for its interaction with p85 (Popa-Nita et al., 2009). 
Likewise, it was shown that MSU crystals induce the rapid tyrosine phosphorylation of Tec 
in a Src-dependent manner (Popa-Nita et al., 2008). Inhibition of Tec reduced IL-8 production 
induced by MSU, which indicates that Tec is necessary for the MSU-induced secretion of IL-
8 from human neutrophils (Popa-Nita et al., 2008). In addition to IL-8, MSU is also known to 
promote the release of IL-1b and IL-1ra from neutrophils (Torres et al., 2009). The 
observation that MSU can activate PI3K (Popa-Nita et al., 2007), along with a recent 
demonstration that this kinase is involved in cytokine production (including that of IL-8) 
(Fortin et al., 2011), suggests that PI3Ks might contribute to MSU-induced cytokine 
production. 
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In addition to cytokine and lipid mediator production, degranulation, and oxidative 
burst, MSU-activated neutrophils have also been shown to form NETs (Schorn et al., 2012). 
However, pathways that control NET formation in response to MSU are poorly understood. 
Metroulis et al. demonstrated that both serum and synovial fluid from gout patients can induce 
NET formation by neutrophils from healthy donors. An IL-β inhibitor (Anakinra) partially 
prevented this response, showing that NET formation during gout might be driven at least in 
part by IL-1β. Additionally, NET formation in response to MSU was abolished by 3-
methyladenine (3-MA), which is commonly considered as an autophagy inhibitor, although 
its primary target is class III PI3K (Mitroulis et al., 2011). More evidence for a role of PI3K 
was obtained by use of the pan-PI3K inhibitor, LY294002, which also significantly prevented 
NET formation in response to MSU. In contrast, inhibition of Src had no effect. (Mitroulis et 
al., 2011). Weather NADPH oxidase is required for MSU-evoked NET release remains 
controversial. Schorn et al. demonstrated that in the presence of anti-oxidants (BHT, BHA 
and ascorbic acid) MSU-induced NET formation was disrupted, although no quantification 
data was presented (Schorn et al., 2012). Another study claimed that MSU-activated 
neutrophils from CGD patients failed to form aggregated NETs, also without relying on 
quantitative data analysis (Schauer et al., 2014). However, quantitative analysis performed by 
Linden et.al showed no significant NET inhibition by DPI in response to MSU (Linden et al., 
2017). The same study elucidated effect of p38 MAP kinase, Syk, mTORC2 and PI3K 
inhibition on MSU-induced NETosis. Inhibition of PI3K using wortmannin showed no effect, 
while inhibition of Syk, p38 and mTORC2 significantly decreased the NETosis rate (Linden 
et al., 2017).  
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Collectively, the molecular mechanisms underlying MSU-induced responses are not 
fully understood. There have been studies providing insights into the role of various kinases, 
but these studies on MSU-elicited NETosis have yielded controversial results. Further 
research into MSU signaling are therefore needed, and will be investigated in this thesis.
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HYPOTHESES AND OBJECTIVES 
 
The last decades of research provided new insights into the multiple roles of 
neutrophils during both acute and chronic inflammation. It is now well recognized that 
neutrophils are much more than the suicidal bacterial killers previously depicted in 
immunology textbooks. Neutrophils actually contribute to the course of inflammation by 
performing various functional responses. However, the mechanisms that control neutrophil 
functional responses are incompletely understood. In particular, there are areas of neutrophil 
biology that beg to be revisited and explored.  
 
One such area is NET formation, which is widely considered to be a ROS-dependent 
process despite the fact that several physiological inducers have little or no ability to activate 
the NADPH oxidase. Likewise, information concerning the signaling pathways upstream of 
NET formation is so fragmentary that few conclusions can be drawn. We therefore 
hypothesized that NET formation can occur independently of endogenous ROS, and that 
there must be some common elements among the pathways governing this response.  
Our objectives (Article 1) were to: 
 
1. Develop a specific and reliable method for NET quantification. 
2. Identify signaling events involved in NET formation. in response to physiological stimuli. 
3. Determine to which extent endogenous ROS are necessary for NET formation, and whether 
there exist other mechanims that are perhaps more central to the phenomenon.  
 
Another area of neutrophil biology that features unresolved issues is that of MSU 
interactions with these cells. There is the intriguing issue of neutrophils being the first cells 
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to invade gouty articulations, followed by monocytes. Under several inflammatory settings, 
neutrophils contribute to this sequential leukocyte recruitment, but whether such a scenario 
applies in MSU-activated cells remains surprisingly undocumented. Likewise, the full array 
of proteic mediators and intermediates being generated by neutrophils in response to MSU 
have not been explored. Finally, the signaling pathways mobilized by MSU and contributing 
to its various cellular responses have only been partially investigated. In particular, the fact 
that some immediate-early genes induced by MSU (e.g. IL-1, CXCL8) normally requires 
transcription factor activation in neutrophils, suggests that at least some can be mobilized by 
MSU. We therefore hypothesized that new, biologically relevant information can be gathered 
by examining the genomic and proteomic changes triggered by MSU in neutrophils; and that 
transcription factors are involved in the onset of gene transcription in response to the crystals.  
 
Our objectives (Article 2) were to: 
 
1. Investigate the genomic and proteomic changes elicited by MSU interactions with 
neutrophils.  
2. Characterize the signaling pathways mobilized in neutrophils by MSU, their 
interrelationships, and their impact on functional responses such as cytokine generation and 
NET formation  
3. Characterize transcriptional events participating in cytokine gene induction by MSU
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Abstract  
 
On connaît aux neutrophiles la capacité d’extruder leur chromatine décondensée pour former des 
« NETs » (Neutrophil Extracellular Traps). Ces structures immobilisent les agents pathogènes, ce 
qui empêche leur propagation et favorise leur élimination. Elles contiennent également des molécules 
antimicrobiennes. Les NETs influencent la pathogénèse de maladies inflammatoires chroniques, de 
maladies auto-immunes et de certains cancers. Malgré l'importance des NETs, les mécanismes 
moléculaires sous-tendant leur formation ainsi que les voies de signalisation en amont ne sont que 
partiellement élucidés. De même, les approches méthodologiques actuelles pour quantifier les NETs 
comportent d’importantes lacunes, en particulier des faux positifs parfois prédominants. 
 
Dans cette étude, de nouveaux polymères fluorescents ne liant que la chromatine extrudée ont été 
utilisés, ce qui permet une quantification spécifique et normalisée de la NETose. Cela nous a permis 
de classer de manière fiable l’efficacité relative de divers inducteurs physiologiques des NETs. Chez 
les neutrophiles activés par de tels stimuli, l'inhibition des voies de signalisation Syk ou PI3K bloque 
la NETose en affectant sur les événements tardifs de cette réponse. L'inhibition des voies TAK1, 
MAPK p38 ou MEK diminue également la NETose, mais en agissant sur des événements précoces. 
Par contre, l'inhibition de la PKC, des kinases de la famille Src ou de JNK n'affecte en rien la NETose; 
la cycloheximide ou l'actinomycine D sont tout aussi inefficaces. Tel qu’attendu, la formation de 
NETs est profondément compromise par l'inhibition de la NADPH oxydase chez des neutrophiles 
activés avec le PMA, mais s'est avérée indépendante des ROS en réponse à des agonistes 
physiologiques. A l’inverse, nous montrons pour la première fois que l’inhibition sélective de PAD4 
atténue efficacement la NETose en réponse à tous les stimuli testés. Nos données avancent 
considérablement les connaissances actuelles sur les voies de signalisation contrôlant la NETose, et 
révèlent notamment comment elles affectent les stades précoces ou tardifs du phénomène. Compte 
tenu de l'implication des NETs dans plusieurs pathologies, nos résultats identifier des cibles 
moléculaires pouvant être exploitées pour des thérapies futures. 
 
Abstract 
 
  Neutrophils are known to extrude decondensed chromatin, thus forming NETs 
(neutrophil extracellular traps). These structures immobilize pathogens, thereby preventing 
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their spreading, and are also adorned with antimicrobial molecules. NETs can also influence 
pathogenesis in chronic inflammation, autoimmunity, and cancer. Despite the importance of 
NETs, the molecular mechanisms underlying their formation, as well as the upstream 
signaling pathways involved, are only partially understood. Likewise, current 
methodological approaches to quantify NETs suffer from significant drawbacks, not the least 
being the inclusion of a significant nonspecific signal.  
 
   In this study, we used novel, fluorescent polymers that only bind extruded 
chromatin, allowing a specific and standardized quantification of NETosis. This allowed us 
to reliably rank the relative potency of various physiologic NET inducers. In neutrophils 
activated with such stimuli, inhibition of the Syk or PI3K pathways blocked NETosis by 
acting upon late events in NET formation. Inhibition of the TAK1, p38 MAPK, or MEK 
pathways also hindered NETosis, but by acting on early events. By contrast, inhibiting PKC, 
Src family kinases, or JNK failed to prevent NETosis; cycloheximide or actinomycin D were 
also ineffective. Expectedly, NET formation was deeply compromised following inhibition 
of the NADPH oxidase in PMA-activated neutrophils, but was found to be ROS-independent 
in response to physiological agonists. Conversely, we show for the first time in human 
neutrophils that selective inhibition of PAD4 potently prevents NETosis by all stimuli tested. 
Our data substantially extends current knowledge of the signaling pathways controlling 
NETosis, and reveals how they affect early or late stages of the phenomenon. In view of the 
involvement of NETs in several pathologies, our findings also identify molecular targets that 
could be exploited for therapeutic intervention. 
 
Introduction 
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  Neutrophils are a cornerstone of the innate immune system, by virtue of their 
phagocytic and microbicidal activities, which greatly contribute to pathogen clearance. In 
this context, an important neutrophil response is their ability to extrude decondensed 
chromatin, thus forming extracellular structures termed NETs (for neutrophil extracellular 
traps)[1]. The chromatin backbone of NETs entraps various microorganisms (bacteria, 
viruses, yeasts, and even some parasites)[1-3], and while DNA itself can exert antimicrobial 
effects[4], NETs feature histones, proteases and other components, which all participate in 
microorganism killing. The ability of neutrophils to undergo NETosis is conserved across 
vertebrates, from zebrafish to mammals, and has been observed in several in vivo settings, 
suggesting that it is an important defense mechanism. Experimental evidence supports this 
notion, insofar as intravenous injection of DNase in animals infected with bacteria or viruses 
increases bacteremia or viremia[5,6], confirming that NETs act (at the very least) to prevent 
microorganism dissemination.  
 
  Despite the foremost role NETosis in neutrophil biology, host defence, and 
pathophysiology, the underlying molecular mechanisms remain only partially understood. 
Several studies have shown that endogenous reactive oxygen species (ROS) are needed for 
NET formation. Accordingly, some ROS ( e.g. singlet oxygen, HOCl, H2O2) can directly 
induce NETs in neutrophils[7-10]. More direct evidence is that inhibiting either NADPH 
oxidase or myeloperoxidase prevents NET formation in response to PMA or bacteria[7,9-
11]. Similarly, neutrophils from chronic granulomatous disease patients, which are unable to 
generate ROS[12], fail to undergo NETosis in response to PMA[7]. As a result, it has become 
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widely accepted that NETosis is a ROS-dependent process. This is consistent with the fact 
that most of the studies on NETosis have employed PMA, a powerful NADPH oxidase 
activator. However, the phenomenon is also known to occur in response to stimuli that are 
ineffective ROS inducers, such as calcium ionophores, GM-CSF, TNFa, or IL-1b[11,13], 
which begs for the issue to be revisited.  
 
  Arginine deimination has emerged as another potential underpinning of NETosis, 
insofar as citrullinated proteins, PAD2, and PAD4 associate with NETs in response to 
inflammatory stimuli in humans[14,15]. In addition, pretreatment of human neutrophils with 
the general PAD inhibitor, chloraminidine, was found to hinder NETosis[16-21]. However, 
the actual PAD isoform responsible for this effect has yet to be identified in human 
neutrophils, even though studies conducted in knockout animals have suggested PAD4 as the 
main citrullinating enzyme(Li et al.; Martinod et al.; Kolaczkowska et al.). The recent 
availability of a selective PAD4 inhibitor, GSK484[22], at last offers an opportunity to 
further explore the matter in human neutrophils.  
 
  The intracellular signaling pathways acting upstream of NETosis have also begun 
to be elucidated. However, the overall picture remains blurred, as it mostly consists of 
isolated observations concerning individual pathways, made using different stimuli, and 
using different methods. Thus, the Syk and PI3K pathways appear to be crucial in 
neutrophils stimulated by PMA, inflammatory crystals, or b-glucan[23-25,13,26,27], but 
Syk seems to be dispensable for NETosis triggered by FcgRIIIb clustering[28]. For p38 
MAPK, Behnen et al. reported that it is needed for NET formation induced by immobilized 
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immune complexes(Behnen et al.), but other investigators found no involvement using 
different stimulatory conditions[29,30]. Similarly, MEK was reported to control NETosis 
in response to FcR engagement or calcium pyrophosphate crystals[23-25,13,26-28] but 
little is known about soluble stimuli. In the case of PKC, it was reported to be necessary for 
NETosis elicited by PMA or oxidized LDL[31,28,32], but not in response to mercury-
containing compounds[30]. Finally, one group reported that JNK is required for NETosis 
in cells stimulated by PMA, LPS, or bacteria (Khan et al) while another group showed that 
TAK1 can control NET formation in response to FcRIIIB clustering[23-25,13,26,27]. In 
summary, much remains to be done to sort, complete, and integrate the available 
information.  
 
  Finally, current methodological approaches to quantify NETs suffer from significant 
drawbacks, in particular the inclusion of an abundant nonspecific signal. Here, we describe 
a NET quantification approach based on novel fluorescent polymers that only bind extruded 
chromatin. This allows for a specific, reliable, standardized quantification of NETosis, and 
was applied to decipher some of the underlying mechanisms, as well as the upstream 
signaling pathways controlling the phenomenon.  
 
Materials and Methods 
 
  Antibodies and reagents. Antibodies against myeloperoxidase (A0398) were from 
Dako/Agilent (Mississauga, ON, Canada); antibodies against citrullinated histone H3 were 
from Abcam (Ab5103); phospho antibodies were from Cell Signaling (Beverly, MA, USA). 
Ficoll-Paque Plus was from GE Biosciences (Baie d’Urfé, Qc, Canada); endotoxin-free (< 
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2 pg/ml) RPMI 1640 was from Wisent (St-Bruno, Qc, Canada). Recombinant human 
cytokines were from R&D Systems (Minneapolis, MN, USA). Actinomycin D, 
cycloheximide, N-formyl-methionyl-phenylalanine (fMLP), and phenylmethanesulphonyl 
fluoride (PMSF) were from Sigma (St. Louis, MO, USA). Kinase inhibitors and fluorescent 
probes were all purchased through Cedarlane Labs (Missisauga, Canada). PlaNET reagents, 
fluorescent chromatin-binding polymers, were from Sunshine Antibodies 
(https://sunshineantibodies.com/planet-001.html).  
 
  Cell isolation and culture. Neutrophils were isolated from the peripheral blood of 
healthy donors, under a protocol approved by an institutional ethics committee (Comité 
d’éthique de la recherche du CIUSS de l’Estrie-CHUS). All subjects gave written informed 
consent in accordance with the Declaration of Helsinki. Briefly, whole blood was collected 
using an anticoagulant (sodium citrate), and successively submitted to dextran sedimentation, 
Ficoll separation, and water lysis – as previously described[33]. The entire procedure was 
carried out at room temperature and under endotoxin-free conditions. As determined by 
Wright staining and FACS analysis, final neutrophil suspensions contained fewer than 0.1% 
monocytes or lymphocytes; neutrophil viability exceeded 98% after 4 h in culture, as 
determined by trypan blue exclusion and by Annexin V/propidium iodide FACS analysis.  
 
  NETosis assays. For each condition, a 500-µl drop of a neutrophil suspension 
(2x106/ml in RPMI 1640/2% autologous serum) was deposited onto coverslips that were 
freshly coated with poly-L-lysine, and the cells were left to adhere for 60 min in a cell culture 
incubator. Inhibitors and/or stimuli were then added and the final volume brought to 550 µl, 
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prior to a 4-h incubation (37°C, 5% CO2). Reactions were stopped by adding 500 µl ice-cold 
PBS containing 1 mM PMSF, and the coverslips were placed on ice for 10 min. At this point, 
one of two procedures were followed.  
 
  When antibodies were used for NET detection, the liquid on the coverslips was 
discarded and cells were fixed for 15 min in ice-cold PBS containing 2% paraformaldehyde, 
as well as a nuclear stain ( e.g. DAPI, Hoechst 33342). The fixed cells were then washed 
with ice-cold PBS, and blocked for 60 min with PBS containing 5% normal goat serum (i.e. 
serum from the same species in which the 2nd antibody was raised), hereafter referred to as 
Blocking Buffer. Cells were next incubated in PBS containing the primary antibody (anti 
MPO, 1:1000) for 90 min, washed, and incubated 45 min with an Alexa 568-labeled 
secondary Ab (goat anti-rabbit, Molecular Probes #A11011, 1:2000) in Blocking Buffer. 
Coverslips were then mounted onto glass slides using a drop of mounting medium (ProLong 
Gold, Life Technologies) and sealed, prior to epifluorescence microscopy analysis.  
 
  When PlaNET reagents were used for NET detection, the liquid on the coverslips was 
discarded and cells were incubated (90 min on ice, with gentle shaking) in 1 ml of PBS 
containing 1 mM PMSF and diluted PlaNET reagent (as recommended by the manufacturer). 
Cells were finally fixed (15 min, room temperature) in PBS containing 2% 
paraformaldehyde, as well as a nuclear stain. The fixed cells were washed once with PBS, 
and the coverslips were mounted as described above, and analyzed by epifluorescence 
microscopy. For quantitation, 3 fields at 10x magnification were counted, that never included 
the coverslip edges; this amounts to about 1,000 neutrophils in total. 
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  Immunoblots. Samples were prepared, electrophoresed, transferred onto 
nitrocellulose, and processed for immunoblot analysis as previously described[34,35].  
 
  Data analysis. All data are represented as mean ± SEM. Unless otherwise stated, 
statistical differences were analyzed by Student’s t-test for paired data, using Prism 7 
software (GraphPad, San Diego, CA, USA).  
Results 
  A new approach to visualize and quantify NET formation. Various procedures have 
been used for this purpose, yet they all suffer significant drawbacks, not the least of which 
is the inclusion of a false positive fluorescence signal. A widespread approach is to incubate 
neutrophils with a DNA dye ( e.g. Sytox Green) that is described as cell-impermeable by 
its manufacturer, and to analyze total fluorescence in the supernatants. However, we 
observed that over a concentration range that is far inferior to commonly used (i.e. 5-10 
µM) Sytox Green concentrations[31,36-39], the dye rapidly and dose-dependently leaks 
into living cells (Fig 1A). A notable effect was consistently detected after only 15 min using 
just 100 nM of the dye, and massive leaking was observed using 1 µM by 30 min in 
unstimulated cells (Fig 1A). This was not due to nonspecific staining by Sytox Green of 
DNA from necrotic cells, since the latter were undetectable at short incubation times, as 
determined by a lack of PI staining (not shown). Neither did the cell-associated Sytox Green 
fluorescence result from its staining extracellular DNA, as few NETs were ever observed 
in unstimulated cells, and accordingly, virtually all the fluorescent signal was still present 
following DNase I digestion under these conditions (Fig 1B, left panels). In fMLP-
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stimulated cells, some NETs were observed using Sytox Green, as expected, but much of 
the extracellular signal was not associated with extruded DNA, as it was impervious to 
DNase treatment (Fig 1B, right panels). Thus, the use of Sytox Green entails a large, cell-
permeable, nonspecific signal that cannot be easily distinguished from NET-associated 
fluorescence (unless DNase-treated samples are always processed in parallel).  
 
 
 A1 Figure 1. Detection of NETs using Sytox Green in human neutrophils.  
 
(A) Unstimulated neutrophils were cultured in suspension for the indicated times in the presence of 
increasing concentrations of Sytox Green, prior to the addition of Hoechst 33342 and subsequent 
fluorescence microscopy analysis of unfixed cells. Total Sytox Green fluorescence values were 
divided by total Hoechst 33342 fluorescence, to normalize for cell number. Mean ± s.e.m. from 
duplicate measurements for each experimental condition from a representative experiment, shown on 
the right at 10X magnification. (B) Neutrophils were cultured for 4 h on poly-L-lysine coated 
coverslips with the indicated Sytox Green concentrations, in the absence (“ctrl”) or presence of 30 
nM fMLP. The cells were then digested or not with DNase I (100 U/ml, 30 min, 37°C), then stained 
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with Hoechst 33342, prior to fluorescence microscopy analysis. A representative experiment is shown 
(at 40X magnification).  
 
  Another common approach is to stain NETs using antibodies directed against 
associated proteins. However, this can be misleading as several such proteins ( e.g. MPO, 
elastase) readily associate with cell membranes upon their release from the cells[40,41]. 
And indeed, an important fluorescence signal remains near the cell surface following DNase 
digestion of NETs when the latter are detected using anti-MPO Abs (Fig 2A). This was not 
due to residual background staining, since no second antibody fluorescence (Alexa 568) 
was detectable when the experiment was repeated using an isotype control rabbit antibody 
in substitution for the anti MPO primary antibody (Fig S1).  
 
A1 Figure S 1. Isotope control experiment for MPO NET detection. 
 
Neutrophils cultured on poly-L-lysine-coated coverslips were incubated for 4 h in the presence of 
30nM fMLP. Fixed cells were blocked with PBS containing 5% normal goat serum and DAPI, 
incubated with rabbit IgG at the same concentration as the anti-MPO rabbit IgG, and further incubated 
with goat anti-rabbit-Alexa 568, prior to fluorescent microscopy analysis. A representative 
experiment is shown (10X magnification). 
 
 Thus, commonly used approaches based on the detection of NET-associated granule 
proteins, or on Sytox Green staining, are fraught with complications when total fluorescence 
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is counted (as is usually the case), as it includes a substantial (and often predominant) 
nonspecific signal.  
 
 
A1 Figure 2. Detection of NETs using MPO or PlaNET reagents in human neutrophils.  
(A) Neutrophils cultured on poly-L-lysine-coated coverslips were incubated for 4 h in the absence 
(“ctrl”) or presence of 30 nM fMLP, and digested or not with DNase I, prior to fluorescent microscopy 
detection of MPO as described in Methods. A representative experiment is shown (40X 
magnification). (B) Neutrophils cultured on poly-L-lysine-coated coverslips were incubated for 4 h 
in the absence (“ctrl”) or presence of 30 nM fMLP, and further incubated in the presence or absence 
of DNase I (100 U/ml, 30 min, 37°C), prior to fluorescent microscopy detection of NETs using 
PlaNET Green and Hoechst 33342 counterstaining, as described in Methods. A representative 
experiment is shown (40X magnification). (C) Neutrophils were treated as described in (B); 
fluorescent microscopy detection of NETs was conducted using PlaNET Blue and propidium iodide 
counterstaining (5 µM, 20 min), as described in Methods. A representative experiment is shown (40X 
magnification).  
 
  In an attempt to overcome this shortcoming, we resorted to PlaNET reagents 
– newly developed NET detection reagents that are based on fluorescent, chromatin-binding 
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polymers. As shown in Fig 2B and Fig 2C, PlaNET reagents strongly stain NETs in 
activated cells, and DNase I digestion completely obliterates the PlaNET reagent signal, 
thereby showing that is strictly extracellular. In agreement with these findings, PlaNET 
fluorescnce was also undetectable in cells that were deliberately made necrotic (Fig S2).  
 
 
A1 Figure S 2. PlaNET reagents do not stain necrotic cells. 
 
Neutrophils were cultured overnight without stimulation in 6-well plates, and cells that detached from 
the plates (i.e. necrotic cells) were collected. Necrotic cells were processed following the PlaNET 
Green procedure described in Methods, with the exception that propidium iodide was included (in 
addition to DAPI) during the final fixation step, to confirm that the cells were indeed necrotic. A 
representative experiment is shown (10X   magnification). 
 
 Thus, measuring total PlaNET reagent fluorescence proves to be a straightforward and 
specific way of assessing NETosis, independently of necrosis. To ensure optimal 
  96 
comparisons between samples and experiments, PlaNET fluorescence can be standardized. 
To this end, we developed a Java-based plug-in (available at 
http://mcdonaldlab.co.nf/McDonald_Lab/plugin.html) that counts total PlaNET 
fluorescence and divides it by the number of events (i.e. cells) in the fluorescence channel 
used for the DNA counterstain, yielding standardized NETosis values.  
 
 Induction of NET generation by various stimuli, and signaling pathways involved. We 
used this standardized approach to assess NETosis induction by various neutrophil agonists. 
As shown in Fig 3A, few unstimulated neutrophils generate NETs after a 4-h incubation 
period, whereas exposure to various physiological stimuli, or to PMA, results in abundant 
NET formation. By standardizing NETosis using the Java plug-in, we could compare the 
relative ability of the stimuli to induce this response; fMLP and PMA stood out as the most 
potent inducers, with TNFa and GM-CSF following not far behind (Fig 3B), though 
differences among these stimuli were not found to be statistically significant by one-way 
ANOVA analysis. Several other physiological stimuli (namely, C5a, PAF, IL-8) were also 
found to promote NET formation, albeit less potently (p<0.01 using one-way ANOVA with 
Dunnett’s correction) than fMLP, GM-CSF, or TNF (Fig 3C); in these experiments, we 
used PlaNET Blue, as it offers an even better signal-to-noise ratio than PlaNET Green. 
Finally, other neutrophil stimuli ( e.g. LTB, IFNg) failed to stimulate NETosis altogether 
(Fig 3C).  
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A1 Figure 3. Relative potency of physiological neutrophil agonists or PMA to induce NETosis. 
 (A) Neutrophils cultured on poly-L-lysine-coated coverslips were incubated for 4h in the absence 
(“ctrl”) or presence of 30 nM fMLP, 1 nM GM-CSF, 100 U/ml TNFa, or 50 nM PMA. NETosis was 
then assessed using PlaNET Green as described in Methods. Representative fields are shown at 40X 
magnification. (B) Quantitative representation of the above experiments, in which PlaNET Green 
fluorescence values were standardized according to total cell number (i.e. the number of individual 
events detected using a cell-permeable nuclear stain), thus yielding a NETosis index. Mean ± s.e.m. 
from at least 5 independent experiments. ***, p<0.001 vs unstimulated cells. (C) Neutrophils were 
cultured as described above for 4h in the absence (“ctrl”) or presence of 30 nM fMLP, 1 nM GM-
CSF, 100 U/ml TNFa, 50 nM PMA, 30 nM C5a, 50 nM PAF, 100 U/ml IFNg, 100 nM LTB4, or 10 
nM IL-8. Quantitative representation of these experiments, in which PlaNET Blue fluorescence 
values were standardized as described in (B). Mean ± s.e.m. from 3 independent experiments. **, 
p<0.02 vs unstimulated cells.  
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  We next blocked discrete signaling intermediates using selective inhibitors, prior to 
stimulation with physiological agonists or PMA, to identify which pathways control NET 
generation. As shown in Fig 4A, inhibitors of TAK1, MEK, or p38 MAPK potently 
hindered NETosis in response to GM-CSF, fMLP, or TNFa. In the case of PMA-elicited 
NETosis, MEK and p38 MAPK inhibition also affected this response, but TAK1 inhibition 
failed to do so – in keeping with the fact that PMA does not activate TAK1 in neutrophils 
(our unpublished data). Accordingly, the PMA-induced phosphorylation of ERK, p38 
MAPK and Akt were similarly unaffected by TAK1 inhibition (Fig S3). By comparison, 
inhibition of the Syk, PI3K, and JNK pathways nearly or completely abrogated NET 
formation in response to all agonists tested (Fig 4A). Finally, inhibition of Src tyrosine 
kinases consistently failed to interfere with NETosis (Fig 4A). Likewise, inhibition of PKC 
impaired NETosis elicited by PMA, as expected, but not in response to physiological stimuli 
(Fig 4A).  
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A1 Figure 4. Signaling pathways controlling NETosis induced by physiological neutrophil 
agonists or PMA.  
Neutrophils cultured on poly-L-lysine-coated coverslips were pre-treated (15 min, 37°C) with 
the following inhibitors or their diluent (DMSO): 10 µM piceatannol (Syk inhibitor); 10 µM SrcI1 
(Src family kinase inhibitor); 10 µM LY294002 (PI3K inhibitor); 1 µM (5Z)-7-oxozeaenol (TAK1 
inhibitor); 1 µM SB202190 (p38 MAPK inhibitor); 10 µM U0126 (MEK inhibitor); 10 µM SP600125 
(JNK inhibitor); 10 µM JNK inhibitor VIII (a different JNK inhibitor); 5 µM AS601285 (a third JNK 
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inhibitor); 10 µM Gö6976 (a PKC inhibitor). The cells were then further incubated for 4h in the 
absence (“ctrl”) or presence of 30 nM fMLP, 1 nM GM-CSF, 100 U/ml TNFa, or 50 nM PMA. 
NETosis was assessed using PlaNET Green as described in Methods. (A) Quantitative representation 
of these experiments, expressed as NETosis index. Mean ± s.e.m. from at least 3 independent 
experiments. *, p<0.05; **, p<0.01 vs stimulus alone. (B) Representative fields for each experimental 
condition are shown at 10X magnification.  
 
  In addition to the above quantitative data, direct microscopic observation revealed 
qualitative differences between the effects of the various inhibitors towards NETosis. As 
shown in Fig 4B, inhibition of TAK1, MEK, or p38 MAPK yielded much shorter 
extracellular chromatin filaments, with little or no interconnectivity, whereas chromatin 
extrusion per se was clearly less affected. This suggests that chromatin extrusion and 
filament elongation and/or branching could represent distinct steps in the NETosis process. 
By comparison, cell pretreatment with inhibitors of Syk or PI3K, or the JNK inhibitor, 
SP600125 (Fig 4B), resulted in little or no chromatin extrusion, suggesting that they prevent 
this step (or perhaps upstream events). The particular case of JNK inhibition was 
particularly intriguing, given that some of the stimuli used ( e.g. fMLP, GM-CSF, PMA) do 
not promote the phosphorylation of JNK in neutrophils, and can therefore hardly induce 
neutrophil responses by acting via this kinase. To ensure that the inhibition of NETosis by 
SP600125 cannot be attributed to nonspecific effects, we used a potent and structurally 
unrelated JNK inhibitor (called JNK inhibitor VIII). As shown in Fig 4A (last bar) and Fig 
4B (last pane), NETosis was unaffected using this second JNK inhibitor, for all stimuli 
tested. Similarly, a third JNK inhibitor, AS601245, also failed to affect NETosis (Fig 4A). 
Together, these observations make it very unlikely that JNK participates in controlling 
NETosis.  
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  Because Syk and PI3K emerged as important upstream intermediates controlling 
NETosis, we next investigated whether this reflects early or late signaling events, given that 
NETosis requires 3-4 h to be effectively detected. To this end, kinase inhibitors were either 
added 15 min before neutrophil stimulation, or 60 to 120 min afterwards. As shown in Fig 
5A, NET formation was effectively prevented even when the Syk and PI3K inhibitors were 
added 120 min post-stimulation, indicating that these pathways are mobilized late in the 
NETosis phenomenon. Similar results were obtained using SP600125 (Fig S4), though this 
likely reflects off-target effects, as explained above. By contrast, addition of TAK1, p38 
MAPK, or MEK inhibitors 60 to 120 min after neutrophil stimulation failed to affect NET 
formation (Fig 5A and data not shown), indicating that the contribution of these kinases 
occurs early in the induction of NETosis. Because stimulated neutrophils express several 
cytokine and chemokine genes (and release the corresponding proteins) in the same time 
frame required for NET formation, and since several such products are NET inducers, we 
also examined whether gene transcription or de novo protein synthesis might participate in 
NETosis. As shown in Fig 5B, the blockade of transcription (using actinomycin D) or of 
protein synthesis (using cycloheximide) failed to alter NETosis elicited by physiological 
stimuli or PMA.  
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A1 Figure 5. Identification of early and late processes underlying NET generation.  
(A) Neutrophils cultured on poly-L-lysine-coated coverslips were treated either before or after 
stimulation for the indicated times with the following inhibitors or their diluent (DMSO): 10 µM 
piceatannol (“pic”, Syk inhibitor); 10 µM LY294002 (PI3K inhibitor); 1 µM (5Z)-7-oxozeaenol 
(TAK1 inhibitor); 1 µM SB202190 (p38 MAPK inhibitor); 10 µM U0126 (MEK inhibitor). The cells 
were also stimulated for 4h in the absence (“ctrl”) or presence of 30 nM fMLP, 1 nM GM-CSF, 100 
U/ml TNFa, or 50 nM PMA. NETosis was then assessed using PlaNET Green as described in 
Methods. Quantitative representation of these experiments, expressed as NETosis index. Mean ± 
s.e.m. from 3 independent experiments. *, p<0.05; **, p<0.01 vs stimulus alone. (B) Neutrophils 
cultured on poly-L-lysine-coated coverslips were pre-treated (15 min, 37°C) with 20 µg/ml 
cycloheximide, 5 µg/ml actinomycin D, or their diluent (DMSO), prior to a further incubation of 4h 
in the absence (“ctrl”) or presence of 30 nM fMLP, 1 nM GM-CSF, 100 U/ml TNFa, or 50 nM PMA. 
NETosis was then assessed using PlaNET Green as described in Methods. Quantitative representation 
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of these experiments, expressed as NETosis index. Mean ± s.e.m. from at least 3 independent 
experiments.  
  
  Involvement of endogenous ROS and PAD4 in NET generation. Because NETosis 
can be induced by stimuli that are ineffective ROS inducers[11,13], it would seem that 
under some circumstances, NETosis must take place independently of ROS production. To 
investigate the issue, neutrophils were pretreated with DPI (a NADPH oxidase inhibitor), 
prior to stimulation. As expected, PMA-elicited NETosis was almost entirely dependent on 
NADPH oxidase activation (Fig 6A). NET formation in response to fMLP was also 
significantly affected by DPI, but to a far lesser extent (Fig 6A). In contrast, TNF- or GM-
CSF-induced NETosis were not significantly inhibited by DPI (Fig 6A). These results show 
that the phenomenon is largely ROS-independent in response to various physiological 
agonists.  
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A1 Figure 6. Involvement of endogenous ROS and PAD4 in NET generation.  
(A) Neutrophils cultured on poly-L-lysine-coated coverslips were pre-treated (15 min, 37°C) with 10 
µM DPI or its diluent (DMSO), prior to a further incubation of 4h in the absence (“ctrl”) or presence 
of 30 nM fMLP, 1 nM GM-CSF, 100 U/ml TNFa, or 50 nM PMA. NETosis was then assessed using 
PlaNET Green as described in Methods. Quantitative representation of these experiments, expressed 
as NETosis index. Mean ± s.e.m. from at least 5 independent experiments. **, p<0.01; ***, p<0.0001 
vs stimulus alone. (B) Neutrophils cultured on poly-L-lysine-coated coverslips were pre-treated (15 
min, 37°C) with 10 µM chloraminidine (“Cl-A”, a general PAD inhibitor), 10 µM GSK484 (a PAD4 
inhibitor), or their diluent (DMSO), prior to a further incubation of 4h in the absence (“ctrl”) or 
presence of the above stimuli, followed by determination of the NETosis index. Mean ± s.e.m. from 
at least 4 independent experiments. *, p<0.04; **, p<0.01; ***, p<0.001 vs stimulus alone.  
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  Arginine deimination has also been proposed to participate in NETosis, insofar as 
PAD inhibition or deficiency hinders NETosis[16-19]. To further investigate the role of 
PAD4 in NETosis, we pretreated neutrophils with either chloraminidine (a general PAD 
inhibitor) or GSK484 (a selective PAD4 inhibitor)[22], prior to stimulation with 
physiological agonists or PMA. Both inhibitors abrogated the citrullination of histone H3, 
as expected (Fig S5). As shown in Fig 6B, both chloraminidine and GSK484 strongly 
inhibited NET formation under all conditions tested. NETosis therefore appears to involve 
PAD4 in human neutrophils. Worthy of note is that chloraminidine did not retain its potency 
for more than a month after having been prepared; care should therefore be taken to use 
only freshly-prepared stocks of this inhibitor.  
 
Discussion 
 Since its discovery a dozen years ago, NETosis has emerged as a major neutrophil 
functional response, and its study represents an area of intense ongoing research. Whereas 
diverse methods have been used to assess NETosis, most suffer from significant drawbacks, 
in particular the inclusion of a false positive signal that can often be predominant. In this 
study, we used newly developed fluorescent reagents that allow a streamlined, reliable, and 
standardized assessement of NET formation. This allowed us to quantitatively compare 
NETosis induction by various physiological stimuli, to shed a new light on the signaling 
pathways involved, and to unveil some of the underlying mechanisms.  
 Using PlaNET reagents, we showed that NETosis can be measured specifically, insofar 
as the entire signal disappears following DNase I digestion – unlike widely used assays 
based on the detection of NET-associated proteins (such as myeloperoxidase or elastase), 
in which a strong fluorescent signal remains after DNase treatment, possibly reflecting the 
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propensity of several neutrophil granule proteins to strongly associate with cell membranes 
upon their release from the cells[40,41]. Likewise, PlaNET reagents do not enter live or 
necrotic cells, unlike widely used detection reagents such as Sytox Green, which do so 
rapidly and in a concentration-dependent manner. A workaround for the shortcomings of 
conventional approaches to assess NETosis would be to always carry out experiments in 
the presence and absence of DNase digestion, even though this would automatically double 
the size and cost of any experiment. Thus, the specificity of PlaNET reagents represents a 
major advantage over commonly used approaches to study NETosis. This being said, 
PlaNET reagents are not without some drawbacks, as we found that they are not completely 
suitable for kinetic assessment of NETosis in microtiter plate assays. This is because 
neutrophils co-incubated with PlaNET reagents somehow ingest some of the polymers, 
resulting in a non specific signal. This could be prevented by including PMSF in the culture 
medium, but whether incubation of living cells in the continued presence of this inhibitor 
might affect other processes would be a potential concern. For this reason, we would not 
advise using PlaNET reagents for kinetics studies in a plate reader.  
 We also developed a simple Java plug-in to standardize NETosis measurement based 
on the total number of neutrophils, and found that doing so helps minimize both intra-
experiment and inter-donor variation. In this regard, another group recently reported similar 
benefits from standardizing NET detection[42], though they used Sytox Green which we 
(and other investigators) found to enter the cells to a significant degree. Another important 
benefit of standardizing is that it allowed us to quantitate the relative ability of various 
stimuli to elicit NETosis, and the extent to which various inhibitors affect the phenomenon. 
Thus, we found that fMLP, PMA, TNF, and GM-CSF are potent inducers; IL-8 are also a 
good inducer, but comparatively weaker; finally, C5a and PAF proved to be weak stimuli. 
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Conversely, certain neutrophil activators were found to induce little or no NET formation ( 
e.g. LTB4, IFN𝛾), showing that not all neutrophil stimuli act as NET inducers.  
 Pharmacological blockade of various signaling pathways revealed that several kinases 
( e.g. Syk, PI3K, TAK1, p38 MAPK, MEK) profoundly affect NETosis. Although Syk and 
PI3K inhibitors were consistently more effective than the ones for TAK1 and the MAP 
kinases, this difference was not found to be statistically significant by one-way ANOVA 
analysis. By contrast, inhibition of Src tyrosine kinases consistently failed to interfere with 
NETosis. For physiological stimuli such as TNF⍺, fMLP, or GM-CSF, our data are 
consistent with our previous findings, which showed that they can all signal through the 
TAK1-MEK or TAK1-p38 axes in neutrophils[43,44]. Conversely, PMA does not activate 
TAK1 in these cells (our unpublished data), and accordingly, TAK1 inhibition had no 
significant effect on PMA-elicited NETosis. In the particular case of JNK inhibition, we 
found it surprising that in TNF-stimulated neutrophils, TAK1 inhibition of NETosis was 
less pronounced than that exerted by the widely used JNK inhibitor, SP600125, given that 
TNF activates JNK downstream of TAK1 in these cells[43]. Likewise, we found it peculiar 
that SP600125 should abrogate NETosis even when ineffective JNK activators ( e.g. PMA, 
fMLP, GM-CSF) were used as stimuli. In this regard, SP600125 is known to exert 
nonspecific effects towards 13 other kinases[45], and to even inhibit PI3K as effectively as 
wortmannin in mast cells[46]. The latter observation is particularly alarming, in view of 
how potently PI3K inhibition prevents NETosis, as shown herein and in other 
studies[47,48]. Together, the above considerations cast a serious doubt as to whether 
SP600125 affects NETosis through JNK inhibition, as opposed to off-target actions. To 
settle the matter, we resorted to very selective, structurally unrelated JNK inhibitors (i.e. 
JNK inhibitor VIII and AS601285), which both failed to affect NETosis in response to all 
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stimuli tested. This is compelling evidence that JNK does not control the phenomenon. This 
conclusion contrasts with a recent study, in which SP600125 and TCSJNK6o (also known 
as JNK inhibitor VIII) obliterated LPS-induced NETosis while they only minimally 
affected the phenomenon in PMA-treated cells, using a Sytox Green-based NET assay[39]. 
This discrepancy between their data and ours is not easy to resolve, especially since we used 
similar concentrations of PMA and JNK inhibitors. However, the experimental procedures 
differ significantly. Because we thoroughly controlled for false positives (i.e. DNAse-
insensitive or necrotic cell-derived signals) when assessing NETosis, and because we used 
three different JNK inhibitors, we stand by our conclusion, that JNK does not control 
NETosis in response to several classes of neutrophil stimuli.  
 Previous reports had already shown that Syk and PI3K are crucial for PMA-induced 
NETosis[49,47,48]. Our data confirm these observations, but more importantly, reinforce 
their significance by demonstrating that this is also true of NETosis triggered by 
physiological stimuli. We further showed that Syk and PI3K do so by acting upon chromatin 
extrusion or upstream processes, and that this involves late signaling events in NETosis 
(occurring at about 120 min of stimulation). This is a major new observation. The nature of 
the late processes affecting NETosis, however, remains elusive. We could exclude newly-
made cytokines and chemokines as potential candidates, even though they are produced in 
the right time frame and are potent NET inducers, since neither cycloheximide nor 
actinomycin D were found to affect NETosis in response to any of the stimuli used. Khan 
and colleagues similarly observed that cycloheximide does not affect NET formation in 
response to PMA or ionomycin, but reported that actinomycin D blocks the 
phenomenon[50]. However, another group[51] found no effect of either cycloheximide or 
actinomycin D on NETosis elicited by PMA or C. albicans, in full agreement with our data. 
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Thus, while it is quite clear that de novo protein synthesis does not contribute to NET 
formation, there is growing evidence for a similar conclusion in the case of gene 
transcription. In contrast to Syk and PI3K, other kinases (i.e. TAK1, p38 MAPK, MEK) 
seem to control early events (within the first 15 min) of the NETosis process, and to 
influence the length and degree of branching of extruded chromatin filaments, as opposed 
to chromatin extrusion itself. Studies are in progress to further define each aspect of the 
NETosis phenomenon.  
 We finally revisited the issue of whether NETosis is a ROS-dependent process. In this 
regard, it is noteworthy that the bulk of available data has been obtained using powerful 
NADPH oxidase activators, such as PMA or bacterial phagocytosis. However, NETosis has 
also been observed in response to stimuli that are ineffective ROS inducers, such as 
ionomycin, GM-CSF, TNF⍺, or IL-1[11,13]. We confirmed herein that PMA-induced 
NETosis is indeed ROS-dependent (and PKC-dependent), but also show that NETosis 
occurring in response to various classes of physiologic stimuli is largely unaffected by 
inhibition of the NADPH oxidase or of PKC. These observations agree well with recent 
studies, which have shown that NETosis can take place in a ROS-independent fashion 
following neutrophil exposure to uric acid, mercury, nicotine, immune complexes, or 
endotoxin[52,30,20,42,53]. Our data therefore adds to the mounting evidence that 
endogenous ROS are far from essential for NETosis, though they can certainly contribute to 
the process under some circumstances. By contrast, we found that NETosis occurring in 
response to all stimuli investigated (including PMA) depends on PAD4. Previous reports had 
reached a similar conclusion, based on the fact that chloraminidine prevents NET formation 
in response to calcium ionophores, bacteria, IL-8, PMA, or even nicotine[16,20,21]. 
However, chloraminidine is a general PAD inhibitor that does not discriminate between PAD 
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isoforms, and both PAD2 and PAD4 have been observed on NETs in a pathological setting 
in humans[15]. Mouse studies have suggested that PAD4 might be the relevant molecule, 
insofar as NETosis does not occur in PAD4-deficient animals[17-19], whereas PAD2 is 
dispensable[54]. Our finding, that a selective PAD4 inhibitor prevents NETosis as well as 
chloraminidine in human neutrophils, represents the first demonstration that PAD4 is also 
the relevant PAD isoform in humans. Thus, it appears that NETosis is a PAD4-dependent 
phenomenon that may also require endogenous ROS, depending on the stimulatory 
conditions. This represents a significant shift in how NETosis has heretofore been viewed.  
 In summary, we describe a reliable and specific appoach to assess NETosis. This 
allowed us to determine the relative potency of various physiologic NET inducers; to extend 
our knowledge of the signaling pathways involved, and of how they affect early or late 
stages of the phenomenon; and to identify PAD4 as required for NETosis, whereas ROS do 
not necessarily contribute to this response. In view of the involvement of NETs in several 
pathologies, our findings reveal potential molecular targets that could be exploited for 
therapeutic intervention. In this regard, inhibitors of several such molecules are already in 
phase I/II clinical trials[55-60].  
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Abstract 
 
Objectif. La goutte est une maladie fréquente et invalidante déclenchée par le dépôt de 
cristaux d’urate monosodique (MSU) dans les articulations, lesquelles sont massivement 
infiltrées par des neutrophiles. Bien que certains éléments de signalisation utilisés par le 
MSU chez les neutrophiles aient été décrits, le portrait global demeure très incomplet. De 
façon semblable, l’impact des divers événements de signalisation sur les réponses 
cellulaires est loin d’être complètement élucidé. Dans cette étude, nous avons examiné les 
modifications génomiques et protéomiques déclenchées par le MSU chez les neutrophiles 
humains, ainsi que le rôle de différentes voies de signalisation dans plusieurs réponses 
fonctionnelles importantes de ces cellules. 
 
Méthodes. Les neutrophiles humains ont été stimulés avec du MSU et une analyse 
génétique par micropuces a été réalisée; et les protéines correspondant aux gènes les plus 
induits ont aussi été investiguées. Les voies de signalisation affectées par le MSU et leur 
relation avec les kinases en amont ont été examinées par immunobuvardage. Les facteurs 
de transcription activés par le MSU ont eux aussi été étudiés. L’impact des intermédiaires 
de signalisation sur la production de cytokines et la formation de NETs (Neutrophil 
Extracellular Traps) a été quantifié, respectivement, par ELISA et microscopie à 
fluorescence. 
 
Résultats. Nous rapportons pour la première fois que les neutrophiles peuvent sécréter du 
CCL4 en réponse au MSU. De plus, nous avons trouvé que les facteurs de transcription NF-
kB, CREB et C/EBP sont activés tardivement par les cristaux de MSU, et qu’au moins le 
premier est impliqué dans la production de chimiokines. Enfin, nous démontrons que les 
MAPKs et Akt qui sont activés par le MSU chez les neutrophiles, sont sous le contrôle de 
TAK1 et de Syk, et qu’ils participent à la production de cytokines et à la formation de 
NETs. 
 
 Conclusion. Les résultats actuels dévoilent des cibles thérapeutiques potentiellement 
importantes pour la goutte. 
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Abstract 
Objective. Gout is a prevalent and incapacitating disease triggered by the deposition of 
monosodium urate (MSU) crystals in joints, which are also massively infiltrated by 
neutrophils. Though some of the signaling events mobilized by MSU in neutrophils have 
been described, the picture remains fragmentary. Likewise, the impact of these signaling 
events on cellular responses is incompletely understood. In this study, we examined genomic 
and proteomic changes triggered by MSU in neutrophils, as well as the role of various 
signaling pathways in prominent functional responses. 
  
Methods. Human neutrophils were cultured with MSU and gene microarray analysis was 
performed; and proteins corresponding to the genes most induced were also monitored. 
Signaling pathways mobilized by MSU and their relationship with upstram kinases were 
investigated by immunoblot. Ttranscription factors activated by MSU were also likewise 
studied. The impact of signaling intermediates on cytokine production and neutrophil 
extracellular trap (NET) formation was quantified by ELISA and fluorescence microscopy, 
respectively.  
 
Results. We report for the first time that neutrophils can secrete CCL4 in response to MSU. 
Accordingly, we found that transcription factors NF-kB, CREB, and C/EBP are belatedly 
activated by MSU crystals, and at least the former is involved in chemokine generation. 
Moreover, we show that MAPKs and Akt are activated by MSU in neutrophils, that they are 
under the control of TAK1 and Syk, and that they participate in cytokine generation and 
NETosis.  
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Conclusion. The current findings unveil potentially important therapeutic targets for gouty 
arthritis.  
 
Introduction 
 
 Gout is a prevalent disease (about 1 in 50 people will develop it over a lifetime) that is 
very painful and incapacitating (recurring gout attacks can cause permanent joint damage). 
One clear distinction between gout and other arthritides is that its causative agent is known. 
Deposition of insoluble monosodium urate (MSU) crystals in the joint triggers an acute 
inflammatory reaction that is partially initiated and driven by neutrophils. Accordingly, the 
main mediators detected in the synovial fluid of gouty joints (i.e. IL-1b, IL-6, CXCL8, CCL3, 
TNFa), whether in humans(1) or in animal models(2), can all be secreted by neutrophils. 
More compellingly, neutrophil depletion suppresses the inflammatory response to MSU in 
canine joints (3, 4). Likewise, colchicine, an effective (but poorly tolerated) treatment for 
acute gout, potently inhibits numerous neutrophil functions (5). Together, these observations 
leave little doubt that neutrophils and their products represent important elements in the 
pathogenesis of gout.  
 
 Interactions between neutrophils and MSU crystals are known to elicit several responses. 
One of the first to be documented was the production of reactive oxygen species (ROS) and 
the concurrent release of anti-microbial peptides and proteolytic enzymes (6, 7). Neutrophils 
were also shown to synthesize and release the potent neutrophil chemoattractant, leukotriene 
B4, as well as other neutrophil chemotactic factors in response to MSU (8-11). Likewise, 
MSU-activated neutrophils can secrete cytokines and chemokines in response to MSU, 
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namely IL-1b, IL-1ra, and CXCL8 (12-14). Neutrophils stimulated with MSU crystals also 
display a significantly delayed apoptosis (15, 16), which presumably contributes to their 
increased recruitment and persistence during active gouty inflammation. Finally, the ability 
of MSU to elicit the generation of neutrophil extracellular traps (NETs) was recently reported 
(17, 18).  
 
 Because of the numerous actions of MSU crystals towards neutrophils, several studies 
have focused on the underlying mechanisms; despite this however, our knowledge of the 
signaling pathways being mobilized remains fragmentary. It has been shown, for instance, 
that MSU rapidly triggers the phosphorylation of several neutrophil proteins on tyrosine 
residues, and that accordingly, tyrosine kinases such as Syk and members of the Src family 
are rapidly activated by the crystals in these cells (19, 20). Other kinases, namely 
conventional PKCs, were reported to be activated by MSU in neutrophils, and there is 
evidence that these PKCs can associate with Syk, resulting in its phosphorylation and 
interaction with PI3Ks (21, 22). Finally, studies involving pharmacological inhibitors have 
indicated that Src family kinases, Syk, and PI3Ks act as key signaling molecules for MSU-
elicited degranulation, ROS production, generation of chemotactic activity, and NETosis in 
neutrophils (9, 17, 19, 22).  
 
 In view of the prevalence of gouty arthritis and of the neutrophil involvement in its 
pathogenesis, a better understanding of both MSU-elicited responses and of their molecular 
bases is clearly needed. In this regard, our previous work has provided several potential clues, 
insofar as we have shown the crucial involvement of TAK1, MAPKs, PI3K, and Syk in 
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cytokine generation, delayed apoptosis, and NETosis in response to several physiological 
neutrophil stimuli (23-27). Under the same stimulatory conditions, we have also established 
that several transcription factors ( e.g. NF-kB, C/EBP, CREB) drive cytokine production in 
neutrophils (23, 26, 28, 29). These observations raise the possibility, that some of the same 
kinases (in addition to Syk and PI3K) and transcription factors similarly control MSU-
elicited responses. In this study, we examined the genomic and proteomic changes triggered 
by MSU in neutrophils, as well as the role of various signaling pathways in these and other 
functional responses. We now report for the first time that neutrophils can secrete CCL4 in 
response to MSU. Accordingly, we found that transcription factors NF-kB, CREB, and 
C/EBP are belatedly activated by MSU crystals, and at least the former is involved in 
cytokine generation. Moreover, we show that MAPKs are activated by MSU in neutrophils, 
that they are under the control of TAK1 and/or Syk, and that they participate in cytokine 
generation and NETosis.  
 
Materials and Methods 
 Antibodies and reagents. Antibodies against P-Akt (#4060), P-ERK (#9101), P-p38 
(#9212), P-Src (#2101), P-Syk (#2711), P-C/EBPb (#3084), P-CREB (#9191), P-RelA 
(#3031), IkBz (#9244) and MAP3K8 (#4491) were all from NEB-Cell Signaling (Danvers, 
MA, USA); antibodies against IkB-a (sc-371) and b-actin (sc-1616) were from Santa Cruz 
Biotechnology (Santa Cruz, CA, USA). Ficoll-Paque Plus was from GE Biosciences (Baie 
d’Urfé, Qc, Canada); endotoxin-free (< 2 pg/ml) RPMI 1640 was from Wisent (St-Bruno, 
Qc, Canada). Monosodium urate crystals were from Cayman Chemical (Ann Arbor, MI, 
USA); recombinant human cytokines were from R&D Systems (Minneapolis, MN, USA); 
UltraPure LPS (from E. coli 0111:B4) was from InvivoGen (San Diego, CA, USA). 
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Actinomycin D, cycloheximide, culture-grade dimethyl sulfoxide (DMSO), N-formyl-
leucyl-methionyl-phenylalanine (fMLP), and phenylmethanesulphonyl fluoride (PMSF) 
were from Sigma-Aldrich (St. Louis, MO, USA). Diisopropyl fluorophosphate (DFP) was 
from Bioshop Inc. (Burlington, Ont., Canada). The protease inhibitors, aprotinin, 4-(2-
aminomethyl)benzenesulfonyl fluoride (AEBSF), leupeptin, and pepstatin A, were all from 
Roche (Laval, Qc, Canada). Kinase inhibitors and fluorescent probes were purchased 
through Cedarlane Labs (Missisauga, Canada). PlaNET Blue reagent was from Sunshine 
Antibodies (https://sunshineantibodies.com/planet-002.html). All other reagents were of 
the highest available grade, and all buffers and solutions were prepared using pyrogen-free 
clinical grade water. 
 
 Cell isolation and culture. Neutrophils were isolated from the peripheral blood of healthy 
donors, following a protocol that was approved by an institutional ethics committee (Comité 
d’éthique de la recherche du CIUSS de l’Estrie-CHUS). The entire procedure was carried 
out at room temperature and under endotoxin-free conditions, as described previously (30). 
Purified neutrophils were resuspended in RPMI 1640 supplemented with 5% autologous 
serum, at a final concentration of 5 x 106 cells/ml (unless otherwise stated). As determined 
by Wright staining and FACS analysis, the final neutrophil suspensions contained fewer than 
0.1% monocytes or lymphocytes; neutrophil viability exceeded 98% after up to 4 h in 
culture, as determined by trypan blue exclusion and by Annexin V/propidium iodide FACS 
analysis.  
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 Immunoblots. Samples were prepared, electrophoresed, transferred onto nitrocellulose, 
and processed for immunoblot analysis as previously described (26, 31).  
 Immunoprecipitations and in vitro kinase assays. The procedure used was exactly as 
described(26).  
 
 RNA extractions, real-time PCR analyses, and gene microarray analyses. Procedures 
and primers used are exactly as described (28). When samples were prepared for gene 
microarray analysis, total RNA from 5 x 107 neutrophils was isolated as described (28), 
purified using a Qiagen RNeasy MinElute cleanup kit, and processed for gene microarray 
analysis using the Affymetrix Human Gene 2.0 ST chip (Génome Québec, Montréal, Qc, 
Canada).  
 
 Gene microarray analyses. Total RNA from 5 x 107 neutrophils was isolated as 
described (28), purified using a Qiagen RNeasy MinElute cleanup kit, and processed for 
gene microarray analysis using the Affymetrix Human Gene 2.0 ST chip (Génome Québec, 
Montréal, Qc, Canada).  ELISA analyses. Neutrophils (3 x 106 cells/600 µl) were 
cultured in 24-well plates at 37°C under a 5% CO2 atmosphere, in the presence or absence 
of stimuli and/or inhibitors, for the indicated times. Culture supernatants, as well as the 
corresponding cell pellets, were carefully collected, snap-frozen in liquid nitrogen, and 
stored at -80°C. Samples were analyzed in ELISA using commercially available capture and 
detection antibody pairs (R&D Systems, BD Biosciences).  
 
 NETosis assays. The procedure used was exactly as described (27).  
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 Data analysis. All data are represented as the mean ± SEM. Statistical differences were 
analyzed by Student’s t test for paired data using Prism 7 software (GraphPad Software, San 
Diego, CA, USA).  
 
Results 
 
 Transcriptomic changes elicited by MSU in neutrophils, and its consequences on 
cognate proteins. We first revisited the issue of the genes induced by MSU crystals in 
neutrophils, a response that has not been systematically investigated to date. The cells were 
initially cultured for 1 h with MSU, in an effort to detect immediate-early genes, and total 
RNA was processed for gene microarray analysis. Disappointingly, no transcript was 
induced by more than 1.8 fold; likewise, no transcript was reduced by more than 2 fold (data 
not shown). Thus, transcriptomic changes exerted by MSU at early stimulation times are 
modest at best. We repeated these experiments using neutrophils stimulated with MSU for 
3 h, to determine whether gene expression changes are more pronounced at later times. As 
shown in Fig S1, most genes examined exhibited changes in expression that were less than 
3 fold.  
 
  125 
 
 A2 Figure S 1. Genomic changes elicited by MSU in human neutrophils.  
 
Cells were stimulated with 1 mg/ml MSU (or diluent control) for 3 h at 37°C; total RNA was then 
extracted and 3 µg per experimental condition was pooled among 3 independent experiments and 
processed for gene microarray analysis. The scattergraph depicts the expression of various transcripts, 
relative to unstimulated controls. Colored crosses represent transcripts that are modulated 3-fold or 
more, for which the corresponding protein is known.  
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 A2 Figure S 2. Genomic changes elicited by MSU in human neutrophils.  
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Cells were stimulated and samples processed as decribed in Fig S1, and for genes with known 
corresponding proteins whose expression was modulated 3-fold or more, the extent of modulation is 
depicted.  
 
 Despite this, several genes encoding inflammatory products were detected, whose 
expression was induced 3-fold or more (versus unstimulated cells). These included IL-
1a/b and CXCL8, as already reported (12-14), but also included transcripts that had not yet 
been observed to be induced in response to MSU, such as TNFa, CCL4, and Tpl2/MAP3K8 
(Fig S2). Other genes were similarly induced, whose products are however unknown (Fig 
S2). When we validated these results by qPCR, we confirmed that the TNFa, IL-
1b, CXCL8, CCL4, MAP3K8, and IkBz genes were indeed strongly induced by MSU in 
human neutrophils (Fig 1A).  
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A2 Figure 1. Expression of strongly induced genes, and the corresponding proteins, in MSU-
activated human neutrophils.  
 
(A) Cells were stimulated for 3 h with 1 mg/ml MSU, prior to RNA extraction, reverse transcription, 
and qPCR analysis. Values were normalized over RPL32 and are represented as fold increase relative 
to unstimulated cells. Mean ± s.e.m. from 3 independent experiments, each performed in duplicate. 
(B) Neutrophils were stimulated with 1 mg/ml MSU for the indicated times, prior to ELISA analysis 
of cell-associated chemokines and of chemokines in culture supernatants. Mean ± s.e.m. from 3 
independent experiments, each performed in duplicate. *, p < 0.05 and **, p < 0.01 for total 
chemokine vs the respective unstimulated controls. (C) Neutrophils were cultured in the absence 
(“ctrl”) or presence of 1 mg/ml MSU or 1 µg/ml LPS for the indicated times, prior to immunoblot 
analysis of cellular IkBz, MAP3K8, and b-actin (loading control). A representative experiment is 
shown, along with compiled data from at least 3 independent experiments. **, p < 0.001 vs 
unstimulated control.  
 
 We next investigated whether the corresponding proteins were also upregulated in 
MSU-treated neutrophils. Cells were cultured for increasing lengths of time with the 
crystals, prior to ELISA or immunoblot analysis of the proteins of interest. As shown in Fig 
1B, substantial amounts of CXCL8 and CCL4 were synthesized and secreted over time. 
Initially, most of the released CXCL8 came from preformed pools of the chemokine, 
whereas the later secretion of CXCL8 predominantly involved newly synthesized CXCL8 
(Fig 1B). This is in contrast with the secretion of CCL4, which largely reflects the 
accumulation of newly-made chemokine (Fig. 1B). By comparison, IL-1a/b  or TNFa 
production was either undetected or at the detection limit at 20 h (data not shown). Finally, 
cellular levels of MAP3K8 were not significantly affected in MSU- or LPS-activated cells 
(Fig 2C). Cellular expression of IkBz was also unchanged following MSU stimulation, 
though LPS did induce an accumulation of the protein, as expected (Fig 2C).  
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A2 Figure 2. Phosphorylation of signaling intermediates in MSU-stimulated neutrophils. 
  
Cells were stimulated with 1 mg/ml MSU for the indicated times, prior to immunoblot analysis of 
(A) cellular P-SrcY416 or P-SykY525/526; (B) P-AktS473, P-ERK, or P-p38 MAPK; and b-actin (as 
a loading control). A representative experiment is shown in both panels, along with compiled data 
from at least 3 independent experiments.  
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 Signaling cascades that are rapidly elicited by MSU. Although some signaling 
intermediates are known to be activated by MSU in neutrophils, the picture remains 
incomplete; likewise, their eventual role in neutrophil functional responses needs be 
elucidated. When we monitored the kinetics of various signaling pathways in MSU-treated 
neutrophils, we confirmed that the Src and Syk pathways are quickly activated in these 
cells, with phosphorylated kinases slowly returning to near-baseline levels by 90 min in the 
case of Src, but still elevated in the case of Syk (Fig 2A). We additionally found that MSU-
stimulated neutrophils display a rapid activation of the PI3K/Akt, p38 MAPK and ERK 
pathways (Fig 2B), with Akt showing sustained phosphorylation at 90 min, whereas p38 
MAPK and P-ERK activation appeared to be more transient. By contrast, no changes were 
observed in cellular IkB-a levels; similarly, no inducible phosphorylation of JNK, or of the 
transcriptional activators, RelA, C/EBPb and CREB, were observed under these conditions 
(data not shown). Thus, a discrete set of signaling pathways seem to be mobilized by MSU 
in neutrophils.  
 
 We have shown previously that the p38 MAPK, MEK/ERK, and PI3K/Akt cascades are 
controlled by the MAP3K, TAK1, in human neutrophils exposed to various physiological 
stimuli (24, 25, 32, 33). We therefore verified whether this is also the case in response to 
MSU crystals. As shown in Fig 3A, TAK1 inhibition mostly blocked the phosphorylation 
of all three kinases in response to MSU. We also reported that Syk and Src family tyrosine 
kinases can affect at least some neutrophil responses(26, 27) and our observation that MSU 
rapidly activates these kinases (Fig 2A) prompted us to examine whether they may also act 
upstream of MAPKs and Akt. As shown in Fig 3B, Syk inhibition profoundly hindered the 
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phosphorylation of all three kinases, while Src inhibition only significantly affected that of 
p38 MAPK. Thus, both TAK1 and Syk act upstream of MAPKs and Akt, while Src family 
kinases contribute only to p38 MAPK activation.  
 
A2 Figure 3. Effect of Src, Syk and TAK1 inhibition on Akt and MAP kinase activation in MSU-
stimulated human neutrophils.  
 
Cells were pretreated for 10 min in the absence or presence of (A) a TAK1 inhibitor (1 μM 5(Z)-7-
oxozeaenol) or (B) a Src inhibitor (10 µM SrcI1) or a Syk inhibitor (10 μM piceatannol), prior to 
stimulation for 15 min with 1 mg/ml MSU or diluent control (“unstim”). Whole-cell samples were 
processed for immunoblot analysis of P-AktS473, P-ERK, P-p38 MAPK, or b-actin (as a loading 
control). Representative experiments are shown, along with compiled data from at least 3 independent 
experiments. §, p<0.003 vs unstimulated controls; *, p < 0.05 and **, p < 0.01 vs MSU alone.  
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 Impact of signaling cascades on MSU-elicited cytokine production, and occurrence of 
late signaling events. We next determined which signaling pathways contribute to MSU-
induced cytokine production. To this end, neutrophils were pretreated with various 
inhibitors, prior to stimulation for 20 h. As shown in Fig 4, inhibition of TAK1, p38 MAPK, 
PI3K, and Syk impaired the generation of both CXCL8 and CCL4. In contrast, inhibition 
of the MEK/ERK or STK pathways had no significant effect on chemokine release (Fig 4). 
Blocking protein synthesis with cycloheximide, or transcription with actinomycin D, 
confirmed that MSU-elicited chemokine secretion largely depends on their de novo 
synthesis and gene expression, respectively (Fig 4). In addition, we found that pretreating 
neutrophils with the NF-kB blockers, MG-132 or 15-deoxy-PGJ2, profoundly ihibited 
chemokine production (Fig 4).  
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A2 Figure 4. Effect of various inhibitors on chemokine secretion in MSU-stimulated human 
neutrophils.  
 
Cells were pretreated for 10 min in the absence or presence of inhibitors of TAK1 (1 μM 5(Z)-7-
oxozeaenol), p38 MAPK (1 µM SB202190), MEK (10 µM U0126), PI3K (10 µM LY294002), Syk 
(10 μM piceatannol), Src family kinases (10 µM SrcI1), transcription (5 µg/ml actinomycin D, “AD”), 
protein synthesis (20 µg/ml cycloheximide, “CX”), or NF-κB (1 µM MG-262 or 30 µM 15-deoxy-
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PGJ2). Neutrophils were then cultured in the absence (“ctrl”) or presence of 1 mg/ml MSU for 20 h , 
prior to ELISA analysis of culture supernatants. Mean ± s.e.m. from 11 independent experiments, 
each performed in duplicate. Data is expressed as a ratio to MSU-stimulated cells, which amounted 
to 815 ± 60 pg/106 cells for CXCL8, and 375 ± 63 pg/106 cells for CCL4. §, p<0.0001 vs unstimulated 
controls; *, p < 0.05 and **, p < 0.01 vs MSU alone.  
 
 This was quite unexpected, as both inhibitors target IkB-a degradation, which we had 
found not to occur following MSU exposure, at least over the first 60 min of stimulation 
(data not shown). This notwithstanding, we also observed that few mRNA transcripts 
accumulate in reponse to MSU in that time frame, requiring 3 h instead to be detected in 
abundance (Figs S1, S2). This prompted us to investigate whether transcription factors (and 
associated proteins) might be activated at later time points. As shown in Fig 5A, IkB-a 
degradation was evident by 2 h in MSU-treated neutrophils, and IkB-a levels had still not 
been replenished at 4 h of stimulation. An inducible phosphorylation of transcription factors 
RelA, C/EBPb, and CREB was also found to follow a similar time course (Fig 5). Thus, a 
belated induction of transcriptional events takes place in MSU-activated neutrophils, in 
keeping with the delay in gene expression.  
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A2 Figure 5. Belated phosphorylation of transcription factors and associated proteins in MSU-
stimulated human neutrophils.  
 
Cells were stimulated for the indicated times in the absence (“ctrl”) or presence of 1 mg/ml MSU, 
prior to immunoblot analysis of cellular P-CREBS133, P-RelAS536, P-C/EBPbT235, IkB-a, and b-
actin (as a loading control). A representative experiment is shown, along with compiled data from at 
least 3 independent experiments. *, p < 0.05 and **, p < 0.01 vs respective unstimulated controls.  
 
 Signaling cascades involved in MSU-elicited NETosis. Besides cytokine production, 
another major functional response of neutrophils is their ability to form NETs (34). This 
phenomenon was reported to occur in response to MSU crystals (17, 18, 35, 36). To 
determine which MSU-elicited signaling pathways influence NETosis, neutrophils were 
pretreated with various inhibitors, prior to being cultured with MSU. As shown in Fig 6, 
inhibition of the TAK1, p38 MAPK, MEK, PI3K, and Syk pathways partially or totally 
prevented NET generation, whereas blocking Src family kinases had little or no effect on 
this response (Fig 6). Because NETosis was initially thought to depend on endogenous 
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ROS, and because MSU has long been known to promote the formation such molecules in 
neutrophils (37), we investigated whether blocking the NADPH oxidase would interfere 
with NET generation. As shown in Fig 6, MSU-elicited NETosis was found to be ROS-
independent, but it was largely prevented by inhibition of PAD4. Collectively, the above 
findings shed more light on the pathways and processes controlling NETosis in MSU-
stimulated neutrophils.  
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A2 Figure 6. Signaling pathways controlling NET formation induced by MSU.  
 
Neutrophils cultured on poly-L-lysine-coated coverslips were pre-treated (15 min, 37°C) with the 
following inhibitors or their diluent (culture-grade DMSO): 1 μM (5Z)-7-oxozeaenol (TAK1 
inhibitor); 1 μM SB202190 (p38 MAPK inhibitor); 10 μM U0126 (MEK inhibitor); 10 μM LY294002 
(PI3K inhibitor); 10 μM piceatannol (Syk inhibitor); 10 μM SrcI1 (Src family kinase inhibitor); 10 
µM DPI (a NADPH oxidase inhibitor); 10 µM chloraminidine (“Cl-A”, a general PAD inhibitor); or 
10 µM GSK484 (a PAD4 inhibitor). The cells were then further incubated for 4 h in the absence 
(“ctrl”) or presence of 1 mg/ml MSU. NETosis was assessed using PlaNET Blue as described in 
Methods. (A) Representative fields for each experimental condition are shown at 10X magnification. 
(B) Quantitative representation of these experiments, expressed as NETosis index. Mean ± s.e.m. 
from at least 4 independent experiments. §, p < 0.002 vs unstimulated control; *p < 0.05 and **p < 
0.01 vs. stimulus alone.  
 
 
Discussion 
 
 Various aspects of the interaction between MSU crystals and inflammatory cells 
involved in gout pathogenesis have been studied in the last decades. Despite this, many gaps 
in our knowledge remain. In this study, we revisited the genomic and proteomic changes 
triggered by MSU in neutrophils, and the signaling pathways controlling MSU-elicited 
functional responses. This allowed us to uncover a new chemokine secreted in response to 
MSU; three trancription factors belatedly activated by the crystals; and signaling 
intermediates acting upstream of cytokine generation and NET formation.  
 
 Though some neutrophil genes were shown to be induced by MSU over the years, a 
systematic investigation of transcriptomic changes was (somewhat surprisingly) never 
undertaken. Herein, we found that unlike most neutrophil stimuli, which induce early gene 
expression within 30 min, MSU does not even modulate mRNA steady-state levels 2-fold 
over a 60-min stimulation. After 3 h however, the expression of numerous transcripts was 
up- or down-regulated. Among those whose accumulation was induced 3-fold or more were 
previously reported transcripts such as IL-1a/b and CXCL8 (12-14), but also others that 
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had never been observed before. Among the latter, some encode inflammatory mediators ( 
e.g. CCL4, TNFa) or signaling machinery components ( e.g. MAP3K8, IkBz). Yet this still 
represents relatively few genes overall, especially when compared to classical neutrophil 
stimuli (such as LPS or TNFa) which, unlike MSU, strongly promote the expression of 
dozens of genes. Compounding the relative paucity of transcripts induced by MSU, is our 
observation that even fewer of the corresponding proteins actually accumulate. A striking 
example is that of TNFa, whose gene was induced some 70-fold, yet without any detectable 
accumulation of intracellular cytokine. This raises the intriguing possibility, that MSU fails 
to fully mobilize the translational machinery of neutrophils; studies are in progress to 
elucidate this conundrum. Whatever the case may be, our data represents the first report that 
CCL4 can be secreted by MSU-treated neutrophils. This finding has potentially important 
biological implications, insofar as MSU-activated neutrophils can not only contribute to 
their own recruitment into inflamed joints by generating CXCL8, but can also attract 
monocytes through their ability to secrete CCL4.  
 
 The signaling events triggered by MSU crystals in neutrophils have been only partially 
elucidated to date. It has been shown, for instance, that Src family kinases, Syk, PKCs, and 
PI3Ks are activated upon MSU challenge (19-22). We confirmed herein that Syk and Src 
are rapidly phosphorylated in response to MSU; whereas this response was sustained for of 
P-Syk (for at least 90 min), it was transient in the case of P-Src. Importantly, we found that 
p38 MAPK, ERK, and Akt were also rapidly phosphorylated in MSU-stimulated cells, and 
that the phospho-proteins were still detected after 90 min. In the case of p38 MAPK, our 
data confirm and extend recent observations by Rousseau et al. (38), who however only 
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detected weak p38 phosphorylation over a 5-min interval. By comparison, our data 
represents the first demonstration that ERK and AktSer473 can also be activated by MSU. 
Thus, the kinases activated by MSU are essentially the same as those mobilized by several 
physiological neutrophil agonists (23, 25, 26, 33, 39, 40). Morevoer, we found that the 
MSU-elicited phosphorylation of p38 MAPK, ERK, and Akt occurs downstream of TAK1 
and Syk, much like it does in response to several classical neutrophil stimuli (24, 33). Thus, 
the undetectable synthesis of several proteins despite strongly induced corresponding genes 
in MSU-treated cells, cannot be attributed to a general defect in signaling. However, we 
observed that the extent to which Syk, Src, MAPKs and Akt are phosphorylated is lower in 
response to MSU crystals, compared to classical stimuli such as LPS and TNFa. This 
notwithstanding, we showed that the Syk, TAK1, p38 MAPK, MEK/ERK, and PI3K/Akt 
pathways all contribute to chemokine generation and/or NETosis. Therefore, even a 
relatively weaker activation of these kinases by MSU is sufficient to entail functional 
consequences. On final note, it has been reported that the MSU-elicited synthesis and 
secretion of IL-8 in monocytes is dependent on the activity of Src kinases and of ERK1/2 
(41, 42), whereas we found herein that Src inhibition had little impact on CXCL8 generation 
in neutrophils. This indicates that among the various signaling pathways mobilized by 
MSU, different combinations contribute to a given response depending on the cell type.  
 
 Another novel finding reported herein is that the NF-kB, C/EBP, and CREB 
transcription factors are activated in response to MSU crystals in neutrophils. This agrees 
well with the fact that both CXCL8 and CCL4, whose transcripts and proteins are also 
induced by MSU, feature cognate binding sites for these transcription factors in their 
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proximal gene promoters, that are required for induction in human granulocytes (28, 29, 
43). A singular characteristic of transcription factor activation by MSU, is that it was never 
detected at early time points (i.e within 15 min), as is the case with other neutrophil stimuli, 
such as LPS, TNFa, or IL-18 (28, 29, 31, 39). Instead, phosphorylation of RelA, C/EBPb, 
and CREB1, as well as IkBa degradation, were only observed at 120 min and beyond. This 
belated activation mirrors the delayed induction of chemokine genes occurring in response 
to MSU, which was detected at 3 h. This is again in contrast with stimuli such as LPS, 
TNFa, or IL-18, which typically promote chemokine gene induction within 30 min or less. 
Thus, whereas a similar set of transcription factors can be activated by cytokines, TLR 
ligands, and MSU in neutrophils, the latter stimulus does so belatedly, resulting in the late 
induction of target genes. This is not due to a slow ingestion of the crystals, as the process 
takes place within 15 min (44). However, the mechanism remains elusive, which is a 
limitation of the current study.  
 
 Finally, MSU crystals proved to be powerful inducers of NET formation. Whereas other 
investigators had already reported that this response requires the PI3K, RIPK, and MLKL 
pathways (17, 45), we showed herein that it also involves the TAK1, p38 MAPK, 
MEK/ERK, and Syk pathways. With regard to the cellular processes governing NET 
formation, we observed that MSU-elicited NETosis is independent of ROS generation, 
confirming recent reports (36, 46, 47). Conversely, our finding that MSU-induced NET 
formation depends on PAD4, is to our knowledge a first. Thus, MSU appears to function 
like most other physiological neutrophil agonists ( e.g. TNFa, GM-CSF, fMLP, PAF, C5a, 
CXCL8) with respect to the involvement of endogenous ROS and PAD4 (27). Overall, our 
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findings substantially extend our understanding of the mechanisms underlying NET 
generation by MSU crystals.  
 
 In summary, MSU crystals elicit a robust induction of a limited set of genes in 
neutrophils, including some that had not been reported to date ( e.g. CCL4, TNFa, MAP3K8, 
IkBz). However, only some of the corresponding proteins were similarly induced ( e.g. 
CXCL8, CCL4). This involves several signaling pathways ( e.g. Syk, TAK1, p38 MAPK, 
MEK/ERK, PI3K/Akt) and downstream effectors (transcription factors NF-kB, and possibly 
C/EBP and CREB as well). The same signaling pathways also participate in MSU-driven 
NET formation. Thus, our findings unveil several potentially important therapeutic targets 
for acute episodes of gouty arthritis, which feature a massive neutrophil influx. The fact that 
inhibitors for several of these molecular targets are already under active development (48-
50) makes the translation to the patient more than a remote possibility.  
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DISCUSSION 
 
Neutrophils have been described as the "double-edged swords” of innate immunity 
in several reviews (Kaplan and Radic, 2012; Martínez-García et al., 2015; Parkos, 2016; 
Smith, 1994) as these cells aggressively protect or damage the host, depending on the physio-
pathological conditions (Jones et al., 2016; Mayadas et al., 2014; Smith, 1994; Thieblemont 
et al., 2016). It is important to underline that neutrophils are much more than the suicidal 
bacterial killers often depicted in immunology textbooks. The last decades of research 
provided new insights into the complex interactions in which neutrophils engage with 
elements of the surrounding tissue. Upon activation, they can secrete a variety of cytokines, 
chemokines, and lipid mediators attracting more neutrophils, as well as monocytes, 
lymphocytes, and DCs to the infected site (Prame Kumar et al., 2018; Schuster et al., 2013). 
Neutrophil products also support the maturation of monocytes, macrophages, NK cells and 
immature DCs. Additionally, neutrophils carrying phagocytized bacteria can function as 
antigen-presenting cells to DCs as they express MHC II (Vono et al., 2017). This in turn 
leads to a T cell-driven response and activation of adaptive immunity, making neutrophils 
major players in a wide range of immune responses. In addition, recent data show that 
neutrophils are implicated in a broad variety of pathologies (type-1 and type-2 diabetes, 
psoriasis, Alzheimer, rheumatoid arthritis, gout, SLE, cancer, etc.). Likewise, neutrophil 
extracellular trap formation is an area of intense investigation in the context of neutrophil-
related diseases.  
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Despite the increasingly acknowledged significance of neutrophil functional 
responses, some aspects thereof are still poorly understood. In this respect, our recent article 
stressed the urgent need to standardize the methods used for NET assessment and 
quantification (Article 1, Tatsiy and McDonald, 2018). In particular, current methods suffer 
from significant drawbacks. The biggest issue is the inclusion of an important (sometimes 
even predominant) positive signal. In the case of widely used NET quantification based on 
labeling NET-associated proteins ( e.g. MPO or NE), we showed that NET digestion with 
Dnase I doesn’t eliminate much of the signal. An important fluorescence signal remains near 
the cell surface, which may reflect the propensity of several neutrophil granule proteins 
associate with cell membranes upon their release from the cells (Owen et al., 1995; 
Pryzwansky et al., 1979). A significant false positive signal was also observed following 
Dnase I treatment for another popular spectrofluorometric method in which NETs are labeled 
using a DNA dye that is described as cell-impermeable by its manufacturer ( e.g. Sytox 
Green). We also observed that neutrophil incubation with various Sytox Green 
concentrations commonly used for NET quantification (Gray et al., 2013; Gupta et al., 2014; 
Khan et al., 2017; White et al., 2016) resulted in rapid dye leaking into living cells. An 
important part of this thesis was spent on developing a reliable, specific, straightforward, 
standardized quantification method for NETs. Our approach is based on PlaNET reagents, 
which were developed as tools for NET research in the course of our investigations. These 
reagents now provide a viable solution to the methodological issues that have plagued NET 
research up to now, and have allowed us to study the impact of various signaling pathways 
on NET formation, which are summarized below. Despite its obvious advantages, the 
PlaNET-based method also has its limitations. Long-term neutrophil incubations (4h and 
more) results in some polymer uptake by neutrophils via unknow mechanisms. Although it 
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can be prevented by including phenylmethylsulfonyl fluoride (PMSF) in the culture medium, 
the continued presence of the serine protease inhibitor might affect other neutrophil responses 
in unpredictable ways. As a result, PlaNET-based quantification method cannot be used for 
kinetic studies, which require long-term neutrophil co-incubations.  
 
Standardized PlaNET-based quantification allowed us to compare relative NET 
induction by various physiological stimuli. Thus, we showed that fMLP, PMA, TNF and 
GM-CSF are potent NET inducers while IL-8, C5a and PAF also induce NETs but to a lower 
extent. We also elucidated the signaling pathways that are involved, and found that inhibition 
of TAK1, p38 MAPK, or MEK pathways hindered NETosis in response to all physiological 
stimuli tested. We also demonstrated that these kinases seem to control early events (within 
the first 15 min) that influence the length and degree of branching of extruded chromatin 
filaments, as opposed to chromatin extrusion itself. By comparison, inhibiting of Syk or PI3K 
kinases nearly abolished NETosis by acting upon chromatin extrusion or upstream processes: 
this involved late signaling events (occurring at about 120 min of stimulation). This is a major 
new observation. However, the nature of the late processes affecting NETosis remains 
elusive. We could exclude newly made cytokines and chemokines as potential candidates, 
since neither cycloheximide (protein synthesis inhibitor) (Schneider-Poetsch et al., 2010) nor 
actinomycin D (transcription inhibitor) (Bensaude, 2011) were found to affect NETosis in 
response to any of the stimuli used. Finally, inhibiting Src tyrosine kinase, PKC kinase or 
JNK failed to prevent NETosis in response to physiological stimuli. Thus, for physiological 
stimuli such as TNFa, fMLP, or GM-CSF, signaling data that was obtained using PlaNET 
reagent are consistent with our previous findings, which showed that they can all signal 
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through the TAK1-MEK or TAK1-p38 axes in neutrophils (Ear et al., 2010; Sylvain-Prévost 
et al., 2015).  
 
Due to the mounting evidence of NET involvement in various pathologies, our 
elucidation of the signaling pathways controlling NET formation has particular significance. 
A recent review by Boeltz et al., which summarized current areas of consensus and 
controversy about NETs, attracted attention to the poor understanding of NET formation 
signaling in response to physiological stimuli (Boeltz et al., 2019). This led these authors to 
conclude that unifying signaling mechanisms are not applicable to NETosis. However, we 
found otherwise. Using a systematic approach, we showed that there are at least some 
common pathways and mechanisms. In particular, our signaling data adds to the mounting 
evidence that PI3K/Akt and Syk pathways are crucial for NET formation regardless of the 
stiumuls used. Moreover, we showed that for several classes of physiological agonists, the 
TAK1, p38 MAPK and MEK/ERK pathways play an important role.  
 
Figure 8. Common pathways of NET formation in respons to physiological agonists. 
In neutrophils activated with various physiological stimuli, inhibition of TAK1, p38 MAPK, or MEK 
pathways hindered NETosis and effected length and degree of branching of extruded chromatin. 
Inhibition of Syk or PI3K kinases nearly abolished NETosis. However, inhibition of Src, PKC and 
JNK kinases failed to prevent NETosis in response to physiological stimuli. 
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Another area which we explored is the widely accepted notion that NETosis depends 
on endogenous ROS (Brinkmann et al., 2004a; Fuchs et al., 2007). This derives from the fact 
that most of the studies initially performed used PMA as a stimulus, which is a strong 
NADPH oxidase activator (Karlsson et al., 2000). Nevertheless, it was later shown that NETs 
can be formed in response to stimuli (GM-CSF, TNF, calcium ionophore, etc.) that are 
ineffective ROS inducers (Pang et al., 2013b; Parker et al., 2012b). Using PlaNET reagents, 
we confirmed that PMA-induced NETosis is indeed ROS-dependent. However, inhibition of 
NADPH oxidase didn’t affect NET formation activated by various physiological stimuli 
(fMLP, GM-CSF, TNFa, MSU). These data are in agreement with resent observations, that 
NETosis can take place in ROS-independent manner (Arai et al., 2014; Haase et al., 2016; 
Hosseinzadeh et al., 2016; Kraaij et al., 2016; Pieterse et al., 2016). Thus, data obtained 
during the work on this thesis establishe that ROS are not essential for the NET formation in 
response to physiological stimuli, even though they can contribute to the process under some 
circumstances. Conversely, we showed that PAD4 activation is much more central 
mechanism for NETosis. Prior to our work, investigators had used Cl-A, which inhibits 
various PAD isoforms (Luo et al., 2006). It had been assumed that PAD4 was the isoform 
responsible, based on mouse studies, but no evidence had ever been generated in human 
neutrophils (Kolaczkowska and Kubes, 2013; Li et al., 2010; Martinod et al., 2013), which 
happen to express two PAD isoforms (PAD2 and PAD4) (Spengler et al., 2015). During the 
work on this thesis we used the newly available, selective PAD4 inhibitor GSK 484 (Amans 
et al., A1) to resolve the issue. We found that in human neutrophils activated by various 
stimuli, both GSK 484 and Cl-amidine significantly prevent NET formation to the same 
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extent. This demonstrated for the first time that PAD4 is the relevant PAD isoform involved 
in NETosis by human neutrophils.  
 
As a result of this part of my work, we showed that there are common signaling 
components controlling NET formation shared across several classes of physiological NET 
inducers, and these pathways affect either early or late events. The nature of these early and 
late events has yet to be investigated. Thus, chromatin extrusion during NET formation 
requires 4 h and because several neutrophil products that act as NET inducers can be secreted 
during this time frame in stimulated cells (e.g. inflammatory cytokines and chemokines) 
(Fortin et al., 2009, 2011, Naegelen et al., 2015), we analyzed whether the inhibition of gene 
transcription or protein synthesis might interfere with NET formation. Nevertheless, neither 
process was found to be involved ( Tatsiy and McDonald, 2018). While these results exclude 
a contribution of de novo-synthesized proteins to NET formation, the phenomenon could still 
involve pre-stored products or non-protein mediators. Future studies are needed to investigate 
this hypothesis. 
 
Another part of my thesis was devoted to revisiting how MSU crystals interact with 
neutrophils (Article 2). Deposition of insoluble MSU in joint tissues causes gout: an acute 
inflammatory reaction, that is commonly associated with massive neutrophil infiltration 
(Martin and Harper, 2010).  
 
We initiated our investigation by analyzing the genomic changes triggered by MSU 
in neutrophils. Even though gout is a prevalent disease affecting millions of people, 
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systematic transcriptomic analyses was surprisingly never undertaken. The DNA microarray 
assays that we performed demonstrated that unlike most neutrophil stimuli, which induce 
early gene expression within 30 min, MSU doesn’t elicit significant changes in mRNA 
steady-state levels over a 60-min stimulation. However, after 3h of stimulation with MSU, 
we observed up- and down-regulation of numerous transcripts. Three-fold accumulation and 
higher demonstrated previously reported transcripts such as IL-1a/b and CXCL8 (Hachicha 
et al., 1995; Roberge et al., 1991, 1994). In addition, we observed the increased transcription 
of unreported inflammatory mediators ( e.g. CCL4, TNFa) and signaling machinery 
components ( e.g. MAP3K8, IkBx). Overall however, gene induction by MSU was relatively 
low, compared to classical neutrophil stimuli such as LPS or TNFa. In addition, we observed 
that low induction of transcripts in response to MSU was accompanied by even lower 
accumulations of the corresponding proteins. For TNFa, whose gene was induced by almost 
70-fold, no protein accumulation was detectable either extra- or intra-cellularly. This might 
indicate that MSU does not fully mobilize the translation machinery of neutrophils. Even 
though the exact mechanisms of gene induction and translation induced by MSU remain 
elusive, our data represent the first report that MSU-activated neutrophils secrete CCL4. This 
has potentially important biological relevance, as CCL4 is known to be a potent monocyte 
chemoattractant (Maurer and von Stebut, 2004). Thus, MSU-activated neutrophils not only 
contribute to their own recruitment into inflamed joints by generating high levels of CXCL8, 
but can also attract monocytes through their ability to secrete CCL4.  
 
Recent studies of the signaling pathways that drive neutrophil activation by MSU 
crystals have led to the suggestion that Src family tyrosine kinases, Syk, PKC, and PI3Ks are 
  158 
key signaling events (Popa-Nita et al., 2007, 2008, 2009). During the work on this thesis, we 
confirmed that Syk and Src are rapidly activated upon MSU stimulation; P-Syk remains 
sustained for at least 90 min, while the P-Src signal was transient. In addition, we 
demonstrated that p38 MAPK, ERK and Akt are also rapidly activated in response to MSU 
and that their activation remains after 90 min of neutrophil stimulation. Our data represent 
the first-time demonstration that ERK and AktSer473 can be activated by MSU. Although weak 
phosphorylation of p38 MAPK kinase was detected previously over a 5-min interval by 
Rousseau et al (2017), we demonstrated herein that activation of this kinase is much more 
sustained, with a peak at 30 min. In addition, we investigated upstream signaling events. 
Thus, we found that inhibition of TAK1 and Syk kinases strongly diminishes 
phosphorylation of p38 MAPK, ERK and Akt, much like it does in response to several 
classical neutrophil stimuli (Ear et al., 2010, 2017; Fortin et al., 2009, 2013; Sylvain-Prévost 
et al., 2015). In summary, the signaling cascades elicited by MSU are similar to those that 
activated in response to LPS and TNF, however the extent to which Syk, Src, P38 MAPK, 
ERK and Akt are phosphorylated is lower in response to MSU crystals. Although this overall 
weak signaling induction cannot explain why some strongly induced genes do not translate 
into functional proteins, it is quite obvious that even lower activity of Syk, TAK1, p38 
MAPK, MEK/ERK and PI3K/Akt pathways is enough to bring about at least some functional 
responses (chemokine generation and NETosis). In addition, we showed that a specific Src 
inhibitor (SrcI1) (Bain et al., 2007) has no significant impact on CXCL8 and CCL4 
generation by MSU activated neutrophils, whereas in monocytes MSU-elicited synthesis and 
secretion of CXCL8 depend on Src tyrosine kinases activity (Liu et al., 2001). This might 
indicate that various signaling pathways mobilized by MSU contribute differently to a given 
response depending on the cell type. However, another explanation should be taken into 
  159 
consideration, as the study that demonstrated the involvement of Src tyrosine kinases in 
MSU-induced monocyte generation of CXCL8 used PP1 for Src tyrosine kinase inhibition. 
This inhibitor has been shown to nonspecifically interfere with p38 MAPK (Bain et al., 
2007), and the latter was shown to be involved in cytokine production by monocytes in 
response to MSU (Chung et al., 2016). Thus, the results obtained might be due to nonspecific 
inhibition.  
 
As we demonstrated in our research, the signal transduction cascades elicited by MSU 
ultimately lead to responses such as gene expression, but little is known of the transcriptional 
process involved. In monocytes, MSU was reported to activate the IKK/IkB/NF-kB cascade 
(Liu et al., 2001). During the work on this thesis, we showed for the first time that in human 
neutrophils NF-kB, C/EBP, and CREB transcription factors are activated in response to MSU 
crystals. This data agrees well with the fact that both CXCL8 and CCL4, whose transcripts 
and proteins are induced by MSU, feature binding sites for these transcription factors in their 
proximal gene promoters, that are required for induction in human granulocytes (Cloutier et 
al., 2009b; Ear and McDonald, 2008; Mayer et al., 2013). However, the activation kinetics 
of these TFs induced by MSU is different from the one that is typically observed in response 
to other neutrophil agonists. Thus LPS-, TNF-, or IL-18-induced TF activation is detected at 
early time points (i.e. within 15 min), while in response to MSU, phosphorylation of RelA, 
C/EBPb, and CREB1, as well as IkBa degradation, were only observed at 120 min and 
beyond. This delayed TF activation reflects the overall delayed gene induction that is also 
observed in response to MSU. However, the mechanism that control rapid TF activation in 
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response to some stimuli (i.e. LPS, TNF) and delayed in response to others (i.e. MSU) 
remains to be investigated. 
 
Finally, we demonstrated that MSU crystals are powerful NET inducers. It was shown 
previously that MSU-induced NETosis requires the PI3K, RIPK and MLKL pathways (Desai 
et al., 2017; Mitroulis et al., 2011). To study the phenomenon, we applied our standardized 
PlaNET-based quantification method. Results obtained revealed that TAK1, p38 MAPK, 
MEK/ERK and Syk pathways are important for MSU-induced NETosis. In addition, we 
demonstrated that MSU-activated neutrophils undergo ROS-independent NET formation, in 
keeping with recent reports (Chatfield et al., 2018; Linden et al., 2017; Van Avondt et al., 
2016). Conversely, our finding that a specific PAD4 inhibitor significantly decreases 
NETosis in response to MSU, is the first report to our knowledge. Thus, signaling pathways 
that control NET formation in response to MSU appear to be similar to those utilized by other 
physiological stimuli employed during the work on this thesis. This lends further credence to 
our conclusion, that physiological stimuli use several common pathways to induce NET 
formation.  
 
As a perspective for this part of my thesis, additional bioinformatic analysis of MSU-
induced gene expression profile might reveal more protein candidates potentially involved in 
the pathogenesis of gouty inflammation. Thus, a preliminary inquiry of genes expressed by 
MSU-activated neutrophils using the open-source platform: reactome.org, identified gene 
clusters that correlate with NOD1/2, IL4, and IL13 singling pathways. Unveiled pathways 
were shown to play a role in the pathogenesis of various inflammatory diseases (Negroni et 
al., 2018; Caruso et al., 2014; May and Fung, 2015; Oh et al., 2010). However, their 
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intracellular signaling intermediates and role in human neutrophil functional responses is 
poorly understood (Ekman and Cardell, 2010; Impellizzieri et al., 2019) Together, this 
evidence makes them prospective candidates for future MSU related research. 
 
Understanding the molecular mechanisms of disease correspond with treatment 
potency. Thus, drugs currently used for the treatment of gout attacks inhibit amplification of 
the inflammatory response to MSU crystals. For example, colchicine, a drug with clinical 
efficacy in acute gout, inhibits neutrophil recruitment and activation (Ahern et al., 1987; 
Nuki, 2008; Roberge et al., 1994). Non-steroid anti-inflammatory agents (NSAIDs) prevent 
release of PGE2 and other arachidonic acid metabolites from various cells in response to 
MSU crystals (Gordon et al., 1985; Pouliot et al., 1998). However, these treatments also lead 
to undesirable side-effects, and not all patients respond satisfactory (IQWiG, 2018). Through 
targeting of specific molecules and pathways involved in the initiation of neutrophil 
activation, as shown herein, novel treatments may be identified to prevent or treat acute gout 
attacks.  
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CONCLUSION 
 
In present thesis, we describe a reliable and specific approach for NET quantification. 
This new standardized method allowed us to determine the relative potency of various 
physiologic NET inducers. Using newly developed standardized NET quantification method 
we addressed several aspects of NET formation. Thus, we showed for the first time, which 
PAD isoform is involved in NET formation by human neutrophils. Data obtained using 
specific PAD4 inhibitor confirmed that this PAD isoform is involved in NET formation in 
response to physiological stimuli. In addition, we determined that NADPH oxidase activation 
is not essential for all NET-inducing stimuli. In particular we confirmed that NET induced 
by physiological stimuli is largely ROS-independent. We also determined signaling 
pathways that are involved in NET formation. In cells activated with various physiological 
stimuli, inhibition of TAK1, p38 MAPK, or MEK pathways hindered NETosis by acting on 
early events that influence the length and degree of branching of extruded chromatin 
filaments, as opposed to chromatin extrusion itself. By comparison inhibiting Syk or PI3K 
nearly abolished NETosis; this involved late signaling events (occurring at about 120 min of 
stimulation), i.e. chromatin extrusion and/or upstream processes. Finally, we showed that 
inhibition of Src, PKC and JNK kinases failed to prevent NETosis in response to 
physiological stimuli. Quantification data that was obtained using PlaNET reagent 
substantially extends current knowledge of the signaling pathways controlling NETosis, and 
reveals how they affect early or late stages of the phenomenon. In view of the involvement 
of NETs in various pathologies, our findings also identify molecular targets that could be 
exploited for therapeutic interventions.  
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Another part of my thesis was devoted to revisiting how MSU crystals interact with 
neutrophils. In summary, we demonstrated that MSU crystals elicit a robust induction of a 
limited set of genes in neutrophils, including some that had not been reported to date ( e.g. 
CCL4, TNFa, MAP3K8, IkBa). However, only several of the corresponding proteins were 
similarly induced ( e.g. CXCL8, CCL4). In addition, we investigated signaling pathways that 
affect cytokine production and NET formation by MSU activated neutrophils. Thus, our data 
revealed several signaling pathways ( e.g. Syk, TAK1, p38 MAPK, MEK/ERK, PI3K/Akt) 
and downstream effectors (transcription factors NF-kB, and possibly C/EBP and CREB as 
well) that are involved in cytokine production. In addition, we demonstrated that the same 
signaling pathways also participate in MSU-driven NET formation. Likewise we showed for 
the first time that PAD4 is involved in MSU induced NETosis. Thus, our findings unveil 
several potentially important therapeutic targets for acute episodes of gouty arthritis, which 
feature a massive neutrophil influx. The fact that inhibitors for several of these molecular 
targets are already under active development makes the translation (Kim and Giaccone, 2018; 
Li et al., 2018; Patnaik et al., 2016) to the patient more than a remote possibility.  
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